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Abstract 
Introduction 
The experience of a traumatic or extremely stressful event may be sufficient to 
challenge a strongly held set of assumptions about the world and the self.  In some 
people this may lead to the development of Post-Traumatic Stress Disorder (PTSD), 
or the increasingly recognised phenomenon of Positive Psychological Change (PPC) 
whereby a person’s reactions to the challenge are beneficial to one or more areas 
of their life. 
Little work has been undertaken investigating the development and longitudinal 
pattern of PPC in cancer patients, and none with people who have had Head and 
Neck Cancer (HNC).  The aims of the study were two fold; 1) to identify 
demographic, clinical and psychological factors associated with PPC which occur in 
the acute period, defined as 3-12 months after treatment, 2) to investigate, with 
the same factors, how PPC changed over time. 
Method 
The study adopted a realist paradigm using a non-interventionist approach, utilising 
data collected longitudinally.  A literature review supported a quantitative approach 
to understanding the pattern of change in this field.  To minimise response burden 
whilst maximising data collection and granularity, a cross-sequential methodology 
was used.  An annual postal survey was undertaken over a five-year period.  Each 
year all potential participants were sent the Silver Lining Questionnaire (SLQ; a 
measure of PPC), the University of Washington (UoW) HNC quality of life (QoL) 
measure, and the Medical Outcomes Short-Form 12 (SF-12).  Additional 
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biographical and clinical data was collected for each individual from hospital 
databases.  One hundred and eight-five people returned at least one completed, or 
partially completed set of measures. 
Linear mixed-effects modelling (LMM) was undertaken to investigate the 
relationships between the data that might describe or account for, the longitudinal 
nature of PPC.  
Results 
Analysis indicated that the histological stage of the tumour and the treatment 
regimen both have a relationship with the total score of the SLQ.  The participants 
with lower stage tumours and those that only had surgical intervention reported 
more PPC.  The multivariable model adjusting for psychosocial variables showed 
that the SLQ had a relationship with time since diagnosis, increasing initially after 
treatment and stabilising over time.  The longitudinal data collected from the SLQ 
did not show any association when modelled with gender or family status, unlike 
previous research with women who had been treated for breast cancer.  Greater 
levels of longitudinal PPC were reported by participants with high or low socio-
economic status than those of middle socio-economic status, as measured by the 
Indices of Multiple Deprivation.  Socio-economic status was not related to PPC in 
the first year following the completion of treatment. 
The longitudinal model of PPC with the SLQ as the dependent variable found a 
relationship with the categories of chewing, speech and taste from the UoW.  A 
greater level of PPC being present was associated with fewer problems with these 
three factors of HNC QoL.  No association was found with the SF-12 or any of its 
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sub-scales.  When the data collected between 3 and 12 months, was compared 
with data collected longitudinally, stage of tumour, treatment regimen, and socio-
economic status were all significantly associated with higher SLQ scores. 
Discussion 
The current research builds on the minimal prior PPC research undertaken with 
people who have had a diagnosis of HNC.  In particular it demonstrates a model of 
trajectories for the development of PPC over a longitudinal period of time.   
Historically there has been concern that the reported PPC is actually illusory or a 
coping strategy rather than a real change.  It is suggested that the pattern of PPC 
development should include this use of coping and be considered to have three 
distinct stages; the traumatic stressors, the coping and adaptive strategies in an 
acute phase, and the reforming of the assumptive world and stabilisation of new 
cognitions and behaviours.   
Key words 
Positive Psychological Change, Post Traumatic Growth, Longitudinal, Head and Neck 
Cancer 
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1. Introduction 
This thesis contributes to new knowledge by identifying trajectories of positive 
psychological change in a head and neck cancer population.  It adopts a cross-
sequential study design for longitudinal data collection.   
This Introduction will set out the domain of the research (1.1) and the philosophical 
basis (1.5) and then establish the Research Questions (1.6).  The Methodology 
section (2.0) will apply the research philosophy to the domain to describe the 
approach to the research.  It will identify the antecedent models (2.3) and their 
limitations, deriving the methodology from them and the researchers approach to 
data to provide evidence.  The Methods section (3.0) identifies the specific research 
design (3.1), tools for data collection (3.1.6 - 3.1.8, 3.2), recruitment criteria (3.3), 
data collection (3.4) and data analysis (3.6) used in this thesis.  Subsequent sections 
will then report the findings (4.0) and discuss the implications (5.0). 
1.1 Head and Neck Cancer 
In the UK in 2013, 7,591 people were diagnosed with oral cancer, making this the 
16th most common cancer diagnosis (Cancer Research UK, 2015).  In the UK, and 
most other countries, oral cancer is more common in men (3% of all new cancer 
cases) than women (1% of all new cancer cases; Cancer Research UK, 2015).  
However, the sex ratio in the UK has decreased rapidly from around 5:1 
(male/female) fifty years ago to less than 2:1 today (Cancer Research UK, 2015).  
The risk of developing oral cancer increases with age and in the UK the majority of 
cases (87%) occur in people aged 50 and over (Cancer Research UK, 2015).  The 
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incidence of Head and Neck Cancer (HNC) is increasing in younger populations and, 
with improvements in treatment regimens, people are living longer (Cancer 
Research UK 2015).  Aside from traditional risk factors of tobacco and alcohol 
exposure, the causes of the increased cancers in young adults remain unclear 
(Majchrzak et al., 2014).  Agents that might contribute to risk include infection with 
high-risk human papillomavirus subtypes as well as genetic factors or 
immunodeficiency status. 
Although oral cancer is a relatively uncommon disease it carries a high level of 
morbidity and mortality (Cancer Research UK, 2015).  The factors associated with 
this disease have traditionally been studied using a biomedical approach, providing 
insight into the impact of factors such as tumour site and stage (NICE, 2004).  
However, in the last three decades, the biopsychosocial impact of HNC and its 
association with health-related quality of life (HRQoL) outcomes have emerged as 
an important addition to the conventional measures (Rogers, Semple, Babb and 
Humpries, 2016; Semple et al., 2013, 2004).   
1.2 Biopsychosocial view of the world 
According to the biomedical model, disease is a deviation from a measurable 
biological norm.  The model focuses on disease, pain and defect, with the lack of 
these equating to health.  It is based on the assumption that a greater 
understanding of an illness is possible if it can be defined at a biochemical level 
(Maes and van Elderen, 1998). 
Health psychology challenges the biomedical model (Ogden, 2004).  It conceives 
illness as being most often caused by a combination of the biological (e.g. viruses or 
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genetic predisposition), psychological (e.g. beliefs and behaviours) and the social 
(e.g. social class).  These assumptions reflect the biopsychosocial model of health 
and illness proposed by Engel (Engel, 1980, 1977).  The biopsychosocial model 
adopts a holistic approach that a person needs to be considered as a whole.  The 
model maintains that at a micro-level such things as chemical imbalances are 
important but, at the macro-level, factors such as available social support are 
relevant and that these processes will interact to determine someone’s health.  
Halligan (2007, p358) suggests that crucial to this perspective is ‘the belief that 
illness is not just the result of discrete pathological processes but can be 
meaningfully explained in terms of psychological and sociocultural factors.  In 
particular, beliefs held by patients about their health and illnesses are central to the 
way they present, respond to treatment and evaluate their capacity for work.’  
The current study is grounded within the field of health psychology and takes a 
biopsychosocial perspective.  A driving force for this has been the researcher’s 
experiences and recognition that people may survive their cancer but that physical 
survival alone is not the only outcome of relevance to the individual. 
Historically, the surgical resection of tumours involving the oral cavity has been 
associated with significant destruction of normal anatomy, sub-optimal 
reconstruction and poor function (Rogers, 2001).  Despite modern microsurgical 
reconstructive techniques (Kanazawa et al., 2011), patients still experience 
difficulties with many issues such as pain, mastication (chewing), poor diet, weight 
loss and disfigurement (Giles et al., 2016; Rogers et al., 2015).  These treatment 
factors in combination with the lowering age of the HNC cohort mean that there is 
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a greater time for these people to incur such morbidities as trismus (tightening of 
the mastication muscles), xerostomia (dryness of the mouth), fibrosis (firmness of 
the soft tissues of the neck) and osteo and soft tissue necrosis (bone and soft tissue 
breakdown and death).  Reduced social function over this extended time may lead 
to poor body satisfaction and depression (Broomfield et al., 1997), but may also 
provide more time for people to develop positive psychological change (PPC).  
1.3 Positive psychological change 
There is evidence from the literature that some people report benefit from illness 
(e.g. Collins et al., 1990; Giovinco and McDougald, 1994; Laerum et al., 1988; 
LaFortune-Fredette, 1995; O’Connor et al., 1990; Taylor, 1983).  In some cases 
these benefits go some way to mitigating the negative consequences of illness, but 
there are also instances where people report an overall benefit from being ill.  
Positivity in adversity has also been cited in the context of other stressful life events 
such as combat and imprisonment, divorce, care giving and bereavement (Schaefer 
and Moos, 1992).  Stress related growth in adversity is reported to be ‘remarkably 
common’ (Schaefer and Moos 1992, p. 149). 
There is a growing body of literature supporting the suggestion that a stressful or 
traumatic event may be a catalyst for PPC (Tedeschi and Calhoun, 2004; Updegraff 
and Taylor, 2000).  There has been no single term used consistently in the 
literature.  In 1991 Yalom and Lieberman used the term ‘positive psychological 
changes’.  These positive changes, which have also been referred to as ‘perceived 
benefits’, ‘benefit finding’, ‘thriving’, ‘stress-related growth’, ‘adversarial growth’, 
‘post-traumatic growth’, or ‘existential growth’, may concern changes in the 
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perceptions of oneself, social relationships with family and friends and life priorities 
and appreciation of life.  The term ‘Post-traumatic growth’ is now the most widely 
used term due to its ability to describe the need for individuals to have experienced  
trauma before they experience positive change over time.  In this thesis the term 
positive psychological change (PPC) will be used.  The choice of PPC over post-
traumatic growth was made due to the nature of the trauma experienced by the 
participants in this research.  In presenting work on PPC to people who have 
received a diagnosis of HNC the researcher has found that the word ‘growth’ has 
significant negative meaning, as it is a word associated with a cancerous tumour.  In 
working with this group of people it became evident that the phrase positive 
psychological change was better received and facilitated communication with the 
researcher. 
Among breast cancer (BC) survivors, there is evidence indicating that a substantial 
number experience such positive changes, especially in the long term (Thornton, 
2002; Tomich et al., 2005).  Cancer survivors from tumours in a range of locations 
frequently report having altered priorities, more concern for others, a greater sense 
of purpose and a greater appreciation of themselves and their lives life (Dow et al., 
1999; Ferrell et al., 1998; LaFortune-Fredette, 1995; Pelusi, 1997; Schroevers et al., 
2004). 
1.4 Variables associated with PPC 
A number of variables may mediate the relationship between trauma and PPC.  
Within studies these variables can be categorised as demographic, clinical and 
psychological or psychosocial. 
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1.4.1 Demographic 
Using a cross-sectional design with mixed cancer sites, Park et al., (2008) found that 
women consistently reported higher levels of PPC than men.  However, this study 
was of a largely young female cohort and over a comparatively short period of time 
(1 year) which makes it difficult to extrapolate long term to HNC survivors or other 
cancer sites.  
In contrast to this, four studies found no relationship between gender and PPC in 
colorectal cancer (Salsman et al., 2009), hepatobiliary (having to do with liver, bile 
ducts and bile) cancer (Steel et al., 2008) or HNC (Harrington et al., 2008; Ho et al., 
2011).  A key limitation of the studies by Salsman et al. (2009) and Steel et al. 
(2008) were their short duration at only between 3 and 6 months, which is outside 
this study’s definition of long-term and longitudinal.  From current literature it 
remains unclear if gender is associated with PPC over time. 
To date no published studies have found an impact of age on PPC in HNC, though it 
has been found that younger participants with BC reported higher levels of PPC 
(Low et al., 2006; Manne et al., 2004).  The greater number of studies undertaken 
with BC patients, and the larger participant numbers in those studies (due to the 
greater occurrence of BC in the general population), has identified age as a factor in 
the trajectory of change in, and final level, of PPC in BC (Danhauer et al., 2013a, 
2015). 
A mixed picture has been found in relation to ethnicity and PPC.  Bellizzi et al. 
(2010) found that African-Americans treated for BC showed higher levels of PPC 
than Caucasians, whereas Kent et al. (2013) found Caucasians with BC had higher 
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PPC than African-Americans but not higher than Hispanics  (Bellizzi et al., 2010; 
Kent et al., 2013).  Studies of PPC across other traumas also found a mixed pattern.  
Milam (2004), for example, investigated AIDS/HIV and found that African-American 
and Hispanic participants reported higher levels of PPC than Caucasians 
respondents. 
A narrative systematic review by Koutrouli et al. (2012) found that most studies 
reported that people with BC and lower education levels experienced higher levels 
of PPC, whereas in one study of HNC higher educational level was associated with 
greater PPC (Llewellyn et al., 2013) and another found no association with 
education (Ho et al., 2011).  To fully address this factor within a HNC population 
with a similar cohort size to that of BC studies a multi-centre study or a longitudinal 
study would be required.  Given the number of people treated for HNC by Plymouth 
Hospital Trust (the trust where participants were recruited from for the current 
study) a longitudinal study would require ongoing recruitment covering more than 
a decade. 
Two studies following treatment for HNC reported a beneficial effect of marriage or 
stable cohabiting over single status in the reporting of PPC (Ho et al., 2011; 
Llewellyn et al., 2013).  In a study that examined the perspectives of BC patients 
and their partners, Manne et al. (2004) measured marital quality and, despite 
concluding that partners influenced the course of PTG over time, they were not 
responsible for its prediction.  This suggests that a stable social support system may 
have advantages over and above a high quality one-to-one interaction.   
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1.4.2 Clinical 
Five HNC studies to date, using quantitative PPC measures, have investigated 
clinical factors of PPC (Harrington et al., 2008; Ho et al., 2011; Holtmaat et al., 2016; 
Llewellyn et al., 2013; Leong et al., 2015).  Harrington, McGurk and Llewellyn (2008) 
did not find any relationship between PPC and treatment, time since treatment, 
stage of cancer or diagnosis of further illness in people treated for HNC.  This 
pattern was reinforced by the findings of Llewellyn et al. (2011) and Holtmaat et al. 
(2016).  In the same disease population Ho et al. (2011) found that people with 
more advanced cancer (stages III and IV) reported lower levels of PPC, but different 
treatment modalities did not significantly influence PPC.  However Leong et al. 
(2015) failed to find an association with stage of tumour with development of PPC.  
When compared to studies undertaken in BC (Danhauer et al., 2015, 2013a; n=653 
and 267), the five HNC studies have small sample sizes (between 50 and 103 
participants) and lack clarity over the potential impact of, and mediating factors of, 
co-morbidities on PPC trajectories.  Thus it is difficult to draw firm conclusions from 
the literature on clinical factors with respect to PPC in HNC. 
Low et al. (2006) examined the relationship between PPC over time and treatment-
related factors in BC patients and found that those who had received 
chemotherapy or who had had a mastectomy consistently reported higher levels of 
PPC, suggesting that the event or illness has to reach a level that a person perceives 
as traumatic before PPC can develop.  It could be that a discrete lumpectomy as 
treatment does not produce feeling of trauma in at least some individuals.  
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Danhauer et al. (2015) confirmed the findings of Low et al. (2006) and further found 
that BC staging was not significant in PPC trajectories.  
Other studies failed to detect any influence of treatment-related factors at any time 
point (Manne et al., 2004; Salsman et al., 2009).  The effect of treatment regimens 
is suspected to be important but with little supporting evidence and the role of 
tumour stage is less clear. 
1.4.3 Psychological 
Harrington, McGurk and Llewellyn (2008) recruited people with HNC and found that 
dispositional optimism and positive reframing could account for 23% of variance in 
PPC and additionally that higher levels of religious coping was correlated with 
greater PPC.  They did not find any relationship between PPC and anxiety, or 
depression.  Llewellyn et al. (2011) supported Harrington et al’s. (2008) findings 
related to dispositional optimism and positive reframing, and also found that an 
increased use of emotional support and a decrease in self-blame positively affect 
PPC.  This combination of factors was found to account for 39% of PPC variance.  Ho 
et al. (2011) also investigated people who had been diagnosed as having HNC and 
found that the Hope scale, the Life Orientation Test-Revised (LOT-R), and the Post 
Traumatic Growth Inventory (PTGI) were all positively correlated.  Results of 
regression analyses comparing hope and optimism in relation to PPC found that 
they contributed to a 25% variance of PPC as measure by the PTGI.  However, only 
hope was a significant individual indicator of PPC. 
Optimism and its relationship with PPC over time featured in a number of studies 
and disease groups.  Park et al. (1996) reported that in a mixed cancer cohort, 
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increases in optimism over time predicted increases in PPC.  In a study investigating 
the effectiveness of two different forms of therapy for people with multiple 
sclerosis, Hart et al. (2008) found that increases in optimism over time led to 
increases in PPC.   
In other disease groups, quality of life (QoL) is an important psychological factor but 
limited published evidence is available with HNC and PPC.  Llewellyn et al. (2011) 
found that an increase in emotional growth was negatively related to the mental 
component summary (MCS) score.  This indicates that higher levels of emotional 
growth are associated with poorer mental HRQoL, but the study by Llewellyn et al. 
did not use a HRQoL measure specifically designed to assess HNC HRQoL factors.  It 
does not therefore provide information which is specifically relevant to the ongoing 
issues within a cohort of people with HNC. 
Consideration of the construction of the research methodology will now be given 
starting with the philosophical basis for the research. 
1.5 Philosophical basis for the research 
There is a need to discuss philosophy since it has a fundamental impact on the 
research conducted, the results derived and the solution developed.  Creswell 
(1994) identifies five levels of assumptions regarding research in general.  These 
assumptions relate to the ontological, epistemological, axiological, rhetorical and 
methodological positions that researchers adopt when considering their research 
and the questions that they are seeking to answer.  The most fundamental of these 
assumptions is the ontological one since this deals with seeking to define what is 
meant by ‘reality’ and the position of the researcher within that reality.  For this 
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reason it will be considered in some depth, the other assumptions follow on from 
this initial position and the purpose of their inclusion here is to demonstrate an 
understanding of the issues raised and to ensure that a consistent philosophical 
thread runs through the research. 
1.5.1 Ontology 
Ontology relates to the branch of metaphysics concerned with the nature of being, 
that is the degree to which there is an absolute reality that is distinguishable from 
the observer’s perception (Creswell, 1994).  At one end of the ontological spectrum 
there is the existential opinion that there is no absolute reality, that what we know 
as reality is merely a construct formed by our brains to interpret the signals 
received from the senses.  There is no method for independently verifying those 
signals and so there is no method for independently verifying reality.  In a similar 
vein, the causal relationships observed are generated by the brain to interpret 
better the signals received and may not reflect any absolute laws.  At the extreme, 
there can be no independent verification for the existence of others, leading to the 
solipsist stance that everything, including the existence of others, is a construct of 
the brain.  This has profound implications for research since any knowledge 
acquired will be rooted in the constructs of the researcher.  There is thus no way of 
transferring those constructs to another person and is no way of generalising the 
knowledge gained (Creswell, 1994). 
The axiomatic realist approach (Meredith et al., 1989) at the other end of the 
continuum suggests that there is a rational, independent reality and that we all 
experience the same reality (Sears et al., 1987).  Since this reality is external to the 
25 
 
observer, objectivity can be maintained in observing, recording and deducing 
results from those observations.  Quantitative measures should be used to remove 
the scope for interpretative distortion of reality.  For the axiomatic realist, the 
fundamental limitation with research involving not only humans but living systems 
in general, is the lack of repeatability and lack of control over the variables (Kirk and 
Miller, 1991).  
For the purposes of this research, a realist perspective is adopted that recognises 
that a psychological reality can be objectively observed through careful methods 
design (Pawson and Tilley, 1997). 
1.5.2 Epistemology 
Following on from the ontology of the research, consideration of epistemology is 
required.  That is the grounds of knowledge and the relationship between the 
researcher and the research domain (Creswell, 1994).  To maintain philosophical 
integrity there should be a clear route from ontological to epistemological 
assumptions.  Adopting an existential ontology leads one towards a critical theory 
of knowledge generation along the lines of Jürgen Habermas (1991, 1986) where 
the researcher is an integral part of the research domain. 
Quantitative or axiomatic research requires an objective researcher that maintains 
a distance from the research domain so as to maintain the purity of the data 
gathered.  There should be a clear distinction between the researcher, the research 
domain and the grounds upon which the knowledge is formulated. 
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1.5.3 Axiology 
Axiology considers the role of values and the extent to which rules can be 
extrapolated from the knowledge gained about our reality (Creswell, 1994).  If the 
researcher is objectively detached from the research domain, as in quantitative 
research, it is assumed that data will be value-free and bias in raw data will be 
removed through careful experiment design.  
1.5.4 Rhetoric 
The use of language within research changes as one moves along the ontological 
scale.  Quantitative research tends to adopt a formal and impersonal language, 
developing definitions and equations upon which value-free data can be related 
(Creswell, 1994).  Qualitative research uses informal language and story-telling is 
frequently found to develop arguments which explain the value-laden data. 
1.5.5 Methodology 
Finally there is the methodology that is adopted for conducting research, which 
should reflect the assumptions concerning ontology, epistemology, axiology and 
rhetoric (Creswell, 1994).  The quantitative use of questionnaires is consistent with 
the researcher’s ontological position, i.e. that observations can be made that are 
external to the reality of the observer.  
1.5.6 Philosophical conclusion 
Professionals who work in healthcare often see all the difficulties and hurdles that 
can prevent research from succeeding or even being attempted.  Beyond risk 
factors identified by statistical analysis there is no substitute for clinical experience 
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(NHS Scotland, 2016).  Clinical experience suggests that by understanding and 
probing the mechanism of change one can understand the impact of an event or an 
intervention.  The systematic nature of healthcare and the positioning of the person 
within it, combined with real life clinical experience of work with the people who 
have had a diagnosis of HNC and research experiences, have led the researcher to 
embrace a realist perspective in undertaking research (see glossary).  This 
represents a philosophy that is aligned through the levels identified by Creswell 
(1994) and is consistent with the research domain being explored. 
1.6 Introduction summary 
Positive Psychological Change is becoming recognised as a phenomenon in research 
(1.3), but no single definitive model has been developed to explain it.  This study 
contributes to current knowledge by investigating PPC after treatment for HNC.  
The research is being approached from a realist philosophical perspective, 
considering the whole person in demographic (1.4.4), clinical (1.4.2) and 
psychosocial (1.4.3) terms.  Within the realist paradigm the research adopts a non-
interventional approach, utilising data collected longitudinally to address the 
following Research Questions; 
1) After the completion of treatment for Head and Neck Cancer, what are the 
demographic, clinical, and psychological factors associated with positive 
psychological change that occur in the acute period, defined as between 3 
and 12 months? 
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2) After the completion of treatment for Head and Neck Cancer, what are the 
trajectories for positive psychological change longitudinally, defined as 
longer than 12 months? 
There has been little work that has examined variables associated with trajectories 
of PPC, making it difficult to specify further the expected relationships of baseline 
variables with PPC over time.  The remaining chapters will set out the research 
methodology (2.0), describe and justify the specific methods (3.0) and measures 
adopted (3.1.5 – 3.1.8), report the results in five sections that build upon each 
other (4.1 – 4.5) and finally discuss the implications of the study for clinical practice 
(5.3) and future research (5.0). 
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2.0 Methodology 
This chapter covers the methodology adopted to answer the research questions: 
1) After the completion of treatment for Head and Neck Cancer, what are the 
demographic, clinical, and psychological factors associated with positive 
psychological change that occur in the acute period, defined as between 3 
and 12 months? 
2) After the completion of treatment for Head and Neck Cancer, what are the 
trajectories for positive psychological change longitudinally, defined as 
longer than 12 months? 
This research will give consideration to the fundamental beliefs around illness and 
models of social cognitive transition between 'illness' and 'wellness' (2.1).  The 
temporal dimension is then introduced to provide the concept of a trajectory of 
PPC (2.3).  This forms the methodological framework against which data collection 
can be evaluated.  Quantitative and qualitative data methods will be discussed with 
reference to the researcher’s model which identified quantitative data as being the 
most consistent with the underlying philosophy (2.6).  
This section concludes with a detailed consideration of the longitudinal nature of 
PPC (2.5) and how this may reveal or obscure trajectories.  There then follows a 
statement of the chosen methodological model of PPC, the approach to data 
collection and analysis and how to address time in the study (2.7).  The subsequent 
Methods section then sets out the detailed research design (3.0). 
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2.1 Illness beliefs 
It may be argued that the psychosocial element of the biopsychosocial model 
(Engel, 1980, 1977) includes psychological factors that may potentially contribute to 
the understanding, development and evolution of a health problem (Leventhal et 
al., 1992).  Social cognitive models describe the key understanding and inter-
relationships with behaviours that are concerned with how people respond to and 
make sense of socially derived situations.  An area of study with these models 
focuses on how people respond to a range of serious illness including cancer (Taylor 
et al., 1984).   
Studies have emphasised the importance of people’s subjective illness beliefs (i.e. 
their personal understanding and expectations regarding the disease).  Beliefs 
about illness have an important influence on functioning and this is a stronger 
predictor of disability than objective measures of disease activity (Petrie et al., 
1996).   
A study with people who had had HNC found that the stronger a person’s illness 
identity (perceived symptoms), the more pronounced the self-blame (beliefs that 
one’s own behaviour caused the disease), and the greater the perceived 
consequences (expectations that the illness will have a serious impact) (Scharloo et 
al., 2010).  Assessed at diagnosis, each predicted poorer global quality of life (QoL) 
at 2-year follow-up, after controlling for disease stage and age (Scharloo et al., 
2010).  In another study with a HNC cohort, stronger beliefs at diagnosis that the 
illness would last a long time predicted greater subsequent depression at 6 to 8 
months post-treatment (Llewellyn et al., 2007).  In these studies of HNC, negative 
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perceptions about the duration of the illness, perceived consequences and high 
symptom awareness have all been associated with worse QoL (Llewellyn et al., 
2007; Scharloo et al., 2010, 2005).  The impact of HNC and its treatment has 
significant biopsychosocial impact on those diagnosed with the illness.  The 
negative/detrimental elements of the illness and its treatment may be viewed as a 
traumatic experience.  This is a vibrant research domain, but little coherency has 
emerged with multiple studies proposing alternative perspectives.   
2.2 The assumptive world 
In 1975 Parkes used the phrase ‘assumptive world’ to refer to people’s view of 
reality, defined as “a strongly held set of assumptions about the world and the self 
which is confidently maintained and used as a means of recognising, planning and 
acting…. Assumptions such as these are learned and confirmed by the experience of 
many years.”  (Parkes, 1975. p152).  According to this theory, we are rarely aware 
of the fundamental elements of our assumptive world; the minor disappointments, 
challenges and failures of day-to-day life seldom bring them to light.  It has been 
said that they are conservative cognitive schemas that resist change and 
disconfirmation (Janoff-Bulman and Schwartzberg, 1991).  The questioning of the 
basic assumptions is what fractures the assumptive world and triggers the 
rebuilding of them to accommodate new realities (Janoff-Bulman and 
Schwartzberg, 1991).  A life-threatening illness such as cancer could be sufficient to 
shatter a person’s assumptive world.   
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2.3 Models of PPC  
As discussed above, the shattering of assumptions (2.2) and individual social 
cognitions are important for PPC to occur.  Central to this thesis is that an individual 
has experienced an event which they define as a crisis or trauma.  Without the 
sense of crisis, there would be little reason either for distress or change in either 
negative or positive ways. 
Schaefer and Moos (1992, 1998), Tedeschi and Calhoun (1995, 2004) and Joseph 
and Linley (2005) have all proposed models of PPC.  Schaefer and Moos (1998) 
suggest that PPC is determined by 1) event-related factors, 2) environmental 
factors, 3) personal factors, and 4) cognitive and coping responses (Figure 1).  Each 
factor makes a unique contribution and the model makes specific predictions.  For 
example, the severity of the trauma is linked to growth – but only when there is a 
successful outcome in the face of a poor prognosis.  Demographic variables, 
particularly age, are considered important and older age frequently limits potential 
for growth (Schaefer and Moos, 1998).  Schaefer and Moos (1992, 1998) also posit 
that active coping, a form of ‘approach coping’ (i.e., proactively trying to manage 
the problem), promotes growth, whereas avoidance coping (i.e., denial or 
minimization of the problem, venting emotions) leads to poorer adjustment. 
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Figure 1: Life Crisis and Personal Growth (Schaefer and Moos, 1992) 
 
Research into coping has moved on since this model was defined in 1992, and 
problems and issues for coping research have been outlined by Folkman and 
Moskowitz as early as 2004.  Quantative methods have been critised for being 
oboslute one shot approaches to the complex mechanisms involved with different 
types of stress, and failing to take account of individuals varying ways of coping 
with different stressful events (Aldwin & Park, 2004).  It is also sugested that in 
some instances strategies such as expressing emotions or denial can be effective 
(Vos and de Haes, 2007), at least in the short term, while for example waiting for 
the results of diagnositic tests. 
Tedeschi and Calhoun (2004; Figure 2) offer a cognitively oriented model that has 
been considered more comprehensive than Schaefer and Moos (Joseph and Linley, 
2006).  Traumatic experiences are referred to as ‘seismic events’ that shatter a 
person’s assumptive world and lead to emotional distress that initiates a process of 
rumination to make sense of the experience.  Tedeschi and Calhoun use the 
definition of rumination as ‘recurrent event-related thinking, including making 
sense, problem solving, reminiscence, anticipation’ (Martin and Tesser, 1996, p. 
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192).  This is distinct from earlier usage of the term, which referred exclusively to 
negative thinking and self-punishment (Nolen-Hoeksema et al., 1997). 
Tedeschi and Calhoun’s (2004) model focuses in the psychological variables which 
may affect the persons coping and aspects such as rumination which could be 
targeted during psychological interventions. 
Figure 2: Comprehensive model of PTG (Tedeschi and Calhoun, 2004) 
 
Copyright permission for reuse has been granted by the author and publisher Taylor Francis (Agreement in 
Appendix 1) 
Joseph, Murphy and Regel (2012) developed a framework which they title the 
affective-cognitive process (Figure 3).  This models how, through a cycle of events, 
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cognitions appraisal, emotional state and coping, a person attempts to reconcile 
pre-trauma related assumptions with the new trauma-related information.  To 
follow the model the researcher begins with the traumatic event and reads 
clockwise through event cognitions, appraisals, emotional states and coping in a 
repetitive, cyclical process which is ongoing until resolution of the differences 
between the pre-trauma, assumptive world and the new, trauma-related 
information are resolved.   
The affective-cognitive processing model supports the key concepts outlined by 
Tedeschi and Calhoun (2004) (e.g., distress as the engine of PPC), PPC coming from 
the challenge to previously held beliefs and the role of cognitive processing in 
facilitating PPC) but elaborates further on the role of affective, cognitive and coping 
responses on growth development.  Joseph, Murphy and Regel (2012) suggest that 
psychological interventions, activities and strategies facilitate PPC, and the model 
provides examples (Figure 3 italic text in brackets) of training that people may find 
beneficial.
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Figure 3: Affective-Cognitive Processing Model for Post-Traumatic Growth (Joseph et al, 2012) 
 
Copyright permission for reuse has been given by the author (Joseph et al 2012) and publisher of the article (Appendix 2) 
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All three models place emphasis on the importance of social support (Lechner and 
Antoli, 2004), and acknowledge the role of personal factors in promoting PPC.  For 
example, Schaefer and Moos (1992) suggest that an internal locus of control 
predisposes a person to more adaptive, active coping strategies, which in turn 
increase PPC.  All models concur that event severity may enhance growth, but with 
important differences.  Schaefer and Moos (1992, 1998) suggest that PPC occurs 
when a positive outcome follows a poor prognosis (i.e. a ‘lucky escape’), whereas 
Tedeschi and Calhoun (2004) and Joseph and Linley (2005) suggest that the level of 
disruption of core beliefs best explains growth and, in this sense, PPC can occur 
even in the face of a poor prognosis. 
Similarly, Schaefer and Moos (1998) suggest that loss of function reduces prospects 
for PPC, whereas Tedeschi and Calhoun’s (2004) model suggests that loss of 
function (e.g. in terms of eating, chewing, swallowing) can serve as a traumatic 
event and thus prompt growth.  Additionally, Schaefer and Moos suggest that 
multiple factors (event-related, environmental, personal, cognitive and coping) 
determine PPC, whereas Tedeschi and Calhoun propose ‘rumination, social support 
and acceptance coping as the variables that hold most weight in explaining growth’ 
(Calhoun and Tedeschi, 2004, p. 99). 
The Comprehensive model of PTG model (Figure 2) by Tedeschi and Calhoun (2004) 
can be considered to model the main processes suggested to be involved in the 
development of PPC.  However, the model can be criticised for its emphasis on 
cognitive processing as opposed to other forms of coping response, particularly 
affective responses.  The differentiation between different forms of cognitive 
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processing in the PTG model is central and testable.  As stated by Tedeschi and 
Calhoun (2004); in order for PPC to occur, there needs to be some level of distress.  
The more recent model of PPC (i.e. the Affective-Cognitive Processing Model; Figure 
3, Joseph et al., 2012) support the key concepts outlined by Tedeschi and Calhoun 
(2004) but elaborates on the role of affective, cognitive and coping responses on 
growth development.  This development shows the stability of the theoretical 
underpinnings and the influence of the PTG model by Tedeschi and Calhoun (2004). 
2.4 PPC as growth vs illusion 
It has been suggested that PPC may be an illusion, a subjective experience, rather 
than a real change (Sumalla et al., 2009; Zoellner and Maercker, 2006).  It is 
therefore pertinent to ask whether participants reporting change always reflect a 
real, long-term, positive change, whether reported PPC has masked a lack of coping 
and/or denial, or whether it has been used as an acute coping strategy.  If it is 
coping or denial, this would explain the seeming contradiction of a person’s ability 
to show PPC whilst also reportedly experiencing PTSD symptoms.  Zoellner and 
Maercker (2006) suggested in the Janus theory that PPC may have two elements or 
faces: the functional aspect and the illusory dysfunctional aspect.  The latter allows 
for positive illusions to help people compensate for emotional distress, whereas the 
constructive functional component is correlated with healthy adjustment (Pat-
Horenczyk et al., 2015).  If this notion is accurate, longitudinal studies of PPC would 
show positive associations between PPC and psychological adjustment, whereas 
findings in cross-sectional studies would be mixed.  This may indicate a long-term 
effect in coping with trauma, suggesting that the constructive, self-transforming 
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component of PPC increases over time, whereas the illusory component probably 
decreases. 
Sumalla et al (2009) discuss how it tends to be research undertaken from a socio-
cognitive perspective, such as this current work, that confirm the real nature of 
PPC.  The concept of meaning is key to the understanding of adaptation to 
traumatic events.  In the case of the social cognitive models this entails interpreting 
growth as being a result of the struggle against the illness.  Janoff-Bulman and 
Frantz (1997) distinguish between meaning as comprehensibility of the adverse 
event and the reasons why it has taken place.  Although both kinds of meaning are 
involved in PPC, the accommodation process specifically requires the second kind 
(Joseph and Linley, 2006).  If the event or illness is experienced by the subject as 
something important and central to identity (Berntsen and Rubin, 2006) the facts of 
the illness or event become an essential part of the person's identity, whether 
resulting in negative psychopathologic or positive changes as growth after the 
trauma. 
The PTG model of Tedeschi and Calhoun (2004) has influenced the research 
methodology within a social cognitive perspective.  The researcher hypothesises 
that PPC is a real phenomenon, whilst recognising that there are methodological 
challenges in demonstrating this. 
The quantitative measures designed to assess PPC ask respondents to compare 
themselves at a time-point prior to trauma and now.  This requirement for accurate 
recollection makes it difficult for researchers to differentiate answers reporting 
persistent PPC, acute PPC (which some might argue is illusionary in nature), short-
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term coping/cognitive avoidance/benefit finding (e.g., Frazier and Kaler, 2006; 
McFarland and Alvaro, 2000; Tennen and Affleck, 2002; Thornton, 2002), growth, or 
a combination. 
Findings from the literature suggest that there is support for both the illusory and 
real theories.  Frazier and Kaler’s (2006) work within BC found a small relationship 
between perceived growth (measured as growth post-trauma) and actual growth 
(as measured by the difference between a closely controlled BC and non-BC group).  
This was supported by the work of Gunty et al. (2011) with undergraduates who 
suggested that there may be potential moderators to the relationship such as level 
of distress and satisfaction with life.  Ransom et al (2008) made a comparison 
between actual changes and perceived changes and found that PPC was 
significantly related to actual increases (but not perceived increases) in the relative 
importance of intrinsic goals versus extrinsic goals.  It was also related to perceived 
increases, but not actual increases, in positive attributes in a BC and prostate 
cancer cohort.  These studies indicate that PPC may in fact be both illusionary 
(perceived) and actual.  Research across other trauma causes provides evidence of 
the veracity of PPC (Park et al., 1996; Salsman et al., 2009; Wolchik et al., 2008).  
Wolchik et al. (2008) make a case for the passage of time to be considered as 
necessary for the development of PPC, but noted that it can be predicted by active 
coping and social support.   
Overall, the available data investigating the illusionary (perceived) or actual 
occurrence of PPC, appear to support the existence of PPC and its ability to be 
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measured using quantitative tools.  They also indicate that intra-personal variables 
may have an impact upon the development of PPC over time. 
2.5 Longitudinal PPC 
Growth is, by definition, a process that happens over time, so relying upon cross-
sectional, single time point research, or upon research where the time between 
measures is small, is not conducive to understanding the longitudinal patterns or 
trajectories of PPC.  However, to date, the bulk of the research methodology in the 
area of PPC and across disease groups is cross-sectional and longitudinal studies are 
relatively rare (Danhauer et al., 2013b; Harding et al., 2014; Joseph and Linley, 
2008; Wolchik et al., 2008).  It is therefore difficult to predict which factors affect 
PPC and it is likely, given the example of the wider trauma literature, that there are 
complex interactions among demographic, personality, coping, and social support 
variables (Danhauer et al., 2013b; López-García and López-Soler, 2014; Milam, 
2004; Pat-Horenczyk et al., 2015; Tedeschi and McNally, 2011).  However, some 
research has started to address this issue.   
Helgeson et al. (2006) undertook a meta-analytic review which consisted of a 
mixture of trauma cohorts.  These came from backgrounds which included natural 
disasters, bereavement and illness.  They reported that time since trauma was a 
significant predictor for the effect size (moderator) of depression, anxiety and 
global distress, but not of intrusive, avoidant thoughts or subjective health.  In 
studies in which the time since the traumatic event was more than 2 years, they 
further found that PPC was related to lower levels of depression and more positive 
affect, whereas PPC was related to higher levels of global distress when time since 
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the traumatic event was less than 2 years.  Helgeson et al. (2006) also found that 
PPC was related to a reduction in anxiety when the time since the traumatic event 
was 2 years or less.  This suggests that, as time elapses, reports of PPC may be more 
likely to reflect significant life changes and/or reprioritisation of life values in 
response to the trauma rather than coping mechanisms. 
All the longitudinal studies that have investigated possible trajectories of PPC within 
a cancer cohort have so far focused on people who have previously been diagnosed 
as having BC (Danhauer et al., 2015, 2013a, 2009; McDonough et al., 2014; Wang et 
al., 2014).  Studies have found between 4 and 6 PPC patterns or trajectories of 
growth over time, with variables such as mental health (Danhauer et al., 2015, 
2013a; McDonough et al., 2014; Wang et al., 2014), social support (Danhauer et al., 
2015, 2013a, 2009; McDonough et al., 2014) and positive affect (Wang et al., 2014) 
being differentiating factors.  Danhauer (2015) found that those who reported 
elevated levels of PPC at four months post diagnosis maintained these levels and 
could be described as having early onset PPC.  They also found that for those 
people who reported early onset PPC, it tended to increase as time passed so that 
higher levels of PPC are found in proportion to increasing the time from diagnosis.  
Wang et al. (2014) found that women with the lowest of their four identified PPC 
trajectories (showing a significant downward trend overtime) did not have higher 
levels of distress than any of the other three groups.  This may be due to a 
curvilinear relationship between adjustment and PPC.  Alternatively it may be that 
PPC is mediated in people with high QoL or mental health.  The study of Danhauer 
et al. (2015) yielded a model with six PPC trajectories (Figure 4: PTGI total score 
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trajectories (Danhauer et al., 2015)).  Of the six trajectories 1, 4 and 6 were relatively 
stable with non-significant changes over time (as measured using the PTGI total 
scores).  Two additional trajectories (2 and 5) had modest but significant changes of 
approximately 5 units on the PTGI over the 2 years.  Only trajectory 3 demonstrated 
a sizeable increase in PPC; in this trajectory, the participants started out with low 
levels of PPC, increased to moderate levels over the first 16 months following 
diagnosis and then levelled off.  Danhauer et al. (2015) found significant 
associations between their participant characteristics and the membership in the 
six PPC trajectory groups.  Age, race, chemotherapy status, use of adaptive coping 
strategies, illness intrusiveness, depressive symptoms and social support, all 
differed among the groups.  Danhauer et al. (2015) reported that the most 
noticeable differences were between trajectory 1 and trajectories 4-6, but noted 
that those with the lowest (1) and highest (5 and 6) levels of PPC also reported the 
highest levels of social support.  Interestingly only trajectory group 3 had a 
quadratic relationship with a steep increase in PPC, with only modest relationships 
to the predictors.
  
4
5 
Figure 4: PTGI total score trajectories (Danhauer et al., 2015) 
 
Key: Y-axis shows the PTGI total score trajectoires.  Percentages shown are the probablities of grouup membership.  Possible PTGI scores range from 0 to 105. Dashed lines 
relect observed values, and solid lines reflect predicted values.  Figure reproduced by permission of the author and Springer publishers (Agreement in Appendix 3). 
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The models reviewed in section 2.3 of PPC do not specify the time frame over which 
PPC develops.  It is likely to be reliant upon the trauma, the treatment, the side 
effects or long term complications following the traumatic event, and upon other 
factors such as those found by Danhauer et al. (2015), discussed above.  O’Leary 
and Ickovics (1995) postulate that health is not maintenance of homeostasis and 
that theorists, researchers and practitioners need to recognise that there are 
different patterns.  O’Leary and Ickovics (1995) suggested that there are at least 
four potential consequences of trauma.  One possibility is a continued and 
sustained decline in which the initial detrimental effect is maintained.  A second 
possible outcome is a weaker version of the first, where the person makes some 
return to pre-adversity levels but not fully.  In the third pattern a person returns to 
a pre-adversity level of functioning.  The time over which this occurs may be either 
rapid or gradual.  A fourth possibility is that the person may not merely return to 
the pre-adversity level but surpass it in some manner.  The researcher has modified 
the O'Leary and Ickovics (1995) model (Figure 5), using two red dotted lines to show 
how the trajectories of impairment, recovery and growth may change over time, 
and how the incidence of growth and impairment may be mis-interpreted 
depending on the time frame of measurement.  This framework has been 
supported by the Danhauer's study of women with BC up to 24 months post 
treatment (Danhauer et al., 2015). 
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Figure 5: Theorised patterns of PPC development (modified O’Leary and Ickvics, 1995) 
 
Figure 5 might appear to suggest that after a period of time PPC stabilises and that 
there is no further psychological change attributable to the original trauma (O'Leary 
and Ickovics, 1995).  However, as noted above, reported studies have not fully 
addressed the longitudinal nature of PPC.  A stable phenomenon would suggest 
that after a discrete period of time the individual has concluded any psychological 
change that may be attributable to the HNC trauma.  This might suggest a point 
beyond which any further intervention to address that trauma will be without 
effect.  If PPC is a dynamic phenomenon, an individual's psychological state may 
forever be impacted to a varying extent as a result of the trauma.  There might 
potentially be no end-point beyond which the trauma from HNC is stabilised to a 
known level.  An initial challenge therefore is to determine what is meant by 
‘longitudinal’ in relation to HNC. 
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2.5.1 Definition of “longitudinal” 
In planning a study that contains a longitudinal element Rogosa (1995) suggests 
that the researcher reviews the myths about longitudinal research, particularly in 
regards to determining the number of times of measurement.  One such myth is 
that two points of measurement constitute a longitudinal study.  Although the 
amount of change observed between two points in time is possible to determine, 
one cannot determine the shape of the growth curve from only two data points.  
Moreover, if the change is not a straight-line, the time the measurement is taken 
can be influential. 
Rogosa (1995) recommends the use of multiple measurement points for statistical 
analysis and examination of trajectories over time.  But this still leaves the question 
of how many time points?  To define a curve in Euclidian mathematics, a minimum 
of five points is required (Brannan, 2011) and therefore at least 3 points of 
measurement should be included if an investigation is to theorise a non-linear 
relationship (Brannan, 2011; Rogosa, 1995).  The question remains regarding what 
time frame defines ‘longitudinal’ in this context with this cohort of people. 
2.5.2 Defining “long-term” in HNC 
From a clinical perspective at present, there is no evidence that a high frequency of 
follow-up visits confers any benefit in terms of morbidity and mortality (ENTUK, 
2011).  However, there is evidence that the majority of clinicians working with HNC 
in the UK support high-frequency follow-up in the first 2 years followed by a 
decrease in frequency after the second year (Joshi et al., 2010).  The 
recommendation from the British Association of Head and Neck Oncologists 
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(BAHNO) is that follow-up in the first 2 years should be between 4 to 8 weeks and 
from 3 months to 6 months thereafter up to five years after the completion of 
treatment (ENTUK, 2011).  This could lead to a person being sent up to 36 
appointments in the five years after completing treatments (ENTUK, 2011).  Such a 
schedule makes it possible that people attending clinical follow-up would satisfy the 
follow-up recommendations, but would also risk response fatigue if given the 
survey at each clinic visit.  At the time of writing the researcher is unaware of any 
longitudinal studies being undertaken combining PPC and HNC, though research 
has been undertaken with women who have or have been treated for BC (Danhauer 
et al., 2013a). 
Two BC studies have initial time points immediately following surgery (Silva et al., 
2012; Wang et al., 2014).  Wang et al. (2014) then measured PPC again at 3 months 
post-surgery but did not report if adjunctive radiotherapy (with or without 
chemotherapy) was also received, which means participants could still be 
undergoing therapy when the third and fourth measurements are being taken at 6 
and 12 months post-surgery respectively.  This means that there would not have 
been time post-treatment for the participants to adapt to post-treatment regimens.  
Silva et al. (2012) report that participants were still receiving adjunctive therapy 
during their second time point and their third measurement was 6 months post-
surgery (although this is not the same as post-treatment).  The initial time point in 
the BC study by Danhauer et al. (2009) was post-diagnosis, but pre-treatment, with 
the second time point being between 6 and 8 weeks later and the third between 6 
and 8 months following the initial measurement.  As with Silva et al. (2012) and 
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Wang et al. (2014), participants may still be receiving therapy during the second 
time point (Danhauer et al., 2009).  Treatment modalities, length of time from 
diagnosis and from completing treatment are all considered in the current study.  
Manne et al (2004) do not report how long from diagnosis or treatment the data 
were collected.  They simply state that data were collected 3 times, 9 months apart, 
which does not allow any judgement about the impact of time since these two 
major events in the cancer timeline.  Danhauer et al. (2013a, 2015) collect data 
over the longest period of time.  For these researchers, collection occurs over 
eighteen months post diagnosis with time point 1 between 0 and 8 months post 
diagnosis (covering the treatment period), time point 2 measures 6 months 
following time point 1 (i.e. 6-14 months post diagnosis), time point 3, 12 months 
following time point 1 (i.e. 12-20 months post diagnosis), time point 4, 18 months 
following time point 1 (i.e. 18-26 months post diagnosis). 
Although these studies all report collecting PPC data at three or more time points, it 
is not possible to judge if any of the data exceeded 26 months post diagnosis and it 
is possible that this is equivalent to less than two years post treatment.  As 
mentioned above, in the United Kingdom (UK), a five-year follow-up is standard 
practice (ENTUK, 2011).  None of the PPC papers cited above cover this period of 
time (or longer) (Danhauer et al., 2015, 2013a, 2009; Manne et al., 2004; Silva et 
al., 2012; Wang et al., 2014).  None of these papers were conducted with HNC 
patients from the UK, with Danhauer et al. (2015, 2013a, 2009) and Manne et al. 
(2004) being undertaken in the USA, Silva et al. (2009) in Portugal and Wang et al. 
(2014) in Taiwan.  The lack of UK based studies means that the pathway of 
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treatment will be different.  This difference is noticeable in access to treatment 
being by the National Health Service (NHS), as compared to that provided by 
private healthcare in the USA.  Although Portugal and Taiwan do have national 
health systems similar to the NHS, they have distinct differences such as the NHS 
having primary care physicians as gate keepers to secondary or hospital care, 
whereas the Taiwanese system allows for greater patient choice of point of contact 
(Wu, Majeed and Kuo, 2010).  Differences in access to treatment, as well as 
differences in treatment pathways may well add to the traumatic nature of the 
diagnosis, treatment and long-term follow up care between countries.  There may 
well also be cultural differences that are not represented in papers from other 
countries (Weiss and Berger, 2010). 
2.6 Qualitative versus quantitative data collection 
The concept of PPC following adversity has been under investigation since the late 
1980’s (Calhoun and Tedeschi, 2006, p4).  Both qualitative and quantitative 
methods have been used to investigate this phenomenon. 
Qualitative methodologies can provide rich descriptive detail of an event and an 
understanding of the lived experiences of the contributor.  These experiences are 
often lost when using quantitative methods.  These studies may be considered 
reductionist, in that the individual richness present in qualitative work is replaced 
by a great number of people providing numerical responses (Calhoun and Tedeschi, 
2006).  When qualitative methods have been used in PPC, with people who have 
had HNC they tend to focus on asking people about how their functional lives have 
changed as a result of the trauma (Ruf et al., 2009; Thambyrajah et al., 2010).  
51 
 
Interviews, focus groups, open questions with free text responses, questionnaires, 
written essays and life narratives have all been used with mixed traumas and 
diseases (Martino and Freda, 2016; Starnino, 2016; Steel et al., 2008).  It can be 
argued that the responses to this type of knowledge elicitation capture a more 
complete range of growth experiences because respondents are not being limited 
by specific items.  Attention to the wording used in these methods is required. For 
example, inclusion of the terms positive or negative in a question (such as; ‘tell me 
if you have experienced any [positive] changes since completing your treatment’), 
can lead to very different responses and interpretations.  Open-ended questions 
are to be preferred, such as; ‘Have you changed your life in any way as a result of 
being diagnosed with cancer?’ (Steel et al., 2008). 
A number of interview studies with breast cancer (BC) patients (Sears et al. 2003), 
male heart attack patients (Affleck et al., 1987) and other groups such as mothers 
of newborns with serious medical problems (Affleck et al, 1985), reported findings 
that could demonstrate PPC.  These included better perspective on life, closer 
family relations, special appreciation (for the child), emotional growth, value of 
health behaviour and spiritual growth (Affleck et al., 1987, 1985; Taylor et al., 
1984).  With these different patient cohorts the facets of PPC were found in 
different patterns with some being present in 7% of respondents (spirituality in 
mother of children with serious illness; Affleck et al, 1985) and others such as 
changes in life philosophy in 20 to 30% of respondents (mothers of children with 
serious illness; (Affleck et al, 1985) and 7 weeks following a heart attack (Affleck et 
al., 1987).  Sears et al. (2003) found in the qualitative arm of their mixed methods 
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study that 83% of women perceived at least one benefit from their experience with 
BC.  The most common category of benefit involved ‘relating to others’.  
Understanding an individual’s experiences is vital to a health care professional’s 
interventions with them.  While the formation of narratives and other qualitative 
methodologies allow an individual’s journey to be described, the cited studies have 
shown thematic similarities and developed quantitative scales and subscales 
developed to measure PPC (Appendix 4).  Although qualitative methods would 
provide rich real life experience data, it would not allow for a large sample size at 
multiple time points to provide information about the possible patterns of 
development of PPC.  Therefore in keeping with the researcher’s philosophical 
basis, identifying quantitative measures that are objectively separate from the 
individual experience is of interest.  
Quantitative methodologies allow for the collection of data that will permit an 
understanding of how PPC varies as a function of the severity of the illness, and of 
the characteristics of the people involved.  These include age, gender, treatment 
regimen and time since diagnosis or treatment completion.  Several quantitative 
measures have been designed and found to be valid and reliable at providing scales 
that can be given to people who report or are believed to have experienced an 
adverse, stressful or traumatic event or illness.  Appendix 4 provides a non-
exhaustive list of scales that purport to measure PPC.  These measures can allow 
groups of people to be questioned using the same wording, thereby standardising 
data collection with a larger population than is possible with qualitative methods. 
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Joseph, Murphy and Regel (2012) have reported that many of these measures 
assess aspects of PPC.  The scales do this in a variety of ways.  Some, such as the 
Silver Lining Questionnaire (SLQ; Sodergren and Hyland, 2000), offer a 
unidimensional explanation; others, such as the Post-Traumatic Growth Inventory 
(PTGI; Tedeschi and Calhoun, 2004), offer multi-dimensional explanations.  These 
scales have been assessed for their psychometric properties but, as has been 
covered in the introduction, there is no theoretical model which is universally 
accepted.  The measures have been used across various incidents and illnesses 
including; earthquakes (López-García and López-Soler, 2014), combat (Tedeschi and 
McNally, 2011), sexual assault (Frazier et al., 2001), cancer (Harding et al., 2014; 
Steel et al., 2008; Wang et al., 2014), heart attack (Affleck et al., 1987), HIV/AIDS 
(Milam, 2004) and life events such as bereavement (Yalom and Lieberman, 1991), 
with a range of between 30-70% participants reporting having experienced positive 
changes in one form or another (Linley and Joseph, 2004). 
Within the field of PPC and cancer, BC has received the greatest amount of 
attention.  This is likely due to the prevalence of the disease, the size of the 
population that it affects and the availability of funding to investigate the impact of 
the disease and its treatment.  A number of studies in BC have used a single time 
point or cross-sectional method (Bellizzi et al., 2010; Tomich et al., 2005; Wang et 
al., 2014).  Much less attention has been paid to HNC, with only 5 published studies 
at the time of writing (Harrington et al., 2008; Ho et al., 2011; Holtmaat et al., 2016; 
Leong et al., 2015; Llewellyn et al., 2013).  The same limited amount of research is 
true for longitudinal patterns of change, with the current study being the first, to 
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the researcher's knowledge, to assess patterns of PPC over an extended period of 
time in HNC.  To enable a repeatable longitudinal investigation within a large group 
of people, and in order to be able to explore the relationship with medical and 
social factors, the researcher chose to use a quantitative methodology. 
2.7 Methodology summary 
The researcher adopted a realist perspective in undertaking the research.  This 
supports the inclusion in the research process of the perspectives of both the 
researcher and the participant/patient.  The researcher perspective is included 
through reflection in the Discussion section (5.0).  A literature review has supported 
a quantitative approach to understanding the pattern of change in this field (2.6).  
There is also little published work addressing this specific research question.  Such 
findings as do exist support the potential for PPC following the diagnosis and 
treatment of HNC but are not conclusive in respect of the mechanisms or 
predictors. 
The next chapter describes the specific methods adopted in this research. 
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3.0 Methods 
The previous chapters described the research context (1.0) and methodology (2.0).  
In this chapter the arguments are developed to determine appropriate methods to 
answer the research questions.  This section covers the research design (3.1), 
ethical considerations (3.1.4), measurement selection (3.1.5), data collection (3.4), 
the process by which the data was handled (3.5) and analytical tool selection (3.6). 
The methods used in this research allowed the identification of demographic, 
clinical and psychological factors associated with PPC following treatment for HNC.  
It also allowed for an interpretation of the trajectory of a persons’ PPC change up to 
11 years post-treatment for HNC. 
3.1 Design 
To look at change over time a simple, cross-sectional study consisting of at least 
two samples of people at different times from either diagnosis or treatment of HNC 
might be considered.  These people would be drawn from different cohorts and 
measured simultaneously.  This would enable an examination of the relationship 
between early and late PPC without actually waiting for the time to pass.  
Longitudinal conclusions with a HNC population have been drawn from cross-
sectional data (Harrington et al., 2008), but the validity of this is questionable 
(Achenbach, 1978; Kraemer et al., 2000). 
Cross-sectional studies have several characteristics that make them attractive to 
researchers.  They are relatively inexpensive, quick and easy to do, are useful for 
generating and clarifying hypotheses, piloting new measures or technology and can 
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lay the groundwork for decisions about future follow-up studies (Kraemer, 1994).  
They provide information about group differences or inter-individual differences 
(Miller, 2007).  They do not, however, provide information about changes or inter-
individual differences in intra-individual change (Miller, 2007; Wohlwill, 1973).  
Cross-sectional studies are also subject to methodological concerns and limitations.  
They cannot answer questions about the stability of a characteristic or process over 
time (Miller, 2007).  
A further criticism of cross-sectional studies is that their external validity (i.e. 
generalisability) may be affected by historical/cultural differences between cohorts 
(Achenbach, 1978).  This problem is perhaps the most serious limitation of the 
cross-sectional design; that is, one cannot easily separate the effects of age from 
the effects of belonging to a particular cohort, especially if that cohort is defined by 
birth.  Miller (2007) argues that the seriousness of this problem relates to the 
dependent variable: the more basic or biological the variable (e.g. heart rate, visual 
acuity), the less likely it is that the cohort effect will be present.  Adopting a cross-
sectional approach to studying the process of change or development would not 
permit the identification of predictors associated with having a reduced ability to 
speak or eat, whereas adopting a longitudinal approach would allow such analyses 
(Campbell, 1988).   
The meaning of longitudinal has been discussed above, as has the concept of what 
an appreciable length of time might be.  The mediators of this might be the age of 
the cohort and the disease/disorder, traumatic or stressor being investigated.  
Longitudinal designs are useful as they allow researchers to look at intra-individual 
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change, and co-occurring biological changes that enable the development or 
advancement of the theoretical/explanatory accounts of change (McCall, 1977).  
But it is the ability to look at the direct effect of time on an individual (intra-
individual) that could be named as a strength of this research design (Farrington, 
1991; Miller, 2007).  The longitudinal design allows for the investigation of 
individual consistency or change (Farrington, 1991).  It means the causes of intra-
individual change can be explored because of the time ordering of the data 
collection (Baltes and Nesselroade, 1979; Campbell, 1988; Farrington, 1991; 
Pellegrini, 1996; Wohlwill, 1973).  
There are obvious benefits to the longitudinal research strategy, but it is expensive, 
time consuming, and labour-intensive.  Longitudinal research is vulnerable to 
threats to validity such as attrition, and regression to the mean (Shadish et al., 
2001). 
Sample attrition is one of the most common and frustrating problems faced during 
longitudinal research.  Attrition is problematic in that non-responders usually differ 
from responders in ways that might be related to the variables being studied 
(Bergman and Magnusson, 1990; Goldstein, 1979). 
Longitudinal research is also susceptible to a cohort effect, which might have an 
impact upon both the internal and external validity of a study (Achenbach, 1978; 
Baltes et al, 1977; Bergman and Magnusson, 1990).  This effect can be partially 
mitigated by obtaining some cross-sectional data on relevant variables such as 
tumour grade (Bergman and Magnusson, 1990).  It has been demonstrated that a 
combination of cross-sectional and longitudinal research design traits is an 
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appropriate way to assess both the direction and level of change over time (Baltes, 
1968; Schaie, 1965).  This combination of designs has been variously called; 
accelerated longitudinal, convergence, and cross-sequential.  Farrington (1991) 
concluded that the cross-sequential strategy is “a way of achieving the benefits of 
the longitudinal method while minimizing the problems” (p. 369).  The specific 
advantages are that it allows intra-individual changes to be assessed within a 
shorter follow-up period than that required for a traditional longitudinal design and 
that the use of multiple cohorts increases confidence in the generalisability of the 
results to the sample population as a whole (Miller, 2007).  The disadvantage of the 
methodology is that within-individual sequences are shorter than in a traditional 
longitudinal design.  However, this is overcome by ensuring that the matrices 
overlap, allowing analyses to link the shorter sequences together to approximate a 
traditional longitudinal study (Anderson, 1993; Farrington, 1991).  Although 
historically not a widely used methodology, it has been growing in popularity since 
the early 1990’s.  It has been used to investigate offending and criminal behaviour 
(Tonry et al., 1991).  More recently it has been embraced by education to 
investigate such issues as the effectiveness of school screening programmes and 
English proficiency (Dennaoui et al., 2015; Hines et al., 2015) and by healthcare to 
understand health outcomes after exposure to toxins and PTSD in school children 
following an earthquake (López-García and López-Soler, 2014; Remy and Clay, 
2014). 
Given consideration of the factors outlined above, the current study utilises a cross-
sequential study design to look at the effects of treatment for HNC on people’s 
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reported PPC and HRQoL.  The potential limitations identified have been mitigated 
by adopting a longitudinal method, across a time period of up to 5 years but a 
minimum of 3 months post-treatment. 
3.1.1 Real World Data  
Real-world data (RWD) is an encompassing term for different types of healthcare 
data that are not collected in conventional randomised controlled trials (RCT; 
(RAND Corporation, 2016).  RWD in the healthcare sector come from various 
sources and include data from: outcomes (clinical and patient-reported), resource 
use (NHS, patient and societal), treatment pathways, service models and surveys of 
patient preference, experiences and compliance.  
RWD studies have also been referred to as non-interventional or observational 
studies.  These terms are used interchangeably.  Some projects are also termed 
audits or service evaluations.  Most importantly, no treatment or test would be 
changed for a RWD project.  RWD projects can be comparative, considering ‘which 
is best?’ or descriptive, looking at ‘what is happening?’  They can be undertaken 
either retrospectively or prospectively in a primary, secondary or tertiary care 
setting.  Table 1 provides a summary of the differences between RCTs and RWD 
studies.  The present study is an investigation of the impact of the standard clinical 
treatments for HNC.  There was no intention to modify treatment, or to instigate an 
intervention, although collection of data such as treatment regimen allowed for 
evaluation of what might be happening in the population. 
RWD can help to answer questions about the impact upon patients of such things 
as treatments, staff interactions, and environment, in terms that matter to the 
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patients themselves.  This process can be supported through the use of a pragmatic 
research design.  The current study is investigating a relatively small cohort of 
patients and a pragmatic approach to the study design would be to recruit people 
that match routine practice.  An open cohort, recruited prospectively and 
supplemented with data collected from medical records, will garner the richest data 
and thus allow better generalisation of data to the population being studied (abpi, 
2011; Lang and Mack, 2014).  Data from previous studies can provide guidance on 
the type and nature of the variables that should be retrieved from the 
medical/clinical records.  
Table 1: Summary of differences between RCTs and RW studies 
 RCTs Real World Studies 
Type of trial Experimental/interventional Observational/non-
interventional 
Primary focus Efficacy, safety and quality Effectiveness/incidence 
Patient population Narrow and restricted Wide and unrestricted  
Monitoring Intense governance issues 
(International Committee on 
Harmonisation-Good Clinical 
Practice (ICH-GCP) 
compliant) 
Not required 
Comparators Gold standard/placebo None/standard clinical 
practice 
Randomisation & 
Blinding 
Yes No 
Cost ££££ £ 
 
3.1.2 Ethical approval 
The study protocol was reviewed by medical consultants and the Macmillan 
specialist cancer nurse working in the recruiting maxillofacial unit.  Once the 
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methodology and measures were agreed it was submitted to and approved by 
Plymouth Hospital Trust Research and Development Office as the study sponsors.  
The Integrated Research Application System (IRAS) was utilised to obtain ethical 
approval for this study from the Health Research Authority (HRA).  The study was 
approved by Research Ethics Committee 15/EM/0052, with study number 167514.  
Approval was received in November 2009. 
3.1.3 Ethical conduct 
The researcher ensured that the study was conducted in compliance with the 
principles of the Declaration of Helsinki, the International Committee for 
Harmonisation Guidelines for Good Clinical Practice (ICHGCP) and the British 
Psychological Society (BPS).  Normal NHS hospital guidelines regarding data 
protection and patient anonymity were followed. 
3.1.4 Practical ethical considerations 
A number of practical ethical considerations were considered during the planning of 
this research.  The issue of when patients should be approached, with a view to 
minimising the strain on potential respondents, was discussed with the HNC team 
at Derriford Hospital (Plymouth NHS Trust).  The researcher did not feel it was 
appropriate to approach potential participants during pre-treatment clinical 
appointments due to their potentially elevated anxiety at this time.  Immediately 
following treatment, potential participants would be fatigued and still healing from 
their treatment.  A period of three months was consequently selected as the 
minimal post all treatment interval before contact should be attempted, so allowing 
fatigue to decrease, and wounds such as surgical incisions and radiation burns to 
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heal.  By this stage, it was hoped that participants should also have been reassured 
by at least 3 follow-up clinic visits.  
It was important to ensure the review of people’s ongoing medical conditions could 
be undertaken effectively and efficiently, therefore an annual postal survey was 
selected.  An annual posting allowed for one integration of hospital databases to 
identify potential new participants, and to review the status of people who had 
been approached in previous years.  This was considered more suitable than a 
weekly review to identify specific time points such as 3, 6, 9, 12 months for each 
person. 
Only one posting per year was undertaken.  Although a methodology with follow-up 
postings has been shown to have a positive impact on the return rates (Dillman, 
1999), it was decided to minimise demand on potential respondents.  Additionally if 
the measures were returned uncompleted, or if people contacted the researcher to 
give a reason for non-completion, or to express a desire not to be sent 
questionnaires in the future, they were removed from future annual postings. 
The number and length of the measures to be sent to the potential participants was 
part of the review of the psychometric measures, as was the order of presentation.  
These are both considered in the following sections. 
3.1.5 Psychometric measures 
There are many different measures and scales that could be used in this research 
(Appendix 4).  Studies with a HNC cohort have investigated dispositional optimism, 
positive reframing, emotional support, anxiety and depression and hope 
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(Harrington et al., 2008; Ho et al., 2011; Holtmaat et al., 2016; Llewellyn et al., 
2013; Leong et al., 2015).  But only one of them was published prior to the design 
or ethical approval of the current study (Harrington, et al., 2008).   
A review of potential scales was undertaken and the information collected was 
weighed with limitations and practicalities of the study design.  These limitations 
included the need to measure those factors which are applicable to the research 
aims and which have been shown to be reliable and valid.  Where possible the 
measures have been used within the study population previously and shown to be 
sensitive to change. 
From the review of measures and studies, three were chosen for the data 
collection; Quality of Life (QoL) was measured using the Medical Outcomes Short 
Form 12 (SF-12; Ware et al., 1996).  PPC was assessed by the Silver Lining 
Questionnaire (SLQ; Sodergren and Hyland, 2000).  Health related QoL (HRQoL) 
specifically related to HNC was measured using the University of Washington 
questionnaire (UoW; Hassan and Weymuller, 1993). 
Both a QoL and a HRQoL measure were included in the current work as they 
investigate different levels of the QoL concept.  Quality of Life is a broad concept 
which covers all aspects of life.  The SF-12 is a health status QoL measure.  The 
authors of the SF-12 aimed to develop a short, generic measure of subjective health 
status that was psychometrically sound and could be applied to a wide range of 
settings (Ware et al., 1996).  The UoW was included as a HRQoL measure.  It 
focuses on the effects of illness and specifically on the impact treatment may have 
on QoL.  Quality of Life (in this study the SF-12) is therefore broader than HRQoL 
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(UoW) because it includes evaluation of related, non-disease specific features of life 
whereas HRQoL is connected to an individual’s disease status.  HRQoL can help 
understand the distinction between aspects of life related to health. 
3.1.6 Medical Outcomes Short Form 12 Version 2 
The Medical Outcomes Short Form 12 Version 2 (SF-12) is a multipurpose, short-
form questionnaire with only 12 items, all selected from the SF-36 Health Survey 
(Ware et al., 1996).  It is a generic measure, as opposed to one that targets a 
specific age, disease, or treatment group.  It has been proven to be useful in 
measuring outcomes in clinical trials.  The SF-12 was selected for use in this study as 
it is well validated but brief enough to minimise response burden (Melville et al., 
2003; Stoll et al., 2000). 
The SF-12 is a self-administered survey designed to measure health concepts across 
age, disease and treatment groups.  It takes approximately 3 minutes to complete, 
which is a significant advantage compared with the SF-36, which takes 5 to 10 
minutes per respondent (Melville et al., 2003).  It tests eight health domains: 4 of 
physical health (physical functioning, role functioning, bodily pain and general 
health perception), and 4 of mental health (social functioning, role mental, vitality 
and mental health). 
Results for each participant are expressed in terms of two meta-scores; a Physical 
Component Summary (PCS) and a Mental Component Summary (MCS).  To 
calculate the PCS and MCS, test items are scored and normalised in an algorithm 
described in the SF-12 users' manual (Ware et al., 2001).  Raw data are transformed 
into norm-based scores for each domain (population mean 50, standard deviation 
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10) and PCS and MCS measures for each participant are calculated using factor 
score coefficients derived from the general population.  This process yields PCS and 
MCS scores with a range of 0 to 100.  Scores greater than 50 represent above 
average health status, whereas people with a score of 40 function at a level lower 
than 84% of the population (one standard deviation), and people with a score less 
than 30 function at a level lower than approximately 98% of the population (two 
standard deviations). 
Psychometric status of the SF-12 has been found adequate by studies determining 
its concurrent validity with the SF-36.  Using data from 10 general American 
population surveys (n = 24,293) the SF-12 achieved multiple R squares of 0.91 and 
0.92 in predictions of the SF-36 PCS and MCS respectively (Ware, et al., 1996).  The 
SF-12 has demonstrated internal consistencies of α = 0.71 – 0.90 for all of the sub-
scales including the PCS and MCS and test-retest of between r = 0.71 and 0.84 
(Ware, et al., 1996). 
This measure has been used in many fields of health care research including HNC.  
Khafif et al. (2007) investigated generic HRQoL with this measure and its association 
with QoL specifically related to HNC.  Other researchers have utilised the SF-12 to 
compliment the investigate of optimism and pessimism, disfigurement and 
dysfunction and how people with HNC represent their illness in relation to 
Leventhal’s common sense model (Kung et al., 2006; Llewellyn et al., 2007; Terrell 
et al., 1997). 
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3.1.7 Silver Lining Questionnaire 
The 38-item Silver Lining Questionnaire (SLQ; Sodergren and Hyland, 2000) was 
selected for its psychometric properties and its reported ability to measure the 
extent to which people believe their illness has had a positive benefit despite the 
negative consequences of being ill. 
The SLQ measures 10 facets of positivity with illness.  These comprise: restructuring 
of life; reappraisal of life; spiritual gains; self-improvement; self-awareness; skills 
and new pursuits; sensitivity to emotions; confrontation of current concerns; 
improved interpersonal relationships and positive consequences for others.  People 
respond using five categories: strongly agree, agree, not sure, disagree, and 
strongly disagree.  An overall score is obtained by scoring each item as 1 for 
responses strongly agree and agree, and 0 for all the other response options.  The 
total score therefore reflects the total number of items with which the respondent 
agrees (i.e. the number of positive consequences of illness experienced), and varies 
between 0 (low positivity, i.e. the respondent agrees with no items) and 38 (high 
positivity, i.e. the respondent agrees with all items).  Cronbach’s alpha is 0.93 and 
retest reliability is r = 0.90 (Sodergren et al., 2002).  
The authors of the SLQ refer to it measuring adversarial growth.  Although it has 
not been used to investigate PPC in people specifically with or following HNC, it has 
been used with mixed cancer cohorts (breast, colorectal, gynaecological, and lung) 
and found that adversarial growth is related to cancer stage (McBride et al., 2009).  
When assessed in the setting of a range of diseases including a mixed cancer 
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cohort, the severity of the illness affects the level of PPC reported using the SLQ 
(Sodergren et al., 2004; Sodergren and Hyland, 2000). 
No data is currently available on how long it takes to complete the SLQ. 
3.1.8 University of Washington quality of life questionnaire  
This is a broad measure of HRQoL specifically designed for use with people who 
have or have had HNC.  It has good patient acceptability, practicality, validity, 
reliability and responsiveness (Hassan and Weymuller, 1993).  Not only does the 
University of Washington (UoW) measure HRQoL items, it can also predict 
outcomes such as length of stay in hospital (Rogers et al., 2001) and identify 
discrete patient groups (Rogers et al., 2000).  The UoW (Hassan and Weymuller, 
1993) quality of life (QoL) questionnaire version 4 was used and covers 12 domains: 
pain, appearance, activity, recreation, swallowing, chewing, speech, shoulder 
function, taste, saliva, mood and anxiety.  Each question is scaled from 0 (worst) to 
100 (best) according to the hierarchy of response.  There are also three global 
questions, one asking about HRQoL compared to the month before they had 
cancer, one asking about HRQoL during the past 7 days and the third asking about 
overall QoL during the past 7 days.  
The UoW has been validated by comparison to the Karnofsky Scale and Sickness 
Impact Profile demonstrating an average criterion validity of 0.85 (Hassan and 
Weymuller, 1993).  It has also been found to have internal consistency between α = 
0.80 and 0.79 and Test-retest of r = 0.91 (Rogers et al., 2002). 
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The questionnaire was designed to be a self-completed measure specific to HNC 
patients.  Hassan and Weymuller (1993) suggest that the advantages of the UoW 
are that it is brief and self-administered and, from the clinician's perspective, it is 
multi-factorial, allowing sufficient detail to identify subtle change as well as 
providing questions specific to HNC.  It allows no input from the health provider, 
thus reflecting QoL as indicated by the patient. 
3.2 Additional variables recorded 
Previous research with patients with BC has suggested that different genders, ages, 
ethnicities, tumour types, tumour stage, locations and socio-economic status may 
have an effect on the development of PPC (Carver and Antoni, 2004; McBride et al., 
2009; Petrie et al., 1999; Sears et al., 2003; Tomich and Helgeson, 2004).  These 
variables were recorded on a minimum data sheet and entered into SPSS (Statistical 
Package for the Social Sciences, versions 19 - 23) for inclusion in the analysis 
(Appendix 5).   
Staging of HNC is a system designed to communicate the relative severity, or extent 
of the disease, in order to aid the planning of treatment, and to provide an 
indication of prognosis.  Appendix 6 provides information on staging terminology 
and the classification of tumours. 
3.3 Identification of potential participants 
The researcher had permission to access the Somerset Cancer Register (SCR) 
database at Derriford Hospital (Plymouth).  The administrator of this database ran a 
data search within this database and supplied the names, addresses, dates of birth, 
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gender, diagnosis and treatments of people treated by the Head and Neck 
Directorate in the preceding year (see glossary for details).  Participants were 
divided into year-groups, with a year running from September to August.  Five year-
groups were identified over the period 2009 to 2013. 
3.3.1 Head and Neck Cancer group inclusion criteria 
Inclusion criteria for the study were that the person had to be over the age of 18, 
with an understanding of English judged by clinical staff to be sufficient to complete 
a series of questionnaires in English.   
The tumour had to have a histological diagnosis of squamous cell carcinoma (SCC).  
SCC is a malignant neoplasm of epithelial origin that develops from the epithelial 
cells; in this case, those lining the surface of the upper airway and aero-digestive 
tract.  For inclusion in the study the tumour had to be located in the mouth, lip, oral 
cavity, salivary gland, pharynx, nasal cavity or sinuses.   
Participants had to be at least three months post-completion of treatment, which 
could include surgery, radiotherapy or chemotherapy, in isolation or any 
combination.  These were selected as, being the most common treatment 
regimens, they would provide the maximum possible sample size for use in the 
statistical analysis. 
This study was interested in psychological change over time.  Annual requests were 
made to those people identified via the SCR as being at least 3 months after 
treatment completion.  Three months was chosen in discussion with clinicians in 
the maxillofacial unit treating the participants.  It was felt that this allowed for 
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physical recovery from treatment, some of which may hamper the physical 
completion of the measures.  No maximum time from treatment was imposed.  The 
time since diagnosis and the time since treatment were both calculated from the 
data extracted from the SCR database and the dates on the returned surveys.  
These variables were included in the analysis.   
3.3.2 Exclusion criteria  
People were not approached or were excluded from one or more rounds of the 
data collection if they were newly diagnosed with cancer, either a primary or 
recurrence, or with a tumour or recurrence in a location not included in this 
research, e.g. breast cancer.  ‘Newly diagnosed’ was defined as being post-
diagnosis, but pre-treatment.  People were excluded if they were diagnosed with 
terminal cancer and/or were under-going palliative treatment.  Additionally if a 
person contacted (or had relatives contact) the researcher to request that no future 
questionnaires be sent, they were excluded from future mailings.  
3.4 Data collection 
At each time point, approaches were made to all people treated under the auspices 
of the ‘Head and Neck Directorate’ and represented on the SCR database (see 
glossary for further details).  As new people with HNC were added and reached 
inclusion criteria (being 3 months post-treatment), they were added to the list of 
people sent the questionnaire battery.  All questionnaires were sent out as hard 
copy via the royal mail along with a stamped, addressed envelope. 
71 
 
Literature on response rates indicates that, for the length of survey (65 questions) 
sent out, a 40% return rate is common (Iglesias et al., 2002).  Analysis of the SCR 
database shows that, on average, 30 new people matching the inclusion criteria 
would complete treatment each year.  One hundred and fifty one people comprised 
the entire respondent pool on the SCR database for year one.  Over the next four 
years a potential pool of 120 participants was expected.  This presented a total 
population of potentially 271 people over five years.  This would give a sample of 
108, with a 40% return rate (at year 5).  However these calculations do not account 
for the average across HNC sites of 50% survival rate at 5 years. 
The researcher is employed within the NHS and has approved access to information 
from NHS databases that can provide demographic, medical and social variables.  
Each year these databases were checked by the researcher to ensure adherence to 
exclusion criteria.  Figure 6 shows the number of surveys sent out and returned 
across the 5 years to all the people on the SCR database.  Some of which were 
participants from previous years and others were approached for the first time. 
3.5 Procedure 
A data management plan (DMP) was constructed.  This was done in order to save 
time by reducing the duplication of effort (e.g. capturing project and data-related 
information at a single entry point).  The aim in its construction was to ensure good 
research practice (e.g. clear and robust plans, the integrity and quality of data) and 
improved compliance with ethical and regulatory requirements (e.g. regarding 
management and retention of data, including confidential data).  It was also 
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designed to ensure the data could be understood and used, when collected and in 
the future. 
3.5.1 Participant information and consent 
A covering letter explaining why the person was receiving the measures was sent 
via Royal Mail® from the maxillofacial consultants (Appendix 7) inviting people to 
complete the questionnaires, which were also included.  A prepaid stamped, 
addressed envelope was included with the letter and questionnaires and it was 
presumed that completion and return of the questionnaires provided consent. 
3.5.2 Questionnaire ordering 
Close attention was paid to the length and number of questionnaires being sent to 
potential participants.  Piloting of the battery (collation of individual measures) on a 
small number (n=10) of people in a HNC clinic found that it took on average 15 
minutes to complete the measures.  The phenomenon of respondent fatigue occurs 
when participants become tired of the survey task and the quality of the data they 
provide begins to deteriorate.  It can be attributed to the respondents’ attention 
and motivation dropping towards the later sections of a measure.  Fatigued 
respondents may more often answer "don't know", may engage in "straight-line" 
responding (i.e. choosing answers down the same column on a page), may give 
more perfunctory answers, or give up answering the questionnaire altogether 
(Herzog and Bachman, 1981). 
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In order to account for possible response fatigue, ‘Latin Squares’ were produced 
which can account for the order of measure presentation (Myers and Well, 1991).  
This shows that the measures could be presented in six different orders (Table 2).   
Table 2: Latin Square for questionnaires for the first 3 years 
Order Presented 1st  Presented  2nd  Presented 3rd  
1 SF-12 UOW SLQ 
2 SF-12 SLQ UOW 
3 UOW SLQ SF-12 
4 UOW SF-12 SLQ 
5 SLQ UOW SF-12 
6 SLQ SF-12 UOW 
Key: This table shows the six different orders that the three questionnaires could have been placed 
in prior to being sent to possible participants from the Maxillofacial Group.  SF-12 = Medical 
Outcomes Short Form 12. UoW = University of Washington. SLQ = Silver Lining Questionnaire.  
3.5.3 Distribution 
The cover letters (Appendix 7) were mail-merged for all potential participants and 
printed out on Derriford Hospital headed paper.  The questionnaires were then 
printed and collated to attempt to account for ordering effects.  A unique identifier 
for each potential participant was written at the bottom of the last sheet of each 
questionnaire as it was paired with the cover letter. 
3.5.4 Data collection and storage 
Variables including gender, date of birth, ethnicities, tumour types and locations for 
all potential participants were sourced from the SCR Database and collected via a 
minimum data sheet (Appendix 5) for each person.  Employment status and marital 
status were demographic variables provided by participants via the questionnaire 
battery.  This information was gathered by the researcher and subsequently 
entered on to the SPSS database.  The hard copies were filed and stored in a secure 
room within the Maxillofacial Department at Derriford Hospital, Plymouth.  Due to 
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the large number of people treated for HNC it was not possible to review all of their 
clinical notes for further information.  
The data from the measures were entered into the SPSS (versions 19 - 23) database 
with the variables from the minimum data sheet.  The electronically stored 
information was password protected.  All computers are password protected and 
only the researcher had access to the database.  All personnel authorised for this 
access were documented in the study file.  All other documents were coded with 
the participants’ unique identifying number.  Data backup took place at the end of a 
day when data had been entered, manipulated, or analysed.  
Any additional information provided by participants such as reasons for non-
participation was noted by the researcher. 
3.6 Analysis of questionnaires 
Data regarding the reasons for not participating were collected from telephone calls 
made to the researcher by patients and patients’ relatives and from letters and 
returns from the Royal Mail®.  These were collated, reviewed and categorised using 
inductive post hoc categories. 
Descriptive statistics were obtained from the data and normal distribution assessed 
using Kolmogorov-Smirnov Goodness of Fit Test. 
3.6.1 Comparison with normative values 
Summary statistics were produced and compared with published statistics for 
established norms and disease groups, using one sample t-tests.  This allows for 
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evaluation of the extent to which the data collected in the current study may be 
generalised to participants recruited to other research studies. 
3.6.2 Between cohort analysis 
Before analysis of the research questions could be undertaken, the data from the 
five cohorts needed to be combined.  However, the cohorts needed to be assessed 
to ensure they were comparable.  The assessment was undertaken using the 
Kruskal-Wallis one-way analysis of variance, with Mann-Whitney test for post hoc 
analysis. 
3.6.3 Linear mixed-effect modelling 
A linear mixed-effects models (LMM) is a parametric linear model for clustered, 
longitudinal, or repeated-measures data that quantifies the relationship between a 
continuous dependent variable and various predictor variables (West, Welch & 
Galechki, 2014).  Like many other types of statistical models, LMM describe a 
relationship between a response variable and the covariates that have been 
measured or observed along with the response.  An LMM may include both fixed-
effect parameters associated with one or more continuous or categorical covariates 
and random effects associated with one or more random factors.  Longitudinal 
studies such as the present study, as well as other data including that collected in 
the human and biological sciences, have hierarchical and/or clustered structures.  
Linear mixed-effect models recognise the existence of such data hierarchies by 
allowing for residual components at each level in the hierarchy (Leech, Barrett & 
Morgan, 2008; West, Welch & Galechki, 2014).   
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West et al (2014, page 12) define the type of LMM analysis as 2 level longitudinal, 
where the participant is the level 2 unit of analysis, with participant-level covariates 
including, sex and staging of tumour. The level 1 repeated measures with 
participant-factor is time since completion of treatment, with dependent variables 
measured by SLQ. 
This analysis allows a relationship to be described about the longitudinal nature of 
PPC (Research Question 2) as well as how they relate to each other and HRQoL and 
how this is affected by biographical and clinical factors (Research Question 1).  In 
mixed-effects models at least one of the covariates is a categorical covariate 
representing experimental or observational units in the data set.  In the present 
study the observational units are the patients that return the measures.  The 
categorical covariate or covariates are observed at a set of discrete levels.  
Numbers, such as subject identifiers, were used to designate the particular levels 
that are observed but these numbers are simply labels.  
Analysis was undertaken with SPSS (version 19-23) using the linear mixed models 
function (SPSS Inc, 2008) and following the process prescribed by Leech et al (2008, 
chapter 11). 
SPSS uses REML (Restricted Maximum Likelihood) as the estimation method.  This 
adjusts for the fixed effects, usually leading to a reduction in standard error and is 
the default approach in SPSS. 
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3.6.4 Number of questionnaires sent out and returned 
The data collection methodology means that there will be missing information.  The 
phenomenon of missing data is commonly referred to as data holes.  After five 
years of data collection, survey returns stood at a total of 416 from 185 patients 
and; 
 71 people out of a potential 289 returned the survey pack once 
 53 people out of a potential 230 returned the survey pack twice 
 24 people out of a potential 178 returned the survey pack three times 
 15 people out of a potential 146 returned the survey pack four times 
 22 people out of a potential 57 returned the survey pack five times 
Not all of these returns could be used in the analysis due to incomplete responses.  
According to the research design, only the data from those people that returned 
the survey pack three or more times (n=61) are included in the longitudinal analysis 
(Research Question 2).  People that returned data only in years 4 and 5 are included 
in the analysis of research question 1 to increase the power of the statistical 
analysis.   
Data from the Integrated Patient Management System (IPMS) was collected on 
deaths and the SCR database was scrutinised for information on recurrent cancers 
each year.  A record was additionally kept of people that made it known to the 
team that they did not want to complete the survey. 
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Table 3: Numbers of measures sent out and returned across the 5 years 
 Sent Returned (%) 
2009 / Year 1 151 67 (44) 
2010 / Year 2 166 74 (45) 
2011 / Year 3 194 95 (49) 
2012 / Year 4 211 95 (45) 
2013 / Year 5 239 85 (36) 
 
3.6.5 Power and Sample size 
The nature of the data collection in this research was such that all possible 
participants were approached at each time point.  As such power calculations were 
not undertaken.  Therefore the rule of thumb that at least 10 responses per-
variable are needed for the analysis to be reliable is used and applied to the 
analysis related to research questions one and two (Kleinbaum, Kupper and Muller, 
1997). 
3.7 Methods summary 
The process or methods adopted and undertaken in research have been informed 
by theory and the practicalities of working with RWD (3.1.1) and within the ethical 
parameters of a hospital setting (3.1.2) and the researcher’s professional bodies 
(3.1.3).  The psychometric properties of the measures selected to be sent to the 
potential participants was reviewed (3.1.5 – 3.1.8).  The chapter then laid out how 
potential participants were identified (3.3) and the procedure for collecting (3.4) 
and storing the data.  Lastly the process for analysing the data was given (3.6), and 
the number of questionnaires sent out and returned was reported (3.6.4; Table 3, 
Figure 6). 
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The next chapter describes the data (4.1) and the results from four sections of 
statistical analysis (4.2 – 4.6).  The results are presented in the order in which they 
build on the previous section, with the final two sections explicitly address the 
research questions: 1) After the completion of treatment for Head and Neck 
Cancer, what are the demographic, clinical, and psychological factors associated 
with PPC that occur in the acute period, defined as between 3 and 12 months? (4.4) 
2) After the completion of treatment for Head and Neck Cancer, what are the 
trajectories for positive psychological change longitudinally, defined as longer than 
12 months? (4.5). 
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Figure 6: The number of measures sent and returned by year of recruitment 
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4.0 Results 
The results are split into five sections which build upon each other.  The first 
focuses on the response characteristics of the participants and relates that to each 
of the measures used (4.1).  This section provides reasons for missing data (4.1.1), 
as well as the variation is the responses from participants across the psychometric 
measures (4.1.2 – 4.1.5).  The second section covers descriptive statistics (4.2), 
measure of normality (4.2.1) and comparison of the collected data with published 
normative data from the measures used (4.2.2).  The third section examines the 
data for differences between the five cohorts recruited over the duration (4.3).  
These first three sections consider the results from a methodological perspective, 
validate the methods chosen and underpin the discussion section.  With the third 
section (4.3) being critical to justify the combining of data from the new recruits 
year on year. 
The final two sections explicitly address the research questions: 1) After the 
completion of treatment for Head and Neck Cancer, what are the demographic, 
clinical, and psychological factors associated with PPC that occur in the acute 
period, defined as between 3 and 12 months? (4.4) 2) After the completion of 
treatment for Head and Neck Cancer, what are the trajectories for positive 
psychological change longitudinally, defined as longer than 12 months? (4.5) 
At the end of each section the findings are summarised and the implications for the 
following section are given (4.4.4 and 4.5.7).  The interpretation of the findings is 
covered in the Discussion chapter (5.0).  
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4.1 Response characteristics 
Over the five years of data collection, 18 responses which gave reasons for not 
participating were received via telephone calls, direct letters, or returns from the 
Royal Mail® to the Maxillofacial Department (Table 4).  Some respondents had their 
views expressed by family members contacting the researcher to provide a reason 
for not participating in the study (Table 4). In addition to people’s active choice not 
to participate, 56 participants died over the course of the data collection. 
Table 4: Reasons given for not participating in the study 
Reasons for not participating 
Addressee gone away (n=3) 
Confused by the questionnaires - discussed with researcher on phone (n=1) 
Developed dementia (n=1) 
Do not want to complete questionnaires (n=2) 
Doing fine and does not feel need to complete questionnaires (n=1) 
Gone away on extended holiday (n=1) 
In the Royal Navy (n=2) 
Patient has other medical conditions preventing them from completing questionnaires (n=3) 
Patient in residential care home (n=3) 
Thinks questionnaires are a pointless exercise (n=1) 
4.1.1 Reasons for missing data 
Missing data is a recognised issue in clinical research (Little et al., 2012).  Data from 
notes and databases can only be as good as the original note taking and data entry.  
This is the case in this research and missing clinical variables are given below 
(Clinical Variables, 4.1.2).  Reasons for questionnaires being returned partially 
completed were often noted on the questionnaires themselves and these are also 
given below, by questionnaire (4.1.3 – 4.1.5). 
 83 
 
4.1.2 Clinical variables 
The clinical variables were obtained through hospital databases.  This meant that 
the accuracy and completeness was out of the control of the researcher.  The 
researcher planned to include ethnicity in the model, but this major data field was 
routinely not completed in either hospital database or in the hard copy medical 
notes.  Therefore, this variable could not be included in the analysis, but raw 
descriptive data are given below in Table 6. 
4.1.3 Medical Outcomes Short Form 12 Version 2 
The SF-12 is a simple questionnaire, however when questions were not answered 
people either wrote ‘N/A’ (Not Applicable), or ‘Don’t Understand’.  The other cause 
of missing data from this and all other questionnaires occurred when participants 
omitted whole pages, seemingly at random.  One comment written on one 
returned questionnaire was; ‘some of these questions seem a little strange, so I 
have not answered them’.  Across all 5 cohorts and time points, 200 (48%) of 
returned questionnaires contained a fully completed SF-12 that allowed 
comparative analysis. 
4.1.4 Silver Lining Questionnaire 
The SLQ had the most comments and missing data of all the questionnaires.  Across 
all 5 cohorts and time points 102 (29%) of returned SLQ were incomplete.  
However, the measure does have a protocol for filling up to 10% (3 questions) of 
missing responses with the mean average of the other given responses.  When this 
protocol is followed, across all 5 cohorts and time points, 401 (95%) of returned 
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questionnaires had SLQ data available for comparative analysis.  Table 5 gives a list 
of the comments reported on the questionnaires.  In addition to these comments, 
participants provided information on the illnesses they were using as the 
benchmark to respond to the items.  Many of these illnesses were not related to 
HNC, or the treatment and included; depression, anxiety personality disorders, 
Paget's Disease, bipolar disorder, osteo and rheumatoid arthritis, asthma, diabetes, 
Irritable Bowel Syndrome, prostate cancer, fibromyalgia, acne, back problems and 
Chronic Fatigue Syndrome. 
Table 5: Comments supplied by respondents on the Silver Lining Questionnaire 
Respondent Comments 
Can not complete as operation has no effect on my outlook on life 
I am a lucky person as I have always been confident and content with my life 
I didn't have an illness 
I don't understand 
I have never had any serious or prolonged illness  
N/A 
None 
4.1.5 University of Washington quality of life questionnaire 
As with the SF-12, some participants mentioned that they did not understand the 
point to some of the questions so did not answer them.  In some cases a 
respondent ticked two adjacent responses, perhaps to indicate that they felt they 
were between two levels.  However, across all 5 cohorts and time points, 391 (93%) 
of returned questionnaires were fully completed, which allowed calculation of the 
UoW total score and comparative analysis. 
 85 
 
4.1.6 Response characteristic findings summary 
The scales had a variable level of completion from 48% to 95%.  Some of the 
reasons for not returning the questionnaires, or for incomplete responses, were 
related to ongoing or progressive deterioration in health either due to HNC, other 
conditions or ageing.  Other reasons reported by participants were connected to 
beliefs about the methodology (e.g. thinks questionnaires are a pointless exercise), 
or that there is nothing to measure (e.g. Can not complete as operation has no 
effect on my outlook on life).  
In the following section of this chapter the descriptive statistics including the 
assessment for normality of the collected data are presented.  The scales are also 
compared with normative or comparative data from other disease groups where 
available. 
4.2 Descriptive statistics 
Over the course of five years, 278 participants who fulfilled inclusion criteria were 
sent questionnaires (189 male: 89 female).  One hundred and eighty five (66.5%) 
returned at least one completed (or partially completed) questionnaire.  Of those 
returning questionnaires, 128 (69.2%) were male.  The average age of the returning 
group was 61.5 years old (SD 13.2). 
Table 6 gives the ethnic origin of those returning questionnaires, as defined by the 
Somerset Cancer Register. 
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Table 6: Ethnic origin of returns and non-returns 
Returned at least one survey Frequency Percent 
No Return Valid White 36 38.7 
Not stated 57 61.3 
Total 93 100.0 
Returned Valid 
White 161 87.0 
Not stated 24 13.0 
Total 185 100.0 
Key: The ethnic origin of the participants was sourced from either the hospital patient database.  
However it is not routinely recorded on the databases. 
Independent t -tests indicated that between those who returned measures one or 
more times and those that did not, that there were no differences in relation to 
gender (t(276)=-0.605; p=0.546), age at time of diagnosis (t(276)=-0.940; p=0.348), 
stage of tumour (t(276)=-0.526;p=0.600), or socio-economic status as defined by 
the IMD (t(263)=-1.446; p=0.149). 
4.2.1 Normality  
Data was assessed for normality using the Kolmogorov-Smirov test for skewness 
and kurtosis in SPSS.  Values for asymmetry (skewness) and kurtosis between -2 and 
+2 are considered acceptable proof of normal univariate distribution (George and 
Mallery, 2010) and, as can be seen from table 7, this holds for the dependent 
variables (data from measures returned) (George and Mallery, 2010).  Table 7 
shows that there is good to high reliability in all the scales utilised in the current 
research. 
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4.2.2 Comparison with normative data 
Normative data is from a reference population that establishes a baseline 
distribution for a score or measurement.  It provides a score or measurement 
against which the study data can be compared.  Typically normative data is 
obtained from a large, randomly selected, representative sample from the wider 
population.  The values obtained in the current study have been compared with 
previously published work that used the same scales, or values published by the 
scales designers (e.g. SF-12 normative values).  This allows a comparison of the 
study population with 1) the general population, 2) a mixed disease group, 3) a 
cancer group, and 4) a HNC cohort, which can provide some evidence of the ability 
of the data to be generalised to a wider population. 
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Table 7: Descriptive statistics including Cronbach’s Alpha for scales used in the current research 
  
N Minimum Maximum Mean Std. Deviation Skewness Kurtosis Cronbach’s 
Alpha 
Statistic Statistic Statistic Statistic Statistic Statistic Std. Error Statistic Std. Error 
PCS 200 18.41 59.05 43.1698 9.35822 -.521 .172 -.556 .342 .839 
MCS 200 14.28 52.33 37.2141 7.92908 -.554 .172 .028 .342 .839 
SLQ Total 401 38 188 108.95 31.256 -.172 .122 -.120 .243 .971 
UoW Total 391 245 1200 896.82 190.668 -.661 .123 .003 .246 .850 
Key: SLQ Total = Silver Lining Questionnaire Total score, UoW Total = University of Washington Total score, PCS = Physical Component Summary, MCS = Mental 
Component Summary, N = Number of responses included in the analysis, Std Deviation = Standard Deviation, Std Error = Standard Error 
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4.2.2.1 Medical Outcome Short Form 12 Version 2 
The SF-12 manual provides an extensive list of normative data, split for age ranges.  
Table 8 shows the domain results for a population in the United States of America 
(USA), split for participants.  The normative data show that the older group had 
lower scores (therefore worse quality of life) on the SF-12 categories.   
One sample t-tests with Bonferroni correction were undertaken on the normative 
data for the cohort of 55-64 year olds, including both genders (Table 8; Ware, et al., 
1996).  The results show that the recruited study groups (Table 8) have lower scores 
(i.e. worse quality of life) on all the factors of the SF-12 compared to norms (Table 
8; Ware, et al., 1996). 
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Table 8: USA population norms for SF-12 and mean average data from study population 
 All Normative 
Data 
55 – 64 yr old 
Males & 
Females 
Study Data 
One-
sample t-
test 
 Mean SD Mean SD N Mean SD  
Physical 
Functioning 
49.20 10.10 47.46 9.66 407 45.16 12.28 0.001 
Role Physical 49.50 9.90 48.15 9.49 404 26.60 4.37 0.001 
Bodily Pain 49.70 9.80 48.67 9.40 402 47.05 12.25 0.008 
General Health 49.60 9.50 48.43 9.47 407 44.31 11.76 0.001 
Vitality 50.40 9.50 50.29 9.01 407 11.78 21.01 0.001 
Social Functioning 51.00 8.60 49.84 9.02 402 13.67 22.53 0.001 
Role Emotional 51.10 8.60 50.04 9.02 399 19.63 4.48 0.001 
Mental Health 51.70 8.40 51.21 8.63 242 47.19 10.04 0.001 
PCS  48.70 10.20 46.87 9.37 200 43.17 9.36 0.001 
MCS  51.90 8.00 50.94 8.44 200 37.21 7.93 0.001 
Key: The table shows the domain results for a USA sample of population norms (Ware, et al, 1996).  yr= years. N = the number 
of participants who completed the questionnaire.  SD = Standard Deviation.  A higher number indicates a better quality of life. 
N for ‘All’ group = 4142. N for 55-64 year old Males and Females = 1158.  It shows the domain results for the study group. N = 
the number of completed the questionnaires.  SD = Standard Deviation. A higher number indicates a better quality of life. PCS 
= Physical Component Scale of SF-12.  MCS = Mental Component Scale of the SF-12.  
4.2.2.2 Silver Lining Questionnaire 
Limited comparative data are available for the SLQ (Hyland et al., 2006; Sodergren 
et al., 2004), and no data were found to compare against study data in relation to 
age or gender.  Visual inspection of the data from this study and those reported in 
peer reviewed journals suggest that the greater the perceived severity of disease, 
the greater the level of positivity reported by respondents.  For example, data from 
people with sleep apnoea, or asthma showed low levels of positivity (mean 9.11 
and 10.97 respectively; Hyland et al 2006) when compared to data from people 
with lung cancer (mean 13.94; Hyland et al 2006) and also compared to data from 
  
 
91 
the current study (Hyland et al., 2006; Sodergren et al., 2004).  One-sample t-test 
using the data from these two previous publications and the current study data 
(mean 12.39) indicates that the current study group reported significantly more PPC 
than the asthma (P= 0.005) and sleep apnoea (P= 0.001) groups, but less than the 
lung cancer (P= 0.002) group. 
4.2.2.3 University of Washington quality of life questionnaire 
The UoW is a HNC specific measure, and therefore does not have normative data 
for comparison.  Appendix 8 shows data collected over a period of ten years by the 
Merseyside Regional Head and Neck Cancer Centre (MRHNCC).  The data are from 
patients that match the study group (oral cavity cancers), and are split by age group 
and gender.  The three treatment groups were categorised in this way by MRHNCC 
to form sub-groups of the cohort that allow for between treatment group 
comparisons.  The choice of the 3 categories was achieved through multi-
disciplinary discussion (Personal Communication with Professor Simon Rogers).  The 
sample (n = 528) from MRHNCC split by age and treatment does not allow for 
comparative statistical analysis with the current study data.  Appendix 8 shows the 
number of participants selecting each response for each UoW question.  The 
percentages of responses from those figures are then presented in brackets.  Visual 
inspection of the data by age, treatment regimen and UoW response suggests that 
the participants in the current study are similar to those responding to the UoW for 
MRHNCC. 
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4.2.3 Descriptive statistics findings summary 
Independent t-test analysis of gender, age at time of diagnosis, stage of tumour and 
socio-economic status indicated that there were no statistical differences between 
those who returned and those who did not return a questionnaire.  Data from the 
individual scales were normally distributed with high levels of internal reliability (as 
defined by Cronbach’s alpha). 
Comparison of the current study’s SF-12 data with age-matched normative values 
indicated that the participants had a statistically worse HRQoL than the disease free 
normative sample.  The SLQ does not have disease free normative data, but the 
statistical analysis of previous published data with the groups in this study indicated 
that the levels of PPC in the HNC group fall between those of asthmatics and those 
with lung cancer.  Statistical analysis between the study data and that sourced from 
Merseyside was not possible. 
The following section reports on the comparative assessment of the five individual 
cohorts at their initial time points (the first time they are approached to complete 
the questionnaires). 
4.3 Between cohort differences 
The use of a cross sequential study design means that it is important to ensure that 
the cohorts are comparable.  Therefore Kruskal-Wallis analysis was undertaken with 
the categorical data of gender, tumour staging and treatment regimen.  The results 
are presented in table 9. 
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Table 9: Chi-Square between study cohorts for nominal variables 
  Chi-Square Df Sig. 
Gender 2.234 4 0.693 
Tumour staging 0.718 4 0.949 
Treatment regimen 2.920 4 0.571 
Key: Df = Degrees of freedom, Sig = level of significance. 
The remaining data were appropriate for assessment with analysis of variance 
(ANOVA) and Tukey post-hoc testing.  Table 10 presents the statistics from the 
ANOVA.  The post-hoc analysis for all of these variables can be found in appendix 9. 
Table 10: ANOVA between study cohorts 
  F Statistic Df Sig. 
Age at time of diagnosis 1.877 4 0.116 
Age at time of completing the 
first questionnaire 
1.277 4 0.281 
PCS 0.382 4 0.821 
MCS 1.705 4 0.157 
SLQ 0.263 4 0.901 
UoW 0.505 4 0.732 
Key: PCS = Physical Component Scale, MCS = Mental Component Scale, SLQ = Silver Lining 
Questionnaire, UoW = University of Washington, Df = Degrees of freedom, Sig = level of significance. 
4.3.1 Cohort differences summary of findings 
The Kruskal-Wallis test and ANOVA confirmed that all five cohorts were comparable 
with each other across the main variables.  This means that they could be grouped 
for the remaining analysis. 
The remainder of the Results section presents the findings in sections addressing 
each of the research questions. 
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4.4 Research question 1: 
After the completion of treatment for Head and Neck Cancer, what are the 
demographic, clinical, and psychological factors associated with PPC that occur in 
the acute period, defined as between 3 and 12 months? 
4.4.1 Objectives: 
Establish a baseline reference for PPC in people between 3 and 12 months post-
treatment for HNC. 
a) Baseline for medical factors  
b) Baseline for psychological factors  
4.4.2 Medical factors associated with PPC during time point 1 
Twenty-seven female and 55 males, with a mean age of 64.69 years (standard 
deviation 10.28) at time of diagnosis were included in the analysis.  The mean 
average age at time of completing the questionnaires was 65.63 years (standard 
deviation 10.31).  Table 11 summarises descriptive data on all the biopsychosocial 
variables for participants completing the measures between 3 and 12 months.  The 
table provides data on the sample size of each variable including sub-categories of 
variables such as the 4 categories of cancer stage. 
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Table 11: Psychosocial characteristics of participants completing questionnaires between 3 and 12 
months 
   N Mean SD 
IMD 46 18.88 10.74 
Gender 
 Male 36   
 Female 16   
Age at Diagnosis 51 64.54 10.34 
Family Status 
 Married/living with partner 35   
 Living alone 8   
 Living with relatives/friends 1   
Cancer Stage 
 I 10   
 II 1   
 III 13   
 IV 26   
Treatment Regimen 
 Surgery 16   
 Surgery + Radiotherapy 17   
 
Radio with or without Chemo 
therapy (No Surgery) 
18   
Months Since Treatment 52 6.52 2.80 
SF-12 Domains 
 Physical Functioning 47 44.02 11.90 
 Role Physical 47 24.74 4.41 
 Bodily Pain 47 47.67 11.76 
 General Health 48 44.01 11.66 
 Vitality 52 23.66 23.55 
 Social Functioning 52 28.51 25.32 
 Role Emotional 46 19.74 4.61 
 Mental Health 28 49.41 8.72 
 MCS 26 41.68 10.00 
 PCS 26 38.99 8.42 
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   N Mean SD 
SLQ 52 11.85 9.46 
UoW – Total 49 885.00 191.96 
UoW – Domains 
 Pain 52 75.96 23.35 
 Appearance 52 77.46 20.98 
 Activity 52 70.33 23.33 
 Recreation 52 74.31 23.71 
 Swallowing 52 76.98 23.74 
 Chewing 52 68.41 32.04 
 Speech 51 85.82 19.10 
 Shoulder 50 84.25 27.29 
 Taste 51 61.66 33.77 
 Saliva 50 61.84 35.72 
 Mood 51 75.00 23.49 
 Anxiety 51 72.39 24.78 
Key: IMD = Indices of Multiple Deprivation, SF-12 = Short Form 12, MCS = Mental Component Scale, 
PCS = Physical Component Scale, SLQ = Silver Lining Questionnaire, UoW = University of Washington. 
Table 12 shows the results of LMM with SLQ as the dependent variable.  This 
modelling was split into 4 sections to allow for the number of responses per 
variable to not exceed Kleinbaum, et al (1997) rule of thumb of 10 responses per-
variable.  The first included modelling with IMD (measure of socio-economic 
status), gender, age at diagnosis, and family status.  The second included modelling 
treatment regimen and time since treatment (Table 12).  The third section included 
modelling the SF-12 with the mental and physical component scales, but not the 
other sub-scales due to the small number of respondents.  The fourth section 
included modelling with the total UoW without the sub-scales for the same reasons 
as not including the SF-12 sub-scales.   
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These suggests that between 3 and 12 months, family status, stage of the tumour 
and the treatment regimen all have a relationship with PPC as defined with the SLQ 
(P≥0.050, P≥0.006 and P≥0.044 respectively).  Figure 7 shows that between 3 and 
12 months post-treatment, participants with low stage tumours (stage 1) have a 
higher reported level of PPC than those with stage 2 and 3 tumours and noticeably 
higher than those with stage 4 tumours.  In the same time frame, participants that 
had surgery alone reported more positive changes either than those who had 
surgery with radiotherapy or than those who were not treated surgically but who 
had radiotherapy, with or without chemotherapy. 
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Table 12: Association of demographic, medical and psychosocial characteristics with SLQ scores 
  Baseline model 
Covariate  Estimate (SE) p-value 
IMD 8.706 (16.941) 0.114 
Gender  0.128 (6.108) 0.321 
Age at Diagnosis  8.637 (18.590) 0.257 
Family Status   0.050 
Married/living with partner -7.600 (9.428) 
Living alone -18.125 (9.860) 
Living with relatives/friends - 
Cancer Stage   0.006 
I 11.900 (3.104) 
II & III combined 50.090 (9.437) 
IV -0.804 (3.209) 
Treatment Regimen   0.044 
Surgery 6.989 (3.104) 
Surgery + Radiotherapy 22.764 (3.056) 
Radio with or without Chemo therapy ( No Surgery) - 
Time Since Treatment  14.549 (25.252) 0.806 
SF-12 Domains     
 MCS 91.333 (74.573) 0.634 
 PCS 91.333 (74.573) 0.634 
UoW – Total 57.000 (30.468) 0.231 
 
Key: SE = Standard Error, IMD = Indices of Multiple Deprivation, SF-12 = Short Form 12, MCS = 
Mental Component Scale, PCS = Physical Component Scale, SLQ = Silver Lining Questionnaire, UoW = 
University of Washington, - = covariance parameter is redundant, * = insufficient data for calculation 
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Figure 7: Relationship between SLQ and cancer stage 
 
Time since completion was entered into the model as raw interval data (unlike data 
used in the longitudinal model where time is categorised into groups) and did not 
show any relationship with change. 
4.4.3 Psychosocial factors associated with PPC during time point 1 
Figure 8 shows how family status, was associated with PPC (SLQ total).   
In the period covered by this analysis it appears that living alone, rather than with a 
partner is associated with a greater level of PPC (Table 12). 
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Figure 8: Relationship between SLQ and family Status 
 
4.4.4 Research question 1 findings summary 
Time since completion of therapy in the short term, between 3 and 12 months, did 
not show any relationship with PPC.  However, some medical factors did show 
some association.  Analysis suggests that stage of the tumour and the treatment 
regimen undergone by the participant both have a relationship with PPC as defined 
with the SLQ.  Participants with stage 1 tumours have a higher reported level of PPC 
than those with stage 2 and 3 and noticeably higher than those with stage 4 
tumours.  Participants that had surgery alone reported more PPC than those that 
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had surgery with radiotherapy, and those who were not treated surgically but who 
had radiotherapy with or without chemotherapy.  A social factor related with 
higher levels of PPC in this time frame was being married or living with a partner 
when compared to living alone or with relatives. 
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4.5 Research question 2: 
After the completion of treatment for Head and Neck Cancer, what are the 
trajectories for positive psychological change longitudinally, defined as longer than 
12 months? 
4.5.1 Objectives: 
Investigate the longitudinal pattern of PPC following treatment for HNC; 
a) How it relates to medical factors  
b) How it relates to psychological factors 
The data were assessed to construct longitudinal models of PPC.  Linear mixed-
effects models were used to evaluate the effects of demographic, medical, and 
psychosocial variables on SLQ scores.  Random coefficient models were used to 
assess the effects of these variables on SLQ scores over all time points.  Time was 
calculated as months since treatment completed, and grouped categorically.  The 
intercept and time slope were included as random effects in the models. 
Predictor variables included in the model were socio-demographic factors (age, 
family status, marital status) and medical factors (cancer stage, treatment regimen).  
The longitudinal model included baseline values for demographic variables and 
cancer stage.  Time-varying predictors where entered as baseline values and as 
changes from baseline at each subsequent time point.  Beta coefficients and 
standard errors were estimated using models containing all covariates listed earlier 
(4.4.2 – 4.4.3).  Least squares mean estimates for SLQ were calculated from the 
models with covariates set to the mean levels.  
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4.5.2 Longitudinal pattern of change  
Data for time were collected as interval data, and grouped into categories guided 
by the clinical practice of patient review post-therapy.  Tables 13-18 summarise 
descriptive data, including the sample size, of all the biopsychosocial variables at 
seven categorical time points.  ANOVA with post-hoc analysis (Appendix 9) 
indicated that the SLQ did not show any significant change over time.  No sub-scale 
of the HRQoL (as measured by the SF-12), or the HNC-specific QoL (as measured by 
the UoW) factors.  Age at time of diagnosis showed a significant difference on 
ANOVA analysis, but post-hoc 'Tukey' analysis failed to locate the time points were 
a significant difference lay.  This is because the Tukey procedure controls the Type I 
error rate and requires a larger difference to declare significance compared to if no 
adjustment was used. 
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Table 13: Biological and social characteristics by time since treatment completed 
  3 to 6 months 7 to 12 months 13 to 18 months 19 to 24 months  
  N Mean SD N Mean SD N Mean SD N Mean SD P-Value 
IMD 37 19.02 11.82 33 18.73 9.56 22 20.91 10.52 11 26.78 13.65 0.362 
Gender 
 Male 26   26   15   8    
 Female 14   11   7   3    
Age at Diagnosis 39 65.59 11.54 37 63.433 8.937 22 59.41 9.05 11 59.55 12.91 0.042 
Family status 
 Married/living with partner 26   24   13   7    
 Living alone 9   6   4   3    
 Living with relatives/friends 2   0   0   1    
Cancer Stage 
 I 9   5   3   2    
 II 5   2   3   4    
 III 5   11   3   0    
 IV 19   15   9   3    
Treatment Regimen 
 Surgery 16   11   5   5    
 Surgery + Radiotherapy 14   14   12   2    
 Radio with or without Chemo 
therapy (No surgery) 8   12   4   4    
Key: N = number of participants completing the measure, SD = Standard Deviation, P-Value = statistical level of significance 
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Table 14 Biological and social characteristics by time since treatment completed 
  25 to 36 months 37 to 60 months 61+ months  
  N Mean SD N Mean SD N Mean SD P-Value 
IMD 20 23.39 12.53 23 19.43 8.63 25 21.72 13.31 0.362 
Gender 
 Male 13   17   18    
 Female 7   6   7    
Age at Diagnosis 20 64.95 15.34 23 58.87 10.86 25 57.64 10.69 0.042 
Family status 
 Married/living with partner 16   14   17    
 Living alone 1   5   5    
 Living with relatives/friends 2   1   1    
Cancer Stage 
 I 4   8   6    
 II 4   5   7    
 III 2   5   8    
 IV 9   5   4    
Treatment Regimen 
 Surgery 8   10   9    
 Surgery + Radiotherapy 7   8   14    
 Radio with or without Chemo 
therapy (No surgery) 4   5   2    
Key: N = number of participants completing the measure, SD = Standard Deviation, P-Value = statistical level of significance    
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Table 15: Psychosocial characteristics by time since treatment completed 
  3 to 6 months 7 to 12 months 13 to 18 months 19 to 24 months  
  N Mean SD N Mean SD N Mean SD N Mean SD P-Value 
Time since treatment 40 4.23 1.27 37 9.00 1.62 22 15.23 1.77 11 21.55 1.81  
SF-12 Domains       
 Physical 
Functioning 
30 46.45 11.30 18 41.20 11.62 16 47.34 10.15 6 45.02 12.93 0.483 
 Role Physical 30 25.39 4.42 18 23.91 4.35 16 25.51 4.72 6 26.47 4.76 0.414 
 Bodily Pain 30 48.27 10.82 18 46.68 13.75 15 47.93 11.85 6 45.55 13.54 0.698 
 General Health 30 43.66 12.26 19 45.31 10.70 17 43.10 8.70 6 50.13 5.90 0.789 
 Vitality 40 33.30 21.66 37 16.43 22.47 22 27.64 23.27 11 19.64 20.56 0.708 
 Social Functioning 40 36.12 23.25 37 22.88 25.72 22 34.44 25.79 11 26.27 26.11 0.667 
 Role Emotional 30 19.92 4.58 17 19.57 4.89 16 18.69 4.88 6 20.67 2.89 0.388 
 Mental Health 21 49.45 9.37 7 49.74 7.76 8 50.83 7.10 6 43.21 8.40 0.292 
 MCS 18 37.10 8.78 16 40.05 8.15 12 37.75 5.83 7 36.92 3.96 0.120 
 PCS 18 41.48 11.28 16 42.05 8.92 12 42.74 10.66 7 47.05 6.84 0.186 
SLQ 28 11.21 9.84 23 12.70 9.33 16 12.75 9.83 6 17.83 13.60 0.223 
Key: N = number of participants completing the measure, SD = Standard Deviation, P-Value = statistical level of significance, SF-12 = Short Form 12, MCS = Mental Component Scale, 
PCS = Physical Component Scale, SLQ = Silver Lining Questionnaire, N/A = Not applicable 
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Table 16: Psychosocial characteristics by time since treatment completed 
  25 to 36 months 37 to 60 months 61+ months  
  N Mean SD N Mean SD N Mean SD P-Value 
Time since treatment 20 31.15 3.59 23 49.22 6.87 25 82.36 20.01  
SF-12 Domains       
 Physical 
Functioning 
9 48.83 6.72 14 44.20 12.92 16 45.20 13.93 0.483 
 Role Physical 9 26.47 3.99 13 24.58 4.78 16 25.51 4.72 0.414 
 Bodily Pain 10 49.29 10.52 13 48.03 14.69 16 43.43 13.86 0.698 
 General Health 10 42.37 9.77 14 44.59 9.40 16 42.18 13.53 0.789 
 Vitality 20 20.86 23.12 23 22.40 25.50 25 26.04 27.62 0.708 
 Social Functioning 20 24.25 25.89 23 27.14 25.43 25 27.32 24.96 0.667 
 Role Emotional 10 18.06 5.77 14 19.24 4.76 16 19.04 4.51 0.388 
 Mental Health 9 42.87 10.61 9 48.29 11.41 6 50.32 8.33 0.292 
 MCS 11 32.92 7.31 11 35.58 8.11 8 31.28 6.90 0.120 
 PCS 11 42.31 8.65 11 47.09 6.02 8 44.24 9.51 0.186 
SLQ 9 13.22 6.42 14 16.50 8.14 15 12.40 10.74 0.223 
Key: N = number of participants completing the measure, SD = Standard Deviation, P-Value = statistical level of significance, SF-12 = Short Form 12, MCS = Mental Component Scale, 
PCS = Physical Component Scale, SLQ = Silver Lining Questionnaire, N/A = Not applicable 
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Table 17: Psychosocial characteristics by time since treatment completed 
  3 to 6 months 7 to 12 months 13 to 18 months 19 to 24 months  
  N Mean SD N Mean SD N Mean SD N Mean SD P-Value 
UoW – Total 38 857.24 216.26 34 915.29 149.00 21 910.00 185.40 10 917.00 203.05 0.837 
UoW Domains      
 Pain 40 76.25 23.99 37 79.05 23.21 22 76.14 21.10 11 68.18 25.36 0.604 
 Appearance 40 74.38 20.01 37 77.03 18.98 22 79.55 22.67 11 79.55 21.85 0.254 
 Activity 40 65.00 25.82 36 71.53 23.26 22 75.00 21.82 11 65.91 20.23 0.253 
 Recreation 40 66.25 26.88 36 77.08 21.86 22 81.82 15.78 11 72.73 32.51 0.183 
 Swallowing 38 71.50 31.83 36 81.67 14.83 22 79.09 18.23 11 86.36 15.67 0.590 
 Chewing 40 63.75 37.53 36 72.22 27.89 22 77.27 25.48 11 86.36 23.36 0.664 
 Speech 40 84.25 21.11 36 87.50 15.00 21 91.43 13.89 11 90.91 22.12 0.821 
 Shoulder 40 77.89 32.98 35 87.14 24.44 21 82.86 29.35 11 94.55 12.14 0.426 
 Taste 40 60.25 37.86 35 56.00 30.51 21 69.05 25.87 11 73.64 32.95 0.302 
 Saliva 40 66.75 41.04 34 67.35 28.32 21 48.10 28.92 11 79.09 34.48 0.105 
 Mood 40 73.12 24.93 35 77.86 19.90 21 77.38 20.7 10 70.00 15.81 0.847 
 Anxiety 40 71.50 24.13 35 76.00 19.88 21 70.00 20.49 10 57.00 33.02 0.725 
Key: N = number of participants completing the measure, SD = Standard Deviation, P-Value = statistical level of significance, UoW = University of Washington, N/A = Not applicable 
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Table 18: Psychosocial characteristics by time since treatment completed 
  25 to 36 months 37 to 60 months 61+ months  
  N Mean SD N Mean SD N Mean SD P-Value 
UoW – Total 20 836.25 170.59 21 910.71 221.33 23 891.52 211.53 0.837 
UoW Domains     
 Pain 20 67.50 23.09 21 85.71 21.75 24 77.08 22.01 0.604 
 Appearance 20 80.00 22.36 21 84.52 18.50 24 73.96 26.04 0.254 
 Activity 20 67.50 21.61 21 78.57 22.76 24 70.83 24.08 0.253 
 Recreation 20 66.25 23.33 21 78.57 24.10 24 79.17 21.70 0.183 
 Swallowing 20 73.50 19.81 21 75.24 30.10 24 80.42 21.36 0.590 
 Chewing 20 62.50 31.93 21 61.90 35.02 24 68.75 32.35 0.664 
 Speech 20 84.50 19.60 22 81.36 22.10 24 86.25 15.27 0.821 
 Shoulder 20 78.00 33.81 22 92.73 17.51 24 84.17 5.69 0.426 
 Taste 20 58.50 29.96 22 62.27 39.51 24 59.58 33.81 0.302 
 Saliva 20 51.00 36.11 22 58.64 37.96 23 63.04 34.57 0.105 
 Mood 20 75.00 26.90 22 79.55 23.95 24 75.00 28.55 0.847 
 Anxiety 20 72.00 23.97 22 78.64 24.45 24 75.00 32.30 0.725 
Key: N = number of participants completing the measure, SD = Standard Deviation, P-Value = statistical level of significance, UoW = University of Washington, N/A = Not applicable 
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4.5.3 Medical factors associated with PPC up to 11 years post treatment 
The LMM for research question 2 mirrors the four stages used to assess research 
question 1 (section 4.4.2).  Table 28 in appendix 10 shows the results of LMM with 
SLQ as the dependent variable.  These indicate that stage of the tumour and the 
treatment regimen both have a significant effect on reported PPC (P≥0.009 and 
P≥0.003 respectively).   
Further analysis with ANOVA and post-hoc testing indicated that over the duration 
of data collection (longitudinally), participants with stage 1 tumours at time of 
diagnosis reported more PPC than those with higher stage (3 or 4) tumours at time 
of diagnosis (F=1.533, P≥0.027; Appendix 11 contains post-hoc analysis).  Over the 
same time frame, participants that had surgery alone reported more positive 
changes than those that had surgery with radiotherapy (t=2.317, P≥0.021), and 
those who were not treated surgically, but who had had radiotherapy with or 
without chemotherapy; t=3.213, P≥0.001). 
In the multivariable model that adjusts for psychosocial variables, SLQ had a 
quadratic relationship with time since diagnosis, increasing initially after diagnosis 
and levelling off over time (Figure 9).  
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Figure 9: Quadratic relationship between SLQ and months since completion of treatment 
 
4.5.4 Psychosocial factors associated with PPC up to 11 years post 
treatment 
The SLQ did not show any association when modelled using LMM with gender or 
family status (Appendix 10, P≥0.053 & P≥0.366 respectively).   
Figure 10 shows how socio-economic status, as measured by the IMD, was 
associated with PPC with the SLQ.  It indicates that those participants with high or 
low socio-economic status reported greater levels of PPC than those in the middle 
of the scale.   
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Figure 10: Relationship between SLQ and IMD 2007 
 
Linear mixed-effects modelling with the sub-scales of the UoW found an association 
with positive change.  The majority of the sub-scales did not return a statistical 
value due to the parameter being redundant, but fewer associated problems were 
impacted most by Chewing, Speech and Taste from the UoW (Appendix 10; Table 
28).  The longitudinal model with the SLQ as dependent variable failed to find any 
impact or relationship of the SF-12 physical or mental component scores (Appendix 
10; Table 28). 
4.5.5 Variables associated with PPC 
In the multivariable baseline model, stage of tumour and treatment regimen and 
socio-economic status were significantly associated with SLQ scores.  In the 
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multivariable longitudinal model, lower stage of tumour (Estimate 3.433, P=0.009), 
surgery as the only treatment regimen (Estimate 3.997, P=0.003) were both 
significantly associated with higher SLQ scores (Appendix 10; Table 28).   
4.5.6 Psychosocial factors associated with PPC between baseline and 
longitudinal time points 
Linear mixed-effects models were undertaken on the difference between the 
baseline data (12 months and less since completion of treatment) and the 
longitudinal time points.  The medical and psychosocial variables were fixed factors 
within the model and therefore were not included as predictors in the model.   
The difference between baseline data and longitudinal data was modelled using 
LMM with SLQ as the dependent variable.  Similar issues with parameter 
redundancy relating to the UoW were found.  Only the Physical Component Scale 
(PCS) of the SF-12 and 7 subscales of the UoW (chewing, taste, activity, recreation, 
swallowing, saliva and mood) showed that an improvement in these health-related 
measures over time as associated with the generation of PPC in the participants 
(Appendix 10; Table 28).  
4.5.7 Research question 2 findings summary 
In modelling the longitudinal nature of PPC, the stage of the tumour and the 
treatment regimen both have a relationship with the total score of the SLQ.  The 
participants with lower stage tumours and those that only had surgical intervention 
report more PPC. 
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In the multivariable model that adjusts for psychosocial variables, SLQ had a 
quadratic relationship with time since diagnosis, increasing initially after diagnosis 
and levelling off over time, after about 18 months.  
Longitudinally the SLQ did not show any association when modelled with gender or 
family status.  Other social factors did show a relationship with PPC.  Participants 
with high or low socio-economic status as measured by the IMD reported greater 
levels of PPC than those participants in the middle of the scale.  This differs from 
the results of the short-term baseline data reported above. 
Positive change, with fewer associated problems, was impacted most by chewing, 
speech and taste from the UoW.  The longitudinal model with the SLQ as 
dependent variable did not find a relationship with the SF-12 or any of its sub-
scales. 
When the data were compared at baseline (between 3 and 12 months) and at other 
data points, stage of tumour, treatment regimen, and socio-economic status were 
significantly associated with higher SLQ scores. 
When the difference between baseline data and longitudinal data was modelled 
using LMM with SLQ as the dependent variable, PCS subscales of the SF-12  and 7 
subscales of the UoW (chewing, taste, activity, recreation, swallowing, saliva and 
mood) showed that an improvement over time with the generation of PPC in the 
participants.  
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5.0 Discussion 
There are six major sections to this Discussion chapter.  The first section (5.1) 
provides a review of the studies contribution to new knowledge.  It is followed by a 
critique of the results in relation to the two research questions (5.2.1 and 5.2.2) and 
then a review of the methodology of enquiry (5.3).  This is followed by a review of 
the study design (5.4) including methods and methodology adopted and the 
strengths and weaknesses of the study (5.4.7).  The third section (5.5) relates the 
phenomenon of PPC in a HNC population to the current multidisciplinary guidelines 
for the population’s clinical and psychological treatment.  Lastly suggestions for 
future research are presented(5.6)  
5.1 Contribution to knowledge 
This thesis has created new knowledge through the identification and 
characterisation of trajectories in the development of PPC in a HNC population.  
Trajectories have previously been identified in a BC population (Danhauer, 2015; 
Figure 4), but not with HNC.  It has furthered knowledge by covering a longer time 
span, over 5 years post treatment.  This represents a longitudinal study within a 
cancer population, where previous research has stopped at 12 or 18 months 
following diagnosis or treatment.   
This thesis has further contributed to the knowledge base through the use of a 
cross-sequential methodology in a HNC population.  The adoption of this cross-
sequential methodology allowed for longitudinal data collection in a population 
that present challenges for long term data collection due to the nature of the HNC 
and patterns of survival.   
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5.2 Discussion of Findings 
This section is concerned with discussing the findings and providing some 
interpretation of them.  It reflects on the data collected and how it relates to the 
research questions.  
5.2.1 Research Question 1: After the completion of treatment for Head and 
Neck Cancer, what are the demographic, clinical, and psychological factors 
associated with PPC that occur in the acute period, defined as 3-12 months? 
Linear mixed-effects models suggested that both the clinical stage of the tumour 
and the treatment regimen undergone by the person have a relationship with PPC 
as defined with the SLQ.  People with stage 1 tumours had a higher reported level 
of PPC than those with stage 2 and 3 all of these are higher than those with stage 4 
tumours.  This may be because those people who were diagnosed with a low stage 
(1 or tumour in-situ), did not interpret this as a significant life changing event.  
People diagnosed with stage 4 tumours may have experienced such significant 
distress, or negative treatment side effects, that they have not been able to find 
any positive change, at least yet. 
People that had surgery alone reported more PPC than those that had surgery with 
just radiotherapy and those that had radiotherapy with or without chemotherapy 
(no surgery). 
There is an interrelationship between tumour staging and treatment decision that 
may also impact to PPC. Lower stage, i.e. smaller, locally defined (no invasion into 
other tissues, or metastasis) will receive less aggressive curative treatments.  
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People who are treated with surgery alone, will still have received the diagnosis of 
cancer and had to undergo the same diagnostic investigations as those people who 
have radio and chemo therapy, but their surgery is more likely to be a one off event 
with minimal hospital stay time.  Many surgical interventions do not require 
multiple hospital visits to receive treatment.  On completion of the surgery people 
with low stage tumours may receive a clear report from the surgeon that they were 
able to remove the entire tumour (if the surgery does not fully clear the tumour, 
these people usually go on to receive radiotherapy).  This acute experience of a 
cancer diagnosis and treatment along with reassurance from the surgeon may 
mean that a person does not perceive the experience as traumatic enough to 
shatter their assumptive world. 
Using the IMD to measure socio-economic status showed that, in the short term (3 
– 12 months), there is no relationship with PPC.  This differs from research 
undertaken with people with BC, where those who were more deprived had more 
PPC (Tomich and Helgeson, 2004).  It is unclear why these differences may exist, but 
it may be that the IMD is not sensitive enough to show a change or that the sample 
was not large enough.  It may also be that people with a higher socio-economic 
status are more likely to return the measures and be in the BC than the non-BC 
population, and may be less worried about financial matters in the short term and 
subsequently are able to develop PPC. 
Another social factor related with higher levels of PPC in this short (3 - 12 months) 
time frame was being married, when compared to living alone and this in term was 
more beneficial than living with a partner or relative(s).  This supports the findings 
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of Ho et al., (2011) who found that oral cancer patients who were married reported 
higher levels of PPC than those that were unmarried.  Closer social relationships 
with family and friends is a key trait of PPC (Tedeschi and Calhoun, 2004).   
No psychologically variables (collected using the SF-12 or UoW) showed any 
association with PPC.  This differs from that reported in BC studies.  Danhauer et al. 
(2015), suggest that PPC is mediated in people with "high" quality of life and or 
mental health.  The Danhauer et al (2015) study collected data over an 18 month 
time period with a larger (n=653) number of participants than the current work, 
their ability to differentiate mediating factors could explain the difference between 
their BC groups and the current study population.   
The time since completion of therapy in the short term (between 3 and 12 months) 
did not show any relationship with PPC.  These findings suggest that PPC within an 
HNC population  might be affected by demographic, medical and psychological 
factors in the short (3 to 12 months) term, but that it is primarily a longitudinal 
phenomenon and may not be presented by respondents in the short term. 
5.2.2 Research Question 2: After the completion of treatment for Head and 
Neck Cancer, what are the trajectories for positive psychological change 
longitudinally (defined as longer than 12 months)? 
The short term (between 3 and 12 months) is taken as a baseline in this study, from 
which the longitudinal study extends. In modelling the longitudinal nature of PPC, 
the stage of the tumour and the treatment regimen both had a relationship with 
the total score of the SLQ.  People with lower stage tumours and those that only 
had surgical intervention report more PPC.  This is the same pattern as found in the 
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short term.  The possible explanation for these findings holds for this extended time 
frame; the participants have been able to recover from their discrete episode of 
treatment and develop PPC.  Inhibited development of PPC may also arise in 
prolonged radio and chemo treatments from prolonged health issues, delayed 
recovery from treatment, or adjusting to the long-term consequences of the 
treatment. 
The SLQ score increased initially after diagnosis and stabilised over time, 
demonstrating a relationship with time since treatment, after adjustments for 
psychosocial variables (4.5.4).  This pattern is similar to that found by Danhauer et 
al. (2013a), although that work was only over a 18 month period.  Subsequent work 
by the Danhauer et al. (2015) found that within the same dataset as the 2013 work, 
there were actually 6 trajectories (Figure 4) with differing underlying psychosocial 
and medical characteristics.  It is possible that the current study has a similar 
heterogeneity within its sample, but there are insufficient participants to 
statistically establish them. 
In a different pattern from that found in the short term (between 3 and 12 months; 
4.4), longitudinally the SLQ did not show any association when modelled with 
gender or family status (4.5.4).  Socio-economic status continued to show a 
relationship with PPC.  In the first year following treatment, respondents with a 
high socio-economic status demonstrate PPC (Figure 8; 4.4.3).  This pattern became 
more complicated over the extended time data set.  Respondents with high or low 
socio-economic status reported greater levels of PPC than those people in the 
middle of the scale (Figure 10; 4.5.4).  It is possible that the people at either end of 
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the IMD data set differ in the type or facet of PPC they are experiencing.  The 
literature suggests that there are different facets of PPC, such as; relating to others 
(greater intimacy and compassion for others), new possibilities (new roles and new 
people), personal strength (feeling personally stronger), spiritual change (being 
more connected spiritually), and a deeper appreciation of life (Tedeschi and 
Calhoun, 2004).  The SLQ as used in the current research is analysed as a uni-
dimensional measure of PPC, so it does not contain sub-scales measuring these 
factors, and limits the further interpretation of the pattern found in the current 
work.  Although McBride et al (2008) have suggested that a shorter 24 item version 
of the SLQ loads onto five factors (improved personal relationships, greater 
appreciation for life, positive influence on others, personal inner strength and 
changes in life philosophy), all aligned with the theory of PPC. 
The sub-scales of Chewing, Speech and Taste from the UoW had an association with 
PPC, were a greater level of PPC being present with fewer problems associated with 
these three factors of HNC QoL (Appendix 10).  These three HNC specific factors are 
all known to be negatively affected by radiotherapy and chemo-radiotherapy, more 
than surgery alone (Rogers et al., 2000).  These findings are reassuring and 
supportive in light of the effect of treatment regimen on PPC.  Interestingly, 
longitudinally the global QoL scale (SF-12) did not have any relationship with PPC 
(Appendix 10).  This matches the baseline data (3 to 12 months) suggesting that 
greater numbers of completed SF-12 measures are needed to fully understand 
what this means in the long-term of this patient cohort. 
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Looking between the baseline (3 to 12 months) and other data points, higher SLQ 
scores were significantly associated with lower stage of tumour, surgery as the only 
treatment regimen, high and low socio-economic status, easier chewing, normal or 
low levels of speech problems, and no or low levels of taste concerns (4.5.6). 
Using LMM to examine the differences between baseline (3 to 12months) and 
longitudinal data with the SLQ as the dependent variable found that the PCS 
subscale of the SF-12, and 7 subscales of the UoW (chewing, taste, activity, 
recreation, swallowing, saliva and mood) were associated with higher levels of PPC 
(4.5.6; Appendix 10).  This suggests that there is a change in the characteristics of 
PPC and associated variables after the initial 3 to 12 months post-treatment.  It is 
conceivable that in the short time frame PPC is more related to coping or short 
term benefit finding, than the development of a more permanent change in 
perspective.  The analysis suggests that in the longer term, PCS sub-scale of the SF-
12 and UoW may be the more meaningful variables associated with the 
development or the sustaining of PPC. 
5.2.3 Participant Response Characteristics  
The scales used in the current study had completion rates between 48 and 95 
percent (4.1.6).  Some of the reasons for not returning the questionnaires or 
incomplete responses were related to ongoing or progressive deterioration in 
health either due to HNC, other conditions, or aging (Table 4).  The information 
about progressive health issues not related to cancer were not presented in the 
electronic records interrogated in this research.  Therefore the responses sent back 
providing this information were very useful, and highlight that future longitudinal 
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research needs to record co-morbidities and significant life events that may interact 
with HNC in the developed or moderation of PPC.   
Other reasons for not retuning completed scales were connected to beliefs about 
the methodology (e.g., Thinks questionnaires are a pointless exercise), or that there 
is nothing to measure (e.g., Cannot complete as operation has no affect on my 
outlook on life).  Peoples views about surveys and research in general can not be 
known until they are approached, so although some did not supply data about the 
development of PPC, it was interesting to gain insight into those that did not feel 
they had changed and why others might not have responded. 
The three measures used in the current research contained a total of 65 questions.  
It was estimated that it would take 25 minutes to complete all the questions.  This 
was an estimate from personal observations in pilot testing, as no average time to 
complete has been reported for the SLQ and UoW. 
In the current study there was a surprisingly poor completion rate for the SF-12 
(48%; 4.1.4).  The three measures used (SF-12, SLQ, UoW) were ordered using a 
Latin Square, so it is unlikely that the poor completion rate is due to fatigue related 
to the length of the survey.  It is possible that the SF-12 may have a low level of 
acceptability for respondents.  There has previously been concern over completion 
rates for the SF-12 in community studies.  An Australian study found that 78% 
completed all 12 items (Lim and Fisher, 1999), and a British study found 84.1% of 
55,000 respondents completed all 12 items (Jenkinson et al., 2001), but the current 
study is notably worse than these.  No free-text was asked for from the 
respondents regarding incomplete returns, however, the reason for the high 
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incompletion rate in the current study remains unclear and may be a topic for 
future research and would benefit from the involvement of a formal patient public 
involvement.  The SF-12 remains effective as a brief but broad-ranging instrument, 
suitable for survey use and sensitive to change as an evaluative instrument 
(McDowell, 2006).  Further investigation is required to understand the low 
completion rates in this study, but the researcher would consider retaining this 
measure in future studies/work due to its generic nature and brevity.  
There is no data reporting on completion or partial completion rates where the 
respondents returned it via a postal survey.  One study that recruited 194 patients 
had a 1.5% non-completion rate but did not report how many of their participants 
partially completed measures (Sodergren et al., 2004).  The SLQ authors describe a 
process to calculate a total score from a return that has at least 93% of the items 
completed.  Previous studies have not reported the use of this process for 
calculating a total score from completed returned scores. In the current study there 
was a 71% total completion of the SLQ, with this rising to 95% using the correction 
method (4.1.4).  Those that did not complete the scale at all reported that they “did 
not understand”, but it was not clear if it was the questions or the reason behind 
being asked them (4.1.4, Table 5).  Others commented that they had not had an 
illness, or that the disease/treatment they had had did not have any effect on their 
outlook on life.  This suggests that the questionnaire was well received by the 
people completing it.  
The UoW is a disease specific measure (HNC) and as such focuses on issues relevant 
to people that have had a diagnosis of this type of cancer.  By virtue of its brevity it 
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does not include other issues of QoL, e.g. cognitive function.  The questionnaire has 
proven itself a suitable head and neck measure for routine clinical practice as it is 
quick and simple for patients to complete and is easy for clinicians and researchers 
alike to interpret (Rogers et al., 1998).  A completion rate of 88% was reported in 
study where the measure was compared to QoL measures (Rogers et al., 1998).  In 
the current study 93% of the returns had a fully completed UoW (4.1.5).  The high 
level of completion indicates a good level of acceptability of the questions and 
recognition that the measure is directly related to the person’s experiences of HNC 
and its potential acute and long term consequences.  
As noted in the methods section of this manuscript there are many measures 
designed to look at both PPC and QoL (3.1.5; Appendix 4).  The measures selected 
for use in the current study were chosen following assessment of their 
psychometric properties, previous use in the patient group, and length.  Even so it 
might be that these measures do not ask the type of questions in the way that 
would elicit relevant information from the particular patient cohort.  An elderly 
population such as the HNC cohort, often who have multiple comorbidities, may 
have found that even 25 minutes to complete all the measures was too much of a 
burden. 
Longitudinal studies investigating potential trajectories of PPC in people with BC 
have responses from between 124 and 653 (average 304) participants (Danhauer et 
al., 2015, 2013a, 2009; McDonough et al., 2014; Wang et al., 2014).  Two of these 
studies report about an 80% return rate at their last time point, but do not clarify 
how this related to factors such as the age of their potential participant pool 
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(Danhauer et al., 2013a; Wang et al., 2014).  Other studies have been as low as 40% 
(Manne et al., 2004), which is comparable to the present study. 
5.2.4 Descriptive statistics 
No statistical difference was found between the people that returned and those 
that did not return a questionnaire battery (4.2.2; Table 7).  Data from the 
individual scales was normally distributed with high levels of internal reliability (as 
defined by Cronbach’s alpha). 
Comparison of the SF-12 data with age matched normative values indicated that  
people who had HNC had a statistically worse HRQoL than the disease free 
normative sample, for all ages and an age matched sample (4.2.2.1; Table 8).  The 
SLQ does not have disease free normative data, but the statistical analysis of 
previous published data with these studies groups indicated that the HNC group 
levels of PPC fall between those of asthmatics and those of people with lung cancer 
(4.2.2.2). 
Statistical analysis between the study data and that sourced from the Merseyside 
regional HNC centre was not possible (4.2.2.3).  The Merseyside data (Appendix 8) 
suggests that the participants are somewhat similar to those from the Merseyside 
area, and would allow for comparison of future work. 
5.2.5 Between cohort differences 
New people met the inclusion criteria at each year of data collection.  This led to 
five cohorts in the data set (4.3).  With this type of study design it is important to 
check that each of cohorts are comparable.  Analysis of each cohort with each 
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other, and across the main factors (age at time of diagnosis, age at time of 
completing the first questionnaire, PCS, MCS, SLQ, UoW), found that there were no 
differences between each cohort.  This meant that they could be grouped for the 
analysis. 
5.2.6 Psychometric Measures of PPC 
In the 1990s a number of self-report psychometric measures were developed 
including the SLQ.  Appendix 4 gives an overview of many of these measures, 
however only one study has compared PPC by looking at the structural 
classifications of the measures (Joseph et al., 2004).  Joseph et al. (2004) recruited 
176 adults, who had experienced a range of distressing life events.  These people 
completed the Perceived Benefit Scales, the Thriving Scale, and the Posttraumatic 
Growth Inventory.  Confirmatory factor analysis found that all of these sub-scales 
loaded highly on a single component, which the authors believe is PPC.  There was 
also a suggestion of three second-order components of interpersonal relationships, 
self-perception, and spirituality.  This indicates that many, if not all, developed 
scales in the field of study may measure an umbrella concept which can be labelled 
PPC, but that they may vary in the nature of specific sub-scales.  The SLQ does have 
an advantage over other measures in the current study, although not part of the 
above comparison. 
The SLQ was developed in the same geographical region as the current study 
(Sodergren and Hyland, 1998).  The mixed disease cohort used to develop the SLQ 
included a mixed cancer group who were being treated in the same hospital where 
this study recruited its participants.  The SLQ was developed out of a series of 
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interviews that found 18 categories or themes of PPC.  These categories included; 
improved interpersonal relationships, positive influence on others, reappraisal of 
life, restructuring of life or life style, changes in spirituality, changes in priorities, 
and seeing illness as a challenge to be overcome.  The authors of the scale used 
language that participants in their interviews had used and refined the phrasing in 
in similar cohort (Sodergren and Hyland, 1998).  Although the interview stage of 
SLQ development found 18 themes, some of which directly mapped onto those 
found in the PTGI, the finalised scale is unidimensional.  Although outside the scope 
and time frame of the current study to investigate, McBride et al. (2008) and 
McBride et al. (2009) suggest that similar to the PTGI the SLQ may actually contain 
subscales (improved personal relationships, greater appreciation for life, positive 
influence on others, personal inner strength and changes in life philosophy). 
The SLQ had a 95% completion rate on those surveys that were returned, it was the 
longest of the measures used.  Confirmatory factor analysis of the SLQ by McBride 
et al. (2008) and McBride et al. (2009) suggest that a 16 or 24 (respectively) item 
version of the SLQ with subscales might be valid.  The use of the 16 item version 
would reduce the number of questions being asked by a quarter, which it is 
hypothesised would have a positive impact on the number of measures returned, 
as well as the increasing the completion rate of the measures that are returned.   
The PTGI is currently the most widely used PPC measure in the literature, and as 
this has a small number of items, it could be asked why the SLQ either in its 38, 24 
or 16 item version is necessary.  The researcher felt that the framing of the 
questions, i.e. the language used in the items was not directly relatable to a UK 
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audience.  However, of greater concern are the results of studies attempting to 
cross-validate the work of Tedeschi and Calhoun (1996).  For example, a three-
factor structure was discovered in Spanish female immigrants (Weiss & Beiger, 
2006), and Chinese cancer patients (Ho, Chan, & Ho, 2004), as opposed to the five 
subscales found by the scales developers.  The failure to replicate the factor 
structure of the original PTGI in these samples was attributed to reasons including 
translational difficulties, that certain items of the PTGI were not applicable to 
cancer patients, and that the factor structure of posttraumatic growth may vary 
across different populations (Ho, Chan, & Ho, 2004).  Sheikh and Marotta (2005) 
utilised the original PTGI in a sample of white, middle-aged, cardiovascular disease 
patients from the United States of America and the United Kingdom and found a 
two-factor solution, in which the factors were labelled ‘general posttraumatic 
growth’ and ‘spiritual changes’.   
The SLQ was developed to be used with people that have a generic disease or 
illness as a measure of PPC, whereas the PTGI and other measures were developed 
to assess traumatic events such as earthquakes, rape, and acts of terrorism.  As 
such the SLQ, may be of use to researchers and clinicians who wish to design 
interventions to target specific areas of PPC and to measure the success or 
otherwise of psychosocial intervention strategies purported to be of benefit to 
individuals with chronic illnesses.  Given that Linley and Joseph (2004) concluded 
that there was a need for such measures, it would seem that the use of the SLQ in 
the current study is appropriate as it provides baseline data and insight into the 
natural progression of PPC development.  The researcher believes that the SLQ has 
the potential to provide researcher’s with a multi-dimensional generic tool to 
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measure PPC, and with further investigation into the validity and reliability of a 
shortened version this could be used effectively in research and clinical settings. 
5.2.6.1 Self-reported changes 
The predominately cross-sectional and retrospective nature of PPC measurement 
has led some researchers to suggest that self-reported changes do not represent 
lasting and genuine change or transformation in world view.  It has been argued 
that the responses on measures reflect the ability to find the bright side of the 
situation in otherwise devastating circumstances (McFarland and Alvaro, 2000; 
Tennen and Affleck, 2002), particularly if primed to look for them by a 
questionnaire.  The theories and methods currently in use to conceptualise and 
assess PPC allow multiple explanations as to why people experience actual positive 
changes.  A driving force of the current study was to address one of the noteworthy 
problems with the measurement of PPC; the lack of longitudinal studies, whilst 
noting the continued problem of a lack of baseline data collected prior to the 
events. 
It has been suggested that questionnaires require respondents to undertake a task 
which is mentally taxing.  This has led some researchers to argue that these scales 
measure global perceptions of change, rather than actual growth pre- to post-
trauma, or possibly a broader positive outlook on life.  Jayawickreme and Blackie 
(2014) suggest that participants must attempt the following five steps for each item 
on a PPC questionnaires: (i) deduce current standing on the factor or dimension 
being asked about, (ii) recall prior standing on the dimension before the event had 
occurred, (iii) compare these standings (i-ii), (iv) calculate the degree of change and, 
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finally, (v) evaluate how much of the change was due to the traumatic event.  These 
steps highlight the debate about wither the use of the developed PPC scales 
actually measures change.  There is little option but to rely on a respondent’s 
retrospective self-assessment of change when investigating a historical event within 
a temporal framework.  These challenges are acknowledged, but it is believed that 
the use of PPC measures is an appropriate way to gain an understanding of a 
cohort's development of PPC. 
5.3 Review of the methodology of enquiry  
The methodology of enquiry utilised within the present research was informed by 
the researcher’s knowledge and experience of clinical practice, academic processes 
and rigour and the burden of treatment and recovery on patients.  Clinical 
experience suggests that by understanding and probing the mechanism of change 
one can understand the impact of an event or an intervention (Pawson and Tilley 
1997).  The systematic nature of healthcare, the processes that people experience 
within the system, and their view of their positioning within it, combined with real 
life clinical experience of working with people who have had a diagnosis of HNC and 
research experiences, have led the researcher to embrace a realist perspective in 
undertaking research.  This represents a philosophy that is aligned through the 
levels identified by Creswell (1994) and is consistent with the research domain 
being explored (1.5).  The adoption of the realist perspective supports the inclusion 
in the research process of the perspectives of both the researcher and the 
participant/patient.  A literature review supported a quantitative approach to 
understanding the pattern of change in this field (2.6).  Additionally, the researcher 
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has published a systematic review of literature in the field of PPC and HNC (Harding 
et al., 2014) and since then only two other relevant papers have been published 
(Holtmaat et al., 2016; Leong et al., 2015).  Each of the studies adopts varying 
methodologies and none address the issue of the longitudinal nature of PPC 
development.  Such findings as do exist support the potential for PPC following the 
diagnosis and treatment of HNC but are not conclusive in respect of the 
mechanisms or predictors. 
5.4 Discussion of study design and current state of knowledge 
This section of the Discussion chapter begins by discussing the models of PPC and 
their applicability in the light of the research findings.  It then discusses the study 
design, factors to be identified and issues of validity.  Finally this section concludes 
by identifying the limitations of the current study and identifying areas for future 
work. 
There are specific negative connotations associated with the word 'growth' in 
relation to cancers that makes the widely used term of Post Traumatic Growth 
(PTG) unsuitable in the current study.  It is also not immediately clear from the term 
what the model actually refers to.  For these reasons the current research adopted 
the term Positive Psychological Change (PPC).  In discussing the various models of 
psychological change the term PPC is used unless specifically discussing the 
Tedeschi and Calhoun (2004) paper. 
5.4.1 Current models of PPC 
The dominant model in the PPC literature is that of Tedeschi and Calhoun (2004; 
Post Traumatic Growth, Figure 2).  This model is considered a more comprehensive 
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one than that of Schaefer and Moos (1992; Figure 1).  The Tedeschi and Calhoun 
model gives a broad definition of PTG as: ‘experienced as a result of the struggle 
with highly challenging life circumstances’ (2004, p. 1; Figure 2).  Their model is 
conceptualised as having five domains: 1) a greater appreciation of life, 2) more 
intimate social relationships, 3) heightened feelings of personal strength, 4) greater 
engagement with spiritual questions and 5) new possibilities for their lives.  
Tedeschi and Calhoun’s (2004) theory of PTG has pervaded popular literature and 
has led to a sense that PPC is routine and almost something to be expected 
following a trauma and that this will, over time culminate in greater satisfaction 
with life.  This view of PPC is unique in that the psychological change is seen as both 
a process and outcome.  The pattern of change over time does not yet point to a 
steady outcome in current research, or at least that we have yet to identify when 
the process element has ceased and the outcome has been achieved. 
Joseph and Linley’s (2005) theory takes a slightly different approach in arguing that 
PPC is not distinct from the construct of ‘Psychological Well-Being’ (PWB; Ryff, 
1989).  They argue that work in the field of PPC is essentially measuring increases in 
PWB, as the five domains conceptualised by Tedeschi and Calhoun (2004) are 
equivalent to the constructs of PWB as posited by Ryff (1989).  Joseph and Linley 
suggest that PPC occurs when an individual’s traumatic experience results in an 
increase in the domains of: 1) self-acceptance, 2) purpose in life, 3) environmental 
mastery, 4) autonomy and 5) positive relations with others (Ryff, 1989).  It is 
suggested that traumatic events may leave a person feeling more capable of 
mastering challenges in the social environment, managing their relationships and 
more free to act autonomously in accordance with their values.  The research being 
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presented in this thesis adopted the Tedeschi and Calhoun’s model of PPC 
(Tedeschi and Calhoun, 2004) and subsequently did not use a measure of PPC that 
investigated the factors identified by Ryff (1989) or Joseph and Linley (2005), and 
therefore can not comment on how these factors are affected by the diagnosis and 
treatment of HNC. 
Joseph and Linley’s (2005) model does not require the assumption that trauma is 
necessary for the experience of PPC, rather that it is critical and difficult life 
transitions that are a pathway to the enablement of positive change.  This may be a 
better model to use when considering the nature of cancer as the stressor, as it is 
difficult to identify what the exact stressor might be; this is discussed more in 
below.  Joseph and Linley (2005) make a distinction between subjective and 
psychological (or eudaimonic) well-being.  Subjective well-being refers to an 
individual’s general affective states and global satisfaction with life, whereas 
eudaimonic well-being also encompasses constructs including purpose, meaning 
and autonomy as important indicators of functioning (Jayawickreme et al, 2012).  
How this conceptualisation differs from the PTG model in practice with cancer 
patients was outside the scope of the current study but would be a worthy topic for 
future investigation. 
An important concept that both models appear to agree on is that PPC is not likely 
to occur simply as a direct result of trauma.  The PTG theoretical model developed 
by Tedeschi and Calhoun (2004) indicates that PPC is a result of the “psychological 
struggle” with highly challenging life events.  Psychological struggle would occur 
because a traumatic event challenges one’s core beliefs or assumptive world.  
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Cognitive processing therefore plays a significant role in initiating the PPC processes 
after the core beliefs are challenged.  Cognitive processing includes both intrusive 
thoughts that are often undesired and automatic, and more deliberate and 
constructive rumination (Martin and Tesser, 1996).  Deliberate rumination (i.e., 
seeking to construct a new assumptive world or core beliefs) has been suggested as 
a critical factor in predicting PPC (Tedeschi and Calhoun, 2006).  Empirical studies 
with cancer survivors have mostly supported this model, showing that examining 
core beliefs, engaging in intrusive rumination, and deliberate rumination all 
contribute to PPC (Wilson et al., 2014), but this needs to be investigated in practice 
with psychological interventions. 
The reappraisal of self and the psychological struggle involved with dealing with a 
traumatic event involve having thoughts about the event, intrude on the person.  
These intrusions are outside the control of the person, unlike purposeful 
rumination, and as such could be labelled as a facet of post-traumatic stress 
disorder (PTSD).  Tedeschi and Calhoun’s model of PTG (2004; Figure 2) co-exists 
with many PTSD symptoms, as distress is necessary to engender processes 
considered central to PPC.  They report that different domains of functioning may 
be affected differently by trauma, with some domains positively affected and other 
being harmed.  It is possible that survivors will experience distress related to 
trauma at the same time as they experience PPC.  An example of this may be where 
a person is experiencing fear of recurrence due to being sent a review appointment 
letter, but are grateful that family members are able to offer comfort and support.   
In the same vein as Tedeschi and Calhoun (2004), Joseph and Linley (2005) suggest 
that trauma may leave a person sadder, yet with an enhanced appreciation of what 
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is important and a greater commitment to live in accordance with these values.  A 
person reporting 'new-found meaning and clarity of life priorities’ would still be 
considered to have experienced a positive change, even if that person is not 
reporting feeling more satisfied with life. 
5.4.2 Cross-sequential study design  
As described in the introduction, two commonly used designs for studies examining 
PPC are the cross-sectional design and the longitudinal design (3.1).  The cross-
sequential design represents an alternative to these designs, which aims to correct 
for some of the problems inherent in the cross-sectional and longitudinal designs.  
Farrington (1991) states that the cross-sequential strategy is “a way of achieving 
the benefits of the longitudinal method while minimizing the problems” (p. 369).  
The specific advantages are that it allows intra-individual changes to be assessed 
within a shorter follow-up period than that required for a traditional longitudinal 
design and that the use of multiple cohorts increases confidence in the 
generalisability of the results to the sample population as a whole (Miller, 2007).   
It is important to be mindful of the limitations of the research methodology, and 
the extent to which legitimate and accurate conclusions can be drawn.  The 
researcher believes that this was the appropriate method to undertake data 
collection for the current work, due to the timeframe available, the nature of the 
trauma (cancer) and the desire to understand a longitudinal pattern of 
development and change.  It could be argued that a traditional longitudinal design 
may be methodologically stronger, however it is confounded by the time of 
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measurement.  It would also require more resources and a longer time frame than 
available for the researcher’s professional doctorate.   
Traditionally cross-sequential designs recruit people for a set period of time and 
have overlapping cohorts.  Due to the possibility of the HNC cohort in the current 
study having a recurrence or dying this process was adapted, with the different 
cohorts being constructed.  These factors would be considered if the methodology 
and data collection was to go on for an extended period of time.  The strength of 
this method would be the ability to compare the development (longitudinally) of 
PPC and comparison of cohorts.  This study design has the advantage of being able 
to unpick factors such as whether age or birth cohort makes a difference.  
Danhauer et al. (2015) found in a BC cohort that age had a role in the development 
and trajectory of change of PPC (Danhauer et al., 2015), while this was not the case 
in the current study the methodology had the potential to investigate this.   
The two key disadvantages of this study design that were overcome were; its 
complex nature, and that it is time consuming to run because of the continued 
annual review of data and ongoing recruitment.  The findings are arguably still only 
generalisable to cohorts and the historical periods of time measured. 
5.4.3 Annual Postal Survey 
The data collection for this study was undertaken outside of the researcher’s part-
time role within the maxillofacial department and with minimal impact on other 
staff members' time.  The part-time nature of the job and the short duration of the 
contract meant that it was not possible for measures to be given to potential 
participants during routine follow-up clinic visits, or sent out on a weekly basis 
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when patients reached a specific time point.  It was specifically decided not to 
approach people while attending clinic appointments, as the researcher had been 
informed by people that had had HNC that, even in routine follow-ups, they felt 
anxious from the point of receiving the appointment letter until after seeing the 
consultant.  They also did not want to stay in the hospital to complete a survey 
after their review.  The practical solution to this was a postal survey. 
Data of new people that had received a histological diagnosis of HNC in the 
preceding year had to be requested prior to each posting.  Each new person’s data 
on the cancer database and their hard copy hospital notes had to be reviewed to 
ensure they had completed their treatment and that as many of the other factors 
(Appendix 5; minimum data sheet) were recorded.  Data from people that had been 
approached in previous years was reviewed to ensure that they were not sent 
measures if they had died, had a recurrence and were undergoing treatment, or 
had contacted the researcher to indicate that they did not want to receive the 
measures.  Undertaking the survey annually reduced the number of times this data 
had to be centrally requested.  It also meant that the hospital notes were less likely 
to be in use by the clinical team, so requesting them would not hamper the 
patient’s clinical treatment or review.  This reduced the burden on hospital 
resources and the researcher.  It was hoped that this method would minimise the 
burden on the potential respondents. 
Goldstein, et al. (2010) published information on the response rates for postal 
survey-driven studies in patients with HNC.  In their paper they report a response 
rate from their initial mailing of 35%.  This is similar to the present study's lowest 
  
134 
return year (36%).  After their initial posting Goldstein et al (2010) went on to 
follow what they called a ‘modified Dillman approach’ (Appendix 13; Dillman, 1999) 
to achieve an 80% return rate after 3 postings.  The full modified Dillman was not 
adopted in the current study due to the costs and time resource required, and the 
additional consideration of not wanting to place additional burden on potential 
respondents.  A fully resourced future research project would aim to adopt the 
approach used by Goldstein et al. (2010; Appendix 13).  Overall the response rate in 
the current study reached an acceptable (median 45%) level when comparable to 
other studies undertaken with a HNC population (Millsopp et al. 2006; Vickery et al. 
2003). 
5.4.4 Time points 
In the current research, a person had to have been at least 3 months post 
treatment to be sent the questionnaires (3.3).  Three months was chosen in 
discussion with clinicians in the maxillofacial unit treating the participants.  It was 
felt that this allowed for physical recovery from treatment, some of which may 
hamper the physical completion of the measures. 
It could be argued that the current research does not have a baseline 
measurement, as no data was collected before diagnosis or at least before 
treatment.  The theory of PPC requires there to have been a traumatic or seismic 
event in a person’s life, for their assumptions to have been shattered.  It is not 
practicable to attempt to administer the full suite of research measures on 
everyone at each GP's appointment on the off-chance that it might be the 
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appointment that precedes a diagnosis of cancer.  The question then becomes 
when to measure. 
Most people who receive a diagnosis of cancer are referred to hospitals for 
investigation of their symptoms.  During these investigations and likely at the time 
of referral for investigation, they will be told that cancer is a possible diagnosis, and 
it is likely that they will have elevated levels of anxiety.  Measuring PPC at this point 
would be misleading, as a diagnosis has not been given and confirmation of the 
traumatic event is still pending.  The negative effect of elevated anxiety and worry 
at this time would mean that a return to normal levels of psychological functioning 
may appear to a researcher to be PPC.  The same problems could be seen if the 
initial measurement was undertaken post-diagnosis, but pre-treatment as it was by 
Danhauer et al. (2009) with a BC cohort, Steele et al (2008) with people with 
Hepatobiliary cancer and Llewellyn et al. (2013) with a similar HNC cohort to the 
current research.  Silva et al. (2012) added in further variation where the first 
measurement time point was post-surgery, the second time point was ‘during 
adjuvant’ treatment of chemotherapy, radiotherapy or chemo-radiotherapy, and at 
their third time point 28% of their respondents were still having hormonotherapy, 
even though the authors say that this last measurement was 6 months after 
treatment had been completed. 
This variation in choice of time point for data collection requires consideration to be 
given to the nature of cancer; is it a chronic or acute event?  It can be argued that 
cancer is a chronic extreme event in clinical and conceptual terms.  However, some 
people may see it as an acute event due to a single short treatment, such as a 
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surgical intervention, with a good known outcome (Holman and Lorig, 2000).  The 
researcher believes that cancer should not be regarded as an acute trauma.  The 
characteristics of cancer, such as the difficulty in identifying a sole stressor, the 
internal nature of the illness, the temporal orientation of the persons expectations 
of the future as well as memories of the diagnosis, treatments and other challenges 
that may be experienced due to having HNC, the practical impossibility of 
establishing the onset and termination of the traumatic event, together with 
differences in perceived control, all justify the differential clinical setting of cancer 
as a chronic stressor.  Measuring PPC while treatment is on-going is likely to be 
while the person is still experiencing extreme stress.  It may be for this reason that 
the majority of published works in peer review journals report the time of data 
collection either in relation to time since diagnosis or time since treatment 
completion. 
Time since diagnosis is a commonly used and interesting point of reference (Bellizzi 
et al., 2010; Danhauer et al., 2015; Leong et al., 2015; Manne et al., 2004).  It 
provides an absolute reference point which would be the same for all participants, 
but it does not allow for variation in the time individual treatment regimens can 
take and the subsequent variation in time since completion of treatment that 
would be present within a participant pool.   
The other time point model used is the time since treatment had been completed.  
The time chosen varies between studies without any consensus, Pat-Horenczyk et 
al. (2015) required people to be at least 3 months post treatment, while Sears et al. 
(2003) measured PPC at 20 weeks post-treatment.  Harrington et al. (2008) 
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undertook a prospective study and HNC participants were between 6 months and 
10 years post-treatment.  While Holtmaat et al. (2016) only recruited people that 
were at least 1 month post-treatment, and Ho et al. (2011) required people to have 
completed therapy for at least 6 months.   
Consideration of the impact of the different time frames on change in PPC, 
accounting for the various and continuous stressors experienced by people with 
cancer, and to have a consistent reference point for all people completing the 
measures, were all deliberated during the construction of this present study. 
A difference between the current study and other research in this area is that this 
work sent out the measures to all appropriate potential participants during the first 
week in October for five consecutive years.  Other researchers have had 
participants’ complete measures at specific times, such as 20 weeks post-
treatment.  The method used in this study has the benefit of providing a greater 
resolution of data.  Collecting data at a single calendar time point means that some 
participants will be just over 3 months post-completion of treatment, and some will 
be nearly 12 months post-completion.  Using this method, if a sufficient sample size 
could be collected, it would be possible to have a data point for each week post-
treatment.  The annual nature of the data collection did mean that the individual 
respondents were only approached once, and therefore minimised the burden on 
them to return multiple surveys.  This is a noticeable difference from those studies 
that collect multiple time points over a relatively short duration, such as Wang et al. 
(2014) who collected data one day, and then 3, 6, and 12 months following surgery.   
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A key consideration of the study design was to minimise the burden and intrusion 
on patients.  Surveying annually minimised this burden whilst maintaining good 
data resolution across the sample.  This has allowed insights to be made about PPC 
over the same period of time (5 years) that a HNC patient is followed up following 
treatment. 
5.4.5 Validity issues 
Measurement of PPC is built on the understanding that people are able to recall 
prior trait levels accurately, but as personality psychologists have found, perceived 
change has been shown to be weakly associated with actual change (Herbst et al., 
2000; Robins et al., 2005).  This means that there needs to be the consideration on 
whether growth actually occurs.  
Several researchers have suggested that reports of growth may be illusory, 
inasmuch as individuals may manufacture (the perception of) positive change as a 
way of coping with trauma-related psychological distress (Park and Helgeson, 
2006).  Tennen and Affleck (2002) reviewed the PPC literature and observed that 
people’s reports of growth have been regarded as indicators of real personality 
change and also as reality distortions.  This has been labelled as, selective 
appraisals, coping strategies, personality characteristics, ways of explaining 
characteristic hedonic levels, reflections of people’s implicit theories of change 
(Jayawickreme and Blackie, 2014).  Studies have even suggested downward 
temporal comparisons, believing that their past selves were worse than they 
actually were (Ross and Wilson, 2003).  These alternative explanations for PPC 
could be grouped together into categories such as, re-evaluation of self, coping 
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strategies, and violation of the individual’s assumptive world (Jayawickreme and 
Blackie, 2014). 
Re-evaluation of self suggests that a person may reaffirm aspects of their idea of 
self in order to maintain or enhance positive feelings and confidence in themselves.  
Taylor (1983) suggested that threatening and stressful life events challenge an 
individual’s sense of self-esteem, personal control and optimism about the future.  
Taylor claimed that these re-evaluations or ‘positive illusions’ protect people from 
the initial stressor and allow them to accept the situation or conditions.  McFarland 
and Alvaro (2000) interpreted the results of their work as suggesting that 
participants reported experiencing growth by re-appraising their past selves in light 
of the progress they believed they had made.  They concluded that people may 
falsely perceive PPC by misremembering what they were like prior to the event. 
It has been proposed that perceptions of PPC are actually a coping strategy that 
allows the person to come to terms with a traumatic event.  Tennen and Affleck 
(2002) suggest that the active process of seeking benefit can remind a person of the 
possible benefits and that this is effectively a coping strategy.  There are similarities 
between some of the emotional coping strategies proposed by Folkman and 
Lazarus (1988) and the outcomes that are said to develop due to PPC 
(Jayawickreme and Blackie, 2014).   
The authors of the SLQ suggest that their measure provides a valid assessment of 
PPC.  Sodergren et al. (2004) used a cross-sectional study which precludes a 
conclusion of causal direction, to suggest that positivity in illness is associated with 
existential growth.  Their findings of a non-significant correlation between the SLQ 
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and neuroticism is in the opposite direction predicted by the delusion explanation, 
but the non-significant relationship between the SLQ and repression is in the 
predicted direction.  Therefore they believe that the measure does measure 
positive change, but acknowledge that they can not rule out that their respondents 
may be presenting a coping strategy or illusion.   
Helgeson et al. (2006) in their meta-analysis of relations between PPC and 
psychological distress suggest that reports of growth over time are related to better 
psychological health and, by implication, are more likely to reflect authentic 
growth.  The issue is still a matter of concern and has yet to be resolved in the 
literature.  Given the requirement for more longitudinal studies of PPC a question 
that may be worth asking is, when does a coping strategy resolve into a stable 
personality trait or integrated into long term behaviours? 
The notion that a person can grow from suffering has been raised in many works of 
philosophy, literature and theology and the concept of PPC is increasing prevalent 
in popular culture, from blog posts and books to TED talks (McGonigal, 2012).  The 
exposure this brings to the public is likely to become part of people’s implicit 
theories of change.  People may thus report PPC simply because they have 
expected it (Splevins et al., 2010; Tennen and Affleck, 2002).  Such reports may be 
significantly influenced by expectation biases.  However, the sustained pattern of 
reported change apparent in the longitudinal studies and in the current research 
requires further investigation. 
This raises the additional concern that people who do not experience PPC, or who 
have negative associations with their trauma, may not seek help because they are 
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concerned with being further labelled as 'not normal', or as having failed to manage 
their situation.  The potential for incidence of full or partial PTSD may therefore be 
underestimated, but its association with PPC is worthy of future research 
consideration. 
5.4.6 Real World Data 
The methods section of this thesis identified that RWD in the healthcare sector 
come from various sources and include data from: outcomes (clinical and patient-
reported), resource use (NHS, patient and societal), treatment pathways, service 
models and surveys of patient preference, experiences and compliance (3.1.1).  
These various sources can make isolating variables more difficult than in 
experimental samples and thus detecting relationships becomes more complex 
(McClelland and Judd, 1993).  This occurs because of the reduced statistical power 
inherent in naturalistic studies.  Because the independent variables (e.g., socio-
economic status, family status, cancer stage, treatment regimen and PPC in the 
case of this study) cannot be randomly assigned or experimentally manipulated, 
naturalistic studies tend to have insufficient numbers of cases in jointly extreme 
categories of the independent variables (e.g., men and women with very high or 
very low levels of PPC), compromising their statistical power to detect interaction 
effects.  The problem with power was increased by the return of incomplete 
questionnaires.  Of particular not in the current study were the number of 
incomplete SF-12s.  The spread or range of responses is also a challenge in real 
world data and in the current study, there were not a large number of observations 
at the extreme high end of PPC or at the extreme low end of QoL, reducing the 
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relative statistical power of the research to detect valid statistical interactions.  
McClelland and Judd (1993) estimated that compromised statistical power renders 
approximately 90% of field studies vulnerable to type II errors (i.e., failing to reject 
the false null hypotheses).  One way to overcome these types of errors is to use 
methods for increasing statistical power but these mean accepting higher rates of 
type I errors, which are as undesirable as type II errors.  Addressing type II errors 
through increased observations is not usually an option in RWD studies. 
5.4.7 Limitations of the current research 
The present study has a number of limitations that should be noted.  While this is 
the largest study of its type investigating PPC with people following treatment for 
HNC, it is small compared to BC studies where samples have been as high as 653 
(Danhauer et al., 2013a; 2015).  The collected data was sufficiently powered to 
detect significant effects that were broadly in line with previous studies (Danhauer 
et al., 2013a; Helgeson et al., 2006).  However, a larger sample size would be 
needed to undertake analysis to detect if different trajectories exist within a HNC 
cohort over this longitudinal time frame. 
The response rate or nonresponse error refers to the condition wherein people of a 
particular ilk are systematically not represented because such people are alike in 
their tendency not to respond.  There could be multiple groups of people who do 
not to respond to surveys generically because such groups, by their very nature, are 
disinclined to respond (e.g., introverts, extremely busy people, people with low 
esteem; Krosnick, Lavrakas and Kim, 2013; Porter and Whitcomb, 2005).  In the 
current study there was no difference between responders and non-responders on 
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the variables that we had for non-responders.  There may be factors where they 
would differ, which may make it difficult to say how the entire sample would have 
responded.  Generalising from the sample to the intended population thus 
becomes risky.  For this reason, nonresponse error in mail surveys has long 
concerned social science researchers (Sivo et al., 2006).  However, real world issues 
must be considered and it is not possible to measure every variable that might 
impact on a person’s likelihood of responding, therefore working with the 
information collected, the researcher is confident that the current study 
respondents are representative of the people diagnosed with HNC in the local 
geographical area. 
In relation to the length of the survey sent out, literature on response rates 
indicates that, for the length of survey used in the current study (65 questions), a 
40% return rate is common (Iglesias et al., 2002).  This is very close to that 
obtained, with the worst year being 36% and on average 46%.   
The medical data used in the present study was collected from two hospital 
databases and patient notes.  Neither of the databases was fully populated 
(completed) by hospital staff.  This is often the case when data collection or 
retrieval is outside the primary researcher's control.  Unfortunately, due to cost and 
practicalities of care delivery, these databases are often populated by people who 
have little or no clinical knowledge (Healthcareers, 2016).  The databases are not 
routinely audited or checked for accuracy or how up to date they are.  Quality 
assessing the databases was outside the remit of the research.  For the purposes of 
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this research the data collected from hospital databases was assumed to be 
accurate. 
In the current study, where data was provided, for both responders and non-
responders, participants were categorised as White British (Table 6; Descriptive 
statistics section).  Given the restricted ethnic range of the population in the 
geographical location of the sample this is unsurprising; with the Office for National 
Statistics reporting that 92.6% of Devon and Cornwall’s population being White 
British, 0.6% White Irish and 2.5% White Other (ONS, 2016).  So, although the 
completion of the database is poor the generalisability of the present findings are 
likely to be good.  Although outside the remit of the current study, research is 
needed on cultural and ethnic variation of PPC, especially in the context of the 
measures and their western centric development and validation (Weiss and Berger, 
2010). 
5.5 Current UK multidisciplinary guidelines and PPC 
Survival is usually, and understandably, the initial primary concern of people 
diagnosed with HNC (Rogers, Semple, Babb and Humphris, 2016).  Where this is 
achieved, focus switches towards QoL and living with the aftermath of treatment, 
also called survivorship.  Current guidelines on psychological management for HNC 
patients after treatment, focuses on managing psychological distress and social 
support of the person who had HNC and their family (Humphris, 2016).  These 
guidelines recognise that the majority of people appear to cope, but there are 
people who experience negative psychological effects, such as fear of recurrence, 
changes to their daily lives, and sense of self (Humphris, 2016).  In the current set of 
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guidelines there is no mention of PPC, which is unsurprising given the need to offer 
intervention and treatment to those people with psychological problems.  If people 
are doing well, then there is little imperative for the NHS to engage with them or 
provide services for them.  As Calhoun and Tedeschi (2013, p 13) note 
“posttraumatic growth is common, but it is by no means universal’.  When 
researching this area the researcher has been mindful that not all people who have 
a traumatic experience, specifically HNC, experience PPC or PTSD.  However, 
clinicians should be aware of both possibilities and the range between them.   
5.5.1 PPC in clinical practice 
If PPC is going to be of benefit to health care professionals and service users it 
needs to be harnessed as an intervention or elements of intervention packages.  A 
meta-analysis assessed the relationship between intervention participation and 
PTG, but failed to find any studies that included an outcome measure of PPC 
(Roepke, 2015).  Roepke (2015) suggests that there is a modest increase in PPC 
following intervention, but due to the limited research reported on the natural 
development and time course of PPC, it is possible that even this modest increase 
could be due to the passage of time.  Future clinical practice needs to be mindful of 
these factors and include a measure of PPC in the development and delivery of 
interventions. 
It has been suggested that interventions could be based around an ‘expert 
companionship’ model (Calhoun and Tedeschi, 2013).  This is conceptualised as the 
clinician being a facilitator rather than creator of positive change.  These clinicians 
are also the companions who offer some expertise in nurturing the naturally 
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occurring process of PPC.  How this is delivered has not been precisely prescribed or 
evidenced, but some suggestions have been made; reflective activities that help the 
individual find meaning in the event, make a positive reassessment, and find 
benefits or renegotiate their ‘post-cancer’ identity (Manne et al., 2004; Park et al., 
2010; Rajandram et al., 2011).  These reflective activities can also facilitate and 
enable the expression of emotions (Garland et al., 2007; Manne et al., 2004).  It has 
been further suggested that using cognitive-behavioural techniques might promote 
positive reassessment of the trauma, the development of positive attitudes and 
effective problem solving (Bussell and Naus, 2010).   
A different slant to the expert companion intervention would be the ‘Expert Patient 
Programme’ (EPP) which is a version of the USA developed ‘Chronic Disease Self-
Management Programme’ (CDSMP; Lorig et al 1999).  The EPP is delivered by 
trained individuals who themselves are living with a chronic condition; this may go 
some way to normalising the emotional experience of traumatic event and 
discussion of re-evaluation of self.  The EPP is also open to involving family and 
friends in order to develop their autonomy, skills and sense of belonging to a 
community, which may enhance PPC.   
As a complex phenomenon, what elements of an intervention encourage PPC, and 
what individual and social characteristics are mediators and moderators will be 
important to unpick. 
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5.6 Discussion of future research 
The current research builds on the minimal prior longitudinal research in people 
who have had HNC.  Although it has moved understanding of the PPC phenomenon 
in this cohort, it does leave questions to be answered. 
5.6.1 Multiple Trajectories within HNC 
As noted in the introduction, there has been little work that has examined variables 
associated with trajectories of PPC making it difficult to specify further the expected 
relationships of baseline variables with PPC measures over time.  The current work 
goes some way to examine this, but it is not able to differentiate if sub-groups with 
differing patterns of PPC development exist.  Danhauer et al. (2015) yielded a 
model with six PPC trajectories (Figure 4; Methodology).  They found age, race, 
chemotherapy status, use of adaptive coping strategies, illness intrusiveness, 
depressive symptoms and social support, all differed among the groups.  The 
Danhauer et al. (2013a, 2015) work supports the idea that there are likely to be 
sub-groups within the HNC population.  Greater numbers of people post HNC 
treatment are required to more fully understand differentiating factors. 
5.6.2 Mediators and Moderators of PPC 
The current presented research has been interested in answering the question of 
how PPC develops or is maintained over an extended time frame.  Longitudinal 
research is not the only area that has been identified as requiring attention in this 
field of study.  The identification and statistical analysis of mediating and 
moderating factors still needs addressing (Joseph and Linley, 2008).   
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No research has been published that looks at mediator and moderators of PPC 
within an HNC population, although work has been undertaken in other areas.  Pre-
trauma mental health has been identified by Calhoun and Tedeschi (2006) as 
important for PPC.  They predicted that, in line with some other theorists (e.g. 
Miller and C’deBaca, 1994) “people who experience PTG need to have had room to 
grow, but be healthy enough to cope relatively successfully with their emotional 
distress” (Calhoun and Tedeschi, 1998 p.226).  This is the point in which coping 
plays a part in their model, as those who have adequate coping skills will avoid 
being overwhelmed by trauma, and are more likely to experience PPC. 
In a meta-analysis Helgeson et al., (2006) assesses the time that had passed since 
the trauma.  They observed that PPC after a trauma was more strongly related to 
less depression and more positive affect when the trauma occurred more than two 
years ago.  However, they found that overall time since trauma was not related to 
an increase in PPC.  It could be suggested that time may still be a contributing factor 
and further research could examine this, as out of the 77 articles that Helgeson et 
al. (2006) reviewed, only 6 (8%) contained data concerning the time that had 
passed since the incident occurred.  It is also the case that the variation in the time 
points makes it difficult to make an accurate comment on how time affects the 
development of PPC.  The curvilinear effect of time since diagnosis on PPC 
development in the current study suggests that time may also be a complicating 
factor. 
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The relationships of cancer stage and treatment regimen with PPC found in the 
current study would be an interesting investigation.  As it may be that treatment 
regimens have a moderating effect on the mediator, cancer stage. 
5.6.3 Patient and Clinicians Perspectives of HNC 
Future research that may elicit understanding of the patient’s perspective would be 
to examine patient and clinician interactions, and then subsequently what each 
actor thought independently about the trauma of cancer and the development of 
PPC.  This would allow for insights into the description of the disease, treatment, 
outcomes as well as the short and long term expectations and beliefs about the 
HNC disease journey.  This is important as the understanding of an illness may 
affect the psychological impact of a treatment and its side effects. 
A key consideration which needs illumination is whether HNC is considered to be 
acute or chronic.  It has been suggested that patients with a chronic condition may 
be expected to adopt a more active role in managing their problems than might be 
expected from those with an acute medical problem (White, 2001).  Holman and 
Lorig (2000) have highlighted some differences between acute and chronic illnesses 
(Table 19).  Comparison of the definitions offers a challenge to understanding 
cancer using these headings.  It is likely that some people with cancer had no idea 
that they are going to receive a cancer diagnosis and therefore it can be argued that 
the disease onset is abrupt, but others may have suspected that this diagnosis was 
likely and in some cases have delayed seeking medical intervention and lived with 
the gradually increasing symptoms.  Additionally, how the prognosis is described to 
the patient may well have a lasting impact on when the patient thinks they have 
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‘come out of the other side’ of their illness.  One patient may believe that on 
completion of their surgery they have overcome the disease, whilst another may 
not feel like this until they are discharged from the service five years after they have 
completed their treatment.  Indefinite outcomes and the associated pervasive 
levels of uncertainty surrounding diagnosis and prognosis, as well as the side effects 
of treatment, as outlined in appendix 12, may be central to patients’ perceptions 
and development of PPC.  Accepting the ambiguity of the triggering event may be 
crucial for cancer survivors.   
Table 19: Difference between acute and chronic diseases 
 Acute disease Chronic illness 
Onset Abrupt Usually gradual 
Duration Limited Length, indefinite 
Cause Usually single 
Usually multiple and 
changes over time 
Diagnosis and 
Prognosis 
Usually accurate Often uncertain 
Technological 
Intervention 
Usually effective 
Often indecisive, adverse 
effects common 
Outcome Cure No cure 
Uncertainty Minimal Pervasive 
Knowledge 
Professionals knowledgeable; 
patients inexperienced 
Professional and patients 
have complementary 
knowledge 
From Holman and Lorig (2000), Data Supplement – Box, electronic, British Medical Journal (reprinted 
by kind permission of authors and British Medical Journal, copyright agreement appendix 14) 
 
5.6.4 Hospital Note Interrogation  
As mentioned above in the limitations section of the discussion, hospital note 
interrogation would allow for missing data to be found (as long as it is 
documented).  It would allow researchers to collect information regarding 
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conversations that patients may have had with clinicians or other allied health care 
professionals about any issues relating to PPC or psychological disability or trauma.  
Obviously this is reliant on the clinical or allied health care professional to have 
considered the discussion important enough to note. 
Side effects of treatments (Appendix 12) and other co-morbidities that might be 
mediators to PCC may also be identified and understood through wider 
interrogation of hospital notes. 
5.6.5 Interviews 
The reliance on hospital notes means reliance on the clinician placing enough 
weight on the patients’ comments to record them and/or to arrange further clinical 
interventions (e.g. physiotherapy, surgery, dietician, and speech and language 
therapy).  It would therefore be prudent to interview patients to gain a greater 
understanding of their PPC and what impact it is having on them and their quality of 
life and sense of self.  Patients could be purposely selected from their responses to 
the SLQ, or the other measures depending on the aim of the research, i.e., a specific 
functional deficit identified from the UoW, or those with particular high or low 
scores on the SLQ. 
Interviewing would allow the researcher to ask for concrete examples of how 
different elements of PPC were manifesting themselves in an individual’s daily life. 
5.6.6 Patient Drawings 
There is an issue with interviewing patients that have been treated for HNC, 
especially those with higher staged tumours.  They can have problems with 
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speaking for extended periods of time.  This may be because of; pain, inability to 
open their mouths (trismus) or xerostomia (dry mouth).  Therefore a different 
methodology may be required to gain an insight into changing sense of self, or 
development of PPC.  One such method may be to ask patients to draw a sketch of 
themselves, or elements of their lives they feel have changed due to HNC, their 
treatment or the ongoing side-effects.  This has method has been successfully used 
with people who have had a heart attack (Broadbent, Ellis, Gamble and Petrie, 
2006).  It could be phrased, ‘draw how they remember yourself before your cancer’.  
This in combination with a questionnaire battery, or an abbreviated interview to 
explore the facets of the sketches may reveal interesting issues associated with 
HNC, its treatment and PPC, as well as distress and dysfunction related to HNC.  
Other novel methods such as photography could be used capture the experiences 
of treatment for HNC and how that affects the development of PPC, as it has been 
shown to provide an insight into the everyday experiences of patients away from 
health care settings (Frith and Harcourt, 2007). 
5.6.7 Positive Psychological Change Intervention(s)  
Park and Helgeson (2006) have cautioned against the rapid development of large-
scale PPC interventions among individuals who have experienced a traumatic life 
event before a number of key conceptual and empirical questions are answered, in 
particular, the time course of PPC development.  That is, at what point does a 
coping strategy used by an individual in an acutely stressful period solidify into a 
cognitive and behavioural change?   
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If initial reports of positive change are short term coping or, as discussed above, a 
form of responding in a socially desirable way, this could compromise the 
rehabilitation process as, for example, cancer survivors reporting such PPC may be 
less likely to engage with rehabilitation services or attend hospital review 
appointments. 
The current reported longitudinal research starts to shine a light on the pattern of 
PPC development in people who have been treated for HNC.  However, a greater 
understanding of the development and trajectories of change, including variables 
that differentiate sub-groups, is required before it would be possible to comment 
on whether an intervention had successfully impacted on the development of PPC. 
6.0 Conclusion  
The current research builds on the minimal prior PPC research undertaken with 
people who have had HNC.  In particular, it demonstrates trajectories for the 
development of PPC over a longitudinal period of time, between 3 months and 11 
years post treatment. 
The cancer stage and treatment regimen had a relationship with PPC in both the 
short term (between 3 and 12 months) and longitudinally (between 1 and 11 years), 
with stage 1 cancer and those having surgery without radiotherapy reporting more 
PPC than other people with HNC.  Socio-economic status appears to have a more 
complex relationship where longitudinally both a low and a high status appear to be 
beneficial.  This complex pattern may indicate that SES may actually be a moderator 
of PPC.  In the multivariate model adjusting for psychosocial variables, SLQ had a 
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relationship with time since completing treatment, increasing initially after 
treatment and levelling off over time.   
Historically there has been concern that the reported PPC is actually illusory or a 
coping strategy rather than a real change.  It could be argued that the evidenced 
pattern of PPC development includes this use of coping and should be considered 
to have three distinct stages; the traumatic stressors, the coping and adaptive 
strategies in an acute phase, and then reforming of the assumptive world and 
stabilisation of new cognitions and behaviours.   
The cross-sequential design utilised within this research allowed for longitudinal 
recruitment year on year, thereby maximising participation at each time point, 
whilst accounting for the withdrawal of people with recurrence, those that die, or 
choose not to return a completed set of questionnaires.  The disadvantages of this 
study design are; its complex nature, and the continued annual review of data and 
ongoing recruitment that make it time consuming. 
The current study has progressed the understanding of the PPC phenomenon in a 
HNC cohort.  However further investigation is required and two main avenues are 
identified; 1) identification of sub-groups of PPC development within a HNC cohort 
and 2) statistically modelling of potential mediating and moderating variables.  Both 
of these pieces of work would allow greater understanding of the natural 
development of PPC.  An additional future research project could then seek to 
compare this natural development of PPC to that found in people who undertake a 
psychological intervention to help with cope with HNC.  It would also enable 
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evidence-based decisions to be made on the timing the delivery of intervention, as 
well as which people may benefit most from participating. 
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Glossary 
Critical realism 
A critical realist believes that there is a reality independent of 
our thinking about it that science can study. Critical realist 
recognises that all observation is fallible and has error and 
that all theory is revisable. Because all measurement is 
fallible, the critical realist emphasises the importance of 
multiple measures and observations, each of which may 
possess different types of error, and the need to use 
triangulation across these multiple errorful sources to try to 
get a better bead on what's happening in reality. 
Head and Neck Directorate 
The Plymouth Head and Neck Cancer Directorate at 
Derriford has a small team of specialists dedicated to 
providing first class care to patients with cancer of the 
Head and Neck region (Upper Aero digestive Tract - UAT) 
including mouth, throat, larynx (voice-box), salivary 
gland and thyroid cancers. Referrals come from East and 
North Cornwall, Plymouth city and South and West 
Devon.  The clinical team is made up of Head and Neck 
surgeons (Mr David Courtney, Mr Paul McCardle, and Mr 
Tass Malik), a Consultant Oncologist (Dr Amy Roy), a 
Restorative dentist (Anthony Vaughan), Plastic and 
reconstructive surgeon (Mr Anthony Fitton). There are 
close links with cardio thoracic surgery and 
neurosurgery, as well as cancer specialists with a 
particular expertise in head and neck cancers.  The 
patients are supported by speech, swallowing and 
language therapists, dietitians and a palliative care team, 
including a Macmillan Head and Neck Nurse. The team 
provides a comprehensive service including resection 
(from endoscopic to major tumour surgery), 
reconstruction and rehabilitation. 
Health Related Quality of 
Life 
Health-related quality of life (HRQoL) is a multi-dimensional 
concept that includes domains related to physical, mental, 
emotional, and social functioning. It goes beyond direct 
measures of population health, life expectancy, and causes of 
death, and focuses on the impact health status has on quality 
of life. 
Integrated Patient 
Management System 
iPM is the main hospital administration computer system.  It 
holds details from basic patient's demographic details through 
to clinical information on patient stays, which includes 
referrals, waiting lists, appointments, admissions, theatre and 
case note tracking information.  The system interfaces with 
multiple systems within the Trust with information flowing 
from and to iPM.  There are currently over 2000 users across 
multiple hospitals within the south west of UK. 
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International Classification of 
Disease 10 Code 
The International Classification of Diseases (ICD) is the 
standard diagnostic tool for epidemiology, health 
management and clinical purposes. This includes the analysis 
of the general health situation of population groups. It is used 
to monitor the incidence and prevalence of diseases and other 
health problems, proving a picture of the general health 
situation of countries and populations. 
Longitudinal research or 
data 
The Oxford English Dictionary defines longitudinal in 
terms of research or data as ‘involving information about 
an individual or group gathered over a long period of 
time. 
Quality of Life 
Quality of life (QoL) is the general well-being of individuals 
and societies, outlining negative and positive features of life. 
It observes life satisfaction, including everything from physical 
health, family, education, employment, wealth, religious 
beliefs, finance and the environment. 
Somerset Cancer Register 
The Somerset Cancer Register was set up in 2003 to 
support the cancer waiting time intuitive established 
that year.  The SCR collects all the information necessary 
to make sure that a patient is seen, diagnosed and 
treated as quickly as possible.  The electronic register 
reduces duplication of information and allows for real 
time collection of information about a patient and 
ensures that their journey through the healthcare system 
is as smooth as possible.  Its database continues to 
evolve to meet the challenges of technology changes, 
clinical demands and national requirements.  By having 
an application which collects standard data items, the 
scope for sharing with other Trusts, Networks, Cancer 
Registries, National Audits and Surgeon Level Reporting, 
allows a better understanding of outcomes and future 
management requirements for cancer patients.  It 
provides the majority of data to be held in one place for 
the individual trusts to review patients by cancer site or 
any other database fields. 
Real World Data 
Data used for clinical coverage and payment decision-making 
that are not collected in conventional randomised control 
trials 
Data Management Plan 
A formal document that outlines how data is handled during 
research, and after the project is completed. 
 
 
  
189 
Appendix 1: Copyright agreement for Figure 2 
(Comprehensive model of PTG) 
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Appendix 2: Copyright agreement for Figure 3 (Affective-
Cognitive Processing Model for Post-Traumatic Growth) 
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Appendix 3: Copyright agreement for Figure 4 (PTGI total 
score trajectories) 
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Appendix 4: Measures of PPC 
Questionnaire 
Title 
Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
Adult Hope 
Scale 
AHS Yes 12 
8-point 
Likert-type 
scale 
Few 
Minutes 
The adult hope scale (AHS) 
measures Snyder's cognitive 
model of hope which defines 
hope as "a positive motivational 
state that is based on an 
interactively derived sense of 
successful (a) agency (goal-
directed energy), and (b) 
pathways (planning to meet 
goals)".  
1. Snyder, C. R., Harris, C., Anderson, 
J. R., Holleran, S. A., Irving, L. M., 
Sigmon, S. T., et al.(1991). The will 
and the ways: Development and 
validation of an individual-differences 
measure of hope. Journal of 
Personality and Social Psychology, 60, 
570-585. 2. Snyder, C. R. (1994). The 
psychology of hope: You can get there 
from here. New York: Free Press. 3. 
Snyder, C. R. (2002). Hope theory: 
Rainbows in the mind. Psychological 
Inquiry, 13, 249-275. 
Attributional 
Style 
Questionnaire 
ASQ Yes 12 
 7-point 
Likert-type 
scale 
20 Minutes 
Yields scores for explanatory 
style for bad events and for 
good events using three causal 
dimensions: internal versus 
external, stable versus unstable, 
and global versus specific 
causes. 
1. Buchanan, G. and Seligman, M.E.P. 
(Eds.). (1995). Explanatory Style. 
Hillsdale, N.J.: Erlbaum. 2. Peterson, 
C. (1988). Explanatory style as a risk 
factor for illness. Cognitive Therapy 
and Research, 12, 117-130. 3. 
Peterson, C., Semmel, A., von Baeyer, 
C., Abramson, L. T., Metalsky, G. I., & 
Seligman, M. E. P. (1982). The 
Attributional Style Questionnaire. 
Cognitive Therapy and Research, 6, 
287-300. 4. Seligman, M.E.P., Nolen-
Hoeksema, S., Thornton, N., and 
Thornton, K.M. (1990). Explanatory 
style as a mechanism of disappointing 
athletic performance. Psychological 
Science, 1, 143-146. 5. Seligman, 
M.E.P. and Schulman, P. (1986). 
Explanatory style as a predictor of 
productivity and quitting among life 
insurance agents. Journal of 
Personality and Social Psychology, 50, 
832-838. 6. Sweeney, P.D., Anderson, 
K, & Bailey, S. (1986). Attributional 
style in depression: A meta-analytic 
review. Journal of Personality and 
Social Psychology, 50, 974-991. 
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Questionnaire 
Title 
Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
Benefit Finding 
Scale 
BFS  Yes 17 
5 point 
Likert type 
scale  
Not stated 
Items were adapted from Behr’s 
Positive Contributions scale 
used with parents of disabled 
children (Behr, Murphy & 
Summer, 1991).  Psychometrics 
are established with 364 BC 
patients.  Cronbachs alpha is 
0.95 
1. Tomich, P. L., & Helgeson, V. S. 
(2004). Is finding something good in 
the bad always good? Benefit finding 
among women with breast cancer. 
Health Psychology, 23, 16-23.  2. 
Behr, S.K., Murphy, D.L., & Summer, 
J.A. (1991). Kansas inventory of 
parental perceptions. Lawrence: 
University of Kansas. 3. Carver, C.S. 
(2013) The Benefit Finding Scale for 
breast cancer. Measurement 
Instrument Database for the Social 
Science. Retrieved from www.midss.ie.   
Changes in 
Outlook 
Questionnaire 
 CiOQ Yes 26 
6 point 
Likert type 
scale 
Not stated 
Internal consistency reliability of 
the positive scale is -0.79 and 
negative changes scale has 
been found to be 0.81.  The two 
factors have good properties of 
convergent and discriminant 
validity and has been found to 
relate to posttraumatic stress 
and psychological distress in a 
consistent way.   
Curiosity and 
Exploration 
Inventory 
CEI Yes 7 
 7-point 
Likert-type 
scale 
2 Minutes 
Assessing individual differences 
in the recognition, pursuit, and 
integration of novel and 
challenging experiences and 
information. The CEI has good 
internal reliability, and shows 
moderately large positive 
relationships with intrinsic 
motivation, reward sensitivity, 
openness to experience, and 
subjective vitality.  
1. Kashdan, T.B., Rose, P., & Fincham, 
F.D. (2004). Curiosity and Exploration: 
Facilitating positive subjective 
experiences and personal growth 
opportunities. Journal of Personality 
Assessment, 82(3), 291-305. 2. 
Kashdan, T.B. (2002). Social anxiety 
dimensions, neuroticism, and the 
contours of positive psychological 
functioning. Cognitive Therapy and 
Research, 26, 789-810. 3. Kashdan, 
T.B. (2004) The neglected relationship 
between social interaction anxiety and 
hedonic deficits: Differentiation from 
depressive symptoms. Journal of 
Anxiety Disorders, 18, 719-730. 
  
1
9
4
 
Questionnaire 
Title 
Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
Gratitude 
Questionnaire 
– 6 
GQ-6 Yes 6 
 7-point 
Likert-type 
scale 
5 Minutes 
GQ-6 measures the disposition 
to experience gratitude. It has 
good internal reliability, with 
alphas between .82 and .87, 
and there is evidence that the 
GQ-6 is positively related to 
optimism, life satisfaction, hope, 
spirituality and religiousness, 
forgiveness, empathy and 
prosocial behaviour, and 
negatively related to 
depression, anxiety, materialism 
and envy. 
1. McCullough, M. E., Emmons, R. A., 
& Tsang, J. (2002). The Grateful 
Disposition: A conceptual and 
Empirical Topography. Journal of 
Personality and Social Psychology, 82, 
112-127. 
Inspiration 
Scale  
IS Yes 8 
 7-point 
Likert-type 
scale 
2 Minutes 
IS demonstrates a consistent 
two-factor structure, internal 
consistency, temporal stability, 
and measurement invariance 
across time and across 
populations. It has construct 
validity. 
1. Thrash, T. M., & Elliot, A. J. (2003). 
Inspiration as a psychological 
construct. Journal of Personality and 
Social Psychology, 84, 871-889. 
Meaning in 
Life 
Questionnaire 
MLQ Yes 10 
 7-point 
Likert-type 
scale 
5 Minutes 
MLQ has good reliability, test-
retest stability, stable factor 
structure, and convergence 
among informants. Presence is 
positively related to well-being, 
intrinsic religiosity, extraversion 
and agreeableness, and 
negatively related to anxiety and 
depression. Search is positively 
related to religious quest, 
rumination, past-negative and 
present-fatalistic time 
perspectives, negative affect, 
depression, and neuroticism, 
and negatively related to future 
time perspective, close-
mindedness (dogmatism), and 
well-being. Presence relates as 
expected with personal growth 
self-appraisals, and altruistic 
and spiritual behaviours as 
assessed through daily diaries. 
1. Steger, M. F., Frazier, P., Oishi, S., 
& Kaler, M. (2006). The Meaning in 
Life Questionnaire: Assessing the 
presence of and search for meaning in 
life. Journal of Counseling Psychology, 
53(1), 80-93. 2. Steger, M. F., & 
Frazier, P. (2005). Meaning in life: One 
link in the chain from religion to well-
being. Journal of Counseling 
Psychology, 52(4), 574-582. 
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Questionnaire 
Title 
Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
Mindful 
Attention 
Awareness 
Scale 
MAAS Yes 15 
 6-point 
Likert-type 
scale 
10 Minutes 
MAAS is designed to assess a 
core characteristic of 
dispositional mindfulness, 
namely, open or receptive 
awareness of and attention to 
what is taking place in the 
present. The scale shows 
strong psychometric properties. 
1. Brown, K.W. & Ryan, R.M. (2003). 
The benefits of being present: 
Mindfulness and its role in 
psychological well-being. Journal of 
Personality and Social Psychology, 84, 
822-848. 
Older Adults' 
Attributional 
Style 
Questionnaire 
OAASQ Yes 12 
 7-point 
Likert-type 
scale 
20 Minutes 
OAASQ is a version of the ASQ 
modified to be appropriate to 
the lives of older adults.  
1. Isaacowitz, D.M. & Seligman, 
M.E.P. (2002). Cognitive style 
predictors of affect change in older 
adults. International Journal of Aging 
and Human Development, 54(3), 233-
253. 2. Isaacowitz, D.M. & Seligman, 
M.E.P. (2001). Is pessimistic 
explanatory style a risk factor for 
depressive mood among community-
dwelling older adults? Behaviour 
Research and Therapy, 39, 255-272. 
Perceived 
Benefits Scale 
PBS Yes 38 
5-point 
Likert-type 
scale 
Not stated 
Cronbach’s alpha reliability 
coefficients for the PBS positive 
scales range from 0.73 to 0.93, 
and test-retest correlation 
coefficient reported over 2 
weeks range from 0.66 to 0.97.  
Information for the PBS 
negative scale was not 
reported.  Strong correlations 
between PBS and PTGI were 
reported. 
1. McMillen, J.C., & Fisher, R.H. 
(1998) The Perceived Benefits Scales: 
Measuring perceived positive life 
changes after negative events. Social 
Work Research, 22(3), 173-186.  
Personal 
Growth 
Initiative Scale 
PGIS Yes 9 
 6-point 
Likert-type 
scale 
5 Minutes 
PGIS is scale for personal 
growth initiative. Personal 
growth initiative is a person's 
active and intentional 
involvement in changing and 
developing as a person. There 
is evidence that the PGIS is 
strongly positively related to 
psychological well-being and 
negatively related to 
psychological distress. 
Reliability and validity evidence 
has been strong. 
1. Bartley, D. F., & Robitschek, C. 
(2000). Career exploration: A 
multivariate analysis of predictors. 
Journal of Vocational Behavior, 56, 63-
81. 2. Robitschek, C. (1998). Personal 
growth initiative: The construct and its 
measure. Measurement and Evaluation 
in Counseling and Development, 30, 
183-198. 3. Robitschek, C. (1999). 
Further validation of the Personal 
Growth Initiative Scale. Measurement 
and Evaluation in Counselling and 
Development, 31, 197-210. 4. 
Robitschek, C., & Cook, S. W. (1999). 
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Questionnaire 
Title 
Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
The influence of personal growth 
initiative and coping styles on career 
exploration and vocational identity. 
Journal of Vocational Behavior, 54, 
127-141. 5. Robitschek, C., & 
Kashubeck, S. (1999). A structural 
model of parental alcoholism, family 
functioning, and psychological health: 
The mediating effects of hardiness and 
personal growth orientation. Journal of 
Counseling Psychology, 46, 159-172. 
6. Whittaker, A. E., & Robitschek, C. 
(2001). Multidimensional family 
functioning as predictors of personal 
growth initiative. Journal of Counseling 
Psychology, 48, 420-427. 
Post Traumatic 
Growth 
Inventory 
PTGI Yes 21 
7-point 
Likert-type 
scale 
Not stated 
Internal consistency coefficients 
ranged from 0.67 to 0.85 for the 
subscales.  The alpha 
coefficient for the normative 
sample was 0.90.  Test-retest 
reliability measured two months 
later, was 0.71 for the total 
score, but 0.37 for some of the 
sub-scales. 
1. Tedeschi, R.G., & Calhoun, L.G. 
(1996) Posttraumatic Growth 
Inventory: Measuring the positive 
latency of trauma. Journal of 
Traumatic Stress, 9, 455-471. 
Psychological 
Well-Being 
Scales 
PWB Yes 42 
 6-point 
Likert-type 
scale 
Not stated 
This scale conceptualises 
psychological well-being as 
consisting of 6 dimensions: 
autonomy, environmental 
mastery, personal growth, 
positive relations with others, 
purpose in life, self-acceptance.  
1. Ryff, C.D., & Singer, B. (1998). The 
contours of positive human health. 
Psychological Inquiry, 9, 1-28. 2. Ryff, 
C.D. (1995). Psychological well-being 
in adult life. Current Directions in 
Psychological Science, 4, 99-104. 3. 
Ryff, C.D., & Keyes, C.L.M. (1995). 
The structure of psychological well-
being revisited. Journal of Personality 
and Social Psychology, 69, 719-727. 
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Questionnaire 
Title 
Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
Quality of Life 
Inventory 
QOLI Yes 16 
 6-point 
Likert-type 
scale 
Not stated 
QOLI assesses an individual's 
quality of life through the 
importance they attach to each 
of 16 life domains, as well as 
their current satisfaction with 
each domain. 
1. Frisch, M.B. (1992). Use of the 
Quality of Life Inventory in problem 
assessment and treatment planning 
for cognitive therapy of depression. In 
A. Freeman & F.M. Dattilio (Eds). 
Comprehensive Casebook of Cognitive 
Therapy (pp. 27-52). New York: 
Plenum. 2. Frisch, M.B., Cornell, J., 
Villanueva, M., & Retzlaff, P.J. (1992). 
Clinical validation of the Quality of Life 
Inventory: A measure of life 
satisfaction for use in treatment 
planning and outcome assessment. 
Psychological Assessment: A Journal of 
Consulting and Clinical Psychology, 4, 
92-101. 
Satisfaction 
with Life Scale 
 -  Yes 5 
 7-point 
Likert-type 
scale 
Few 
Minutes 
The Satisfaction with Life Scale 
was developed to assess 
satisfaction with people's lives 
as a whole. The scale does not 
assess satisfaction with specific 
life domains, such as health or 
finances, but allows subjects to 
integrate and weigh these 
domains in whatever way they 
choose. 
1. Diener, E., Emmons, R.A., Larson, 
R.J., & Griffin, S. (1985). The 
satisfaction with life scale. Journal of 
Personality Assessment, 49, 71-75. 2. 
Pavot, W. & Diener, E. (1993). Review 
of the Satisfaction with Life Scale. 
Psychological Assessment, 5, 164-172. 
3. Pavot, W. G., Diener, E., Colvin, C. 
R., & Sandvik, E. (1991). Further 
validation of the Satisfaction with Life 
Scale: Evidence for the cross-method 
convergence of well-being measures. 
Journal of Personality Assessment, 57, 
149-161. 
Silver Lining 
Questionnaire 
SLQ Yes 38 
 5-point 
Likert-type 
scale 
Not stated 
The Silver Lining Questionnaire 
measures the extent to which 
people believe their illness has 
had a positive benefit despite 
the negative consequences of 
being ill. Research suggests 
that this positive interpretation is 
not due to a form of self-
delusion but instead reflects 
personal growth and that it can 
be enhanced by the context. 
1. Sodergren, S. C. & Hyland, M. E. 
(1997). Qualitative phase in the 
development of the Silver Lining 
Questionnaire. Quality of Life 
Research, 6, (7-8), 365. 2. Sodergren, 
S. C., & Hyland, M. E. (2000). What 
are the positive consequences of 
illness? Psychology and Health, 15, 85-
97. 3. Sodergren, S. C., Hyland, M. E., 
Singh, S. J., & Sewell, L. (2002). The 
effect of rehabilitation on positive 
interpretations of illness. Psychology 
and Health; 17, 753-760. 4. 
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Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
Sodergren, S. C., Hyland, M. E., 
Crawford, A., Partridge, M. R. (2004). 
Positivitiy in illness: self-delusion or 
existential growth? British Journal of 
Health Psychology, 9, 163-174. 5. 
Hyland, M. E., Sodergren, S. C., & 
Lewith, G. T. (2006). The role of 
positivity in chronic fatigue syndrome 
(CFS). Journal of Health Psychology, 
11(5), 731-741. 
State-Trait-
Cheerfulness 
Inventory 
STCI Yes  20 / 10 
 4-point 
Likert-type 
scale 
 10 / 5 
Minutes 
STCI instrument measures the 
three concepts of cheerfulness, 
seriousness, and bad mood as 
both states (STCI-S) and traits 
(STCI-T). The concepts are 
considered to assess the 
temperamental basis of humour 
and the scales have been 
validated in a variety of studies 
1. Ruch, W., Kohler, G. & van Thriel 
(1996). Assessing the "humorous 
temperament": Construction of the 
facet and standard trait forms of the 
State-Trait-Cheerfulness-Inventory - 
STCI. In W. Ruch (Ed.), Measurement 
of the sense of humor [special issue]. 
Humor: International Journal of 
Humor Research, 9, 303-339. 2. Ruch, 
W., Kohler, G. & van Thriel (1997). To 
be in good or bad humor: Construction 
of the state form of the State-Trait-
Cheerfulness-Inventory - STCI. 
Personality and Individual Differences, 
22, 477-491. 3. Ruch, W. & Kohler, G. 
(1998). A temperament approach to 
humor. In: W. Ruch (Ed.), The sense 
of humor: Explorations of a personality 
characteristic. (Humor Research 
Series, vol. 3). Berlin: Mouton de 
Gruyter, 203-230. 4. Ruch, W. & 
Carrell, A. (1998). Trait cheerfulness 
and the sense of humor. Personality 
and Individual Differences, 24, 551-
558. 5. Ruch, W. (1997). State and 
trait cheerfulness and the induction of 
exhilaration. European Psychologist, 2, 
328-341. 
Stress-Related 
Growth Scale 
SRGS Yes 50 
4 point 
Likert-type 
scale 
Not stated 
Internal consistency coefficients 
for the SRGS in the mid 0.90s. 
Two week test-retest reliability 
was 0.81. 
Park, C.L., Cohen, L.H., & Murch, R. 
(1996). Assessment and prediction of 
stress related growth. Journal of 
Personality, 64, 71-105. 
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Questionnaire 
Title 
Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
Subjective 
Happiness 
Scale  
SHS Yes 4 
7-point 
Likert-type 
scale 
Not stated 
SHS is a global subjective 
happiness scale. SHS has high 
internal consistency, which has 
been found to be stable across 
samples. Test-retest and self-
peer correlations have 
suggested good to excellent 
reliability, and construct 
validation studies of convergent 
and discriminant validity have 
confirmed the use of this scale 
to measure the construct of 
subjective happiness. 
1. Lyubomirsky, S., & Lepper, H. S. 
(1999). A measure of subjective 
happiness: Preliminary reliability and 
construct validation. Social Indicators 
Research, 46, 137-155. 2. 
Lyubomirsky, S., & Ross, L. (1997). 
Hedonic consequences of social 
comparison: A contrast of happy and 
unhappy people. Journal of Personality 
and Social Psychology, 73, 1141-1157. 
3. Lyubomirsky, S., & Ross, L. (1999). 
Changes in attractiveness of elected, 
rejected, and precluded alternatives: A 
comparison of happy and unhappy 
individuals. Journal of Personality and 
Social Psychology, 76, 988-1007. 4. 
Lyubomirsky, S., & Tucker, K. L. 
(1998). Implications of individual 
differences in subjective happiness for 
perceiving, interpreting, and thinking 
about life events. Motivation and 
Emotion, 22, 155-186. 5. 
Lyubomirsky, S. (2001). Why are some 
people happier than others?: The role 
of cognitive and motivational 
processes in well-being. American 
Psychologist, 56, 239-249. 
Thriving Scale TS Yes 20 
5-point 
Likert-type 
scale 
Not stated 
Cronbach’s alpha reliability 
coefficient for the TS of 0.92. No 
test-retest information is 
reported. 
1. Abraido-Lanza, A.F., Guier, C., & 
Colon, R.M. (1998). Psychological 
thriving among Latinas with chronic 
illness. Journal of Social Issues, 54, 
405-424. 
Transgression-
Related 
Interpersonal 
Motivations 
Inventory 
TRIM Yes 12 
5-point 
Likert-type 
scale 
5 Minutes 
TRIM assesses the motivations 
assumed to underlie forgiving: 
Avoidance and Revenge. TRIM 
subscales not only correlate 
with a variety of relationship, 
offense, and social-cognitive 
variables, they have also 
demonstrated strong 
relationships to a single-item 
measure of forgiveness. 
1. McCullough, M. E., Rachal, K.C., 
Sandage, S. J., Worthington, E. L., 
Brown, Susan W., & Hight, T. 
L.(1998). Interpersonal Forgiving in 
Close Relationships: II. Theoretical 
Elaboration and Measurement. Journal 
of Personality and Social Psychology, 
75, 1586-1603. 2. McCullough, M. E., 
Hoyt, W. T., & Rachal, K. C. (2000). 
What We Know (and Need to Know) 
about Assessing Forgiveness 
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Questionnaire 
Title 
Questionnaire 
Title 
Abbreviation  
Self-
Report 
Number 
of items 
Response 
Format 
Completion 
Time 
Other Details Key References 
Constructs. In McCullough, M. E., 
Pargament, K.I., & Carl E. Thoresen 
(Eds.), Forgiveness: Theory, Research, 
and Practice (pp.65-88). New York: 
Guilford Publications,Inc. 3. 
McCullough, M. E., Bellah, C.G., 
Kilpatrick, S. D., & Johnson, J. L. 
(2001). Vengefulness: Relationships 
With Forgiveness, Rumination, Well-
Being, and the Big Five. Journal of 
Personality and Social Psychology 
Bulletin, 27, 601-610. 
VIA Inventory 
of Strengths 
VIA-IS Yes 240 
5-point 
Likert-type 
scale 
25 Minutes 
VIA-IS has face-validity and is 
intended for use with adults in 
the contemporary United States.  
1. Peterson, C., & Seligman, M. E. P. 
(in preparation). The VIA classification 
of strengths. Cincinnati, OH: Values in 
Action Institute. 2. Peterson, C., & 
Seligman, M. E. P, (2001). VIA 
Inventory of Strengths (VIA-IS). 
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Appendix 5: Minimum data sheet 
Hospital Number: _________________ 
Date of Birth: ___/_____/______ 
Gender (please circle): Male / Female 
Ethnic Origin: 
249 White 258 Other Asian background 
250 Mixed – White and black Caribbean 259 All Asian groups 
251 Mixed – White and black African 260 Black – Caribbean 
252 Mixed – White and Asian 261 Black – African  
253 Other mixed background 262 Other Black backgrounds 
254 All mixed groups 263 All Black groups 
255 Asian – Indian 264 Chinese 
256 Asian – Pakistani 265 Other ethnic group 
257 Asian – Bangladeshi  266 Not Stated 
 
Postcode: __________________ 
Smoking Status: 
  Current / Ex / Non-smoker 
  Number a day: _________ 
  Pack Years: ___________ 
Alcohol: _________________________ 
 
Location of Primary neoplasm 
1. Oral – tongue, FOM, other 
2. Oropharynx – tonsil, base of tongue, other 
3. Glottis 
4. Supraglottis 
5. Transglottis 
6. Other – please specify 
 
Tumour Diagnosis Code: __________ 
Type of Tumour (circle): 1. Squamous 2. Lymphoma 3. Sarcoma 4. Glandular 
Stage of tumour: T ____ N ____ M _____ 
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Treatment regimen 
Surgery 
a) Primary 
0. None 
1. Hemiglossectomy 
2. Total Glossectomy 
3. Segmental mandibulectomy 
4. Oral resection other than above – please specify _____________ 
5. Total Laryngectomy 
6. Transoral conservation surgery 
7. Open partial laryngectomy 
8. Maxillectomy 
9. Orbital exentration 
10. Facial nerve sacrifice 
 
b) Neck dissection type (please circle appropriate selection) 
 
1. Right  None  Radical Modified Selective Extended 
2. Left  None  Radical Modified Selective Extended 
 
c) Reconstruction 
0. None  
1. Local Flap 
2. Pedical flap      a. pecoralis major     b. other – please specify _______ 
3. Free flap 
 
Radiotherapy 
0. None 
1. Curative 
2. Adjuvant (post-operative) 
 
Radiotherapy dosage: ___________Gy  Fractions: _____________ 
 
Chemotherapy 
0. None  
1. Cisplatin 
2. Carboplatin 
3. Cetuximab 
4. Agent Unknown 
5. Other – Please specify ______________ 
 
Date treatment completed: ____ / _____ / _________ 
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Appendix 6: Classification of Tumours and Staging 
The TNM system for describing the anatomical extent of the disease is based on 
three components: 
T – Extent of primary tumour 
N – Absence or presence and extent of regional lymph node metastases 
M – Absence or presence of distant metastases (Roland, Porter, Fish, 
Makura, 2016) 
Table 20: Overview of TNM staging terminology 
T - Primary tumour 
 TX Primary tumour cannot be assessed 
 T0 No evidence of primary tumour 
 Tis Carcinoma in situ 
 T1, T2, T3, T4 Increasing size and/or local extent of the primary tumour 
N - Regional lymph nodes 
 NX Regional lymph nodes cannot be assessed 
 N0 No evidence of regional lymph node metastases 
 N1, N2, N3 Increasing involvement of regional lymph nodes 
M- Distant metastasis 
 M0 No distant metastasis 
 M1 Distant metastasis 
 
After TNM, classification of tumours, a stage grouping is assigned.  The aim is to 
define in patients all of the factors relevant to the natural history and outcome of 
the disease, thereby patients to be groups with other similar cases. 
Table 21: Stage grouping for HNC excluding nasopharynx, thyroid and mucosal melanoma 
Stage 0 Tis N0 M0 
Stage I T1 N0 M0 
Stage II T2 N0 M0 
Stage III 
T1, T2, T3 N1 M0 
T3 N0 M0 
Stage IVA 
T1, T2, T3 N2 M0 
T4a N0, N1, N2 M0 
Stage IVB 
Any T N3 M0 
T4b Any N M0 
Stage IVC Any T Any N M1 
 
  
204 
The TNM data collected and subsequent staging allocation used in analysis during 
the research presenting in this thesis was post-surgical histopathological 
classification.   
Full descriptors of size and extent of tumours and their categorisation can be found 
in TNM Classification of Malignant Tumours (Sobin, Gospodarowicz, Wittekind, 
2009) 
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Appendix 7: Cover letter 
 
HEADED PAPER 
 
Title Forename Surname 
First line of address, 
Second line of address, 
Third line of address, 
Forth line of address 
Postcode 
 
 
Date 
 
Ref No: 
Dear 
I am writing to you as you have received treatment under the Head and Neck team 
(either the Maxillofacial or ENT Department) in Derriford Hospital. 
You may have received this survey from us last year as it is part of an annual survey.  
We would appreciate your time in completing the enclosed questionnaires.  Please 
then returning them to us in the freepost envelope provided.  
We think the survey will take about 30 minutes to complete.  There are no right or 
wrong answers, so please be as open and honest as you can be. 
If you have any questions then please do contact me (tel.) 07981 202032 (email.) 
sam.harding@nhs.net and I will happily discuss them with you.  If I am unavailable 
to answer your call please leave a message and I will contact you as soon as 
possible. 
 
Yours Sincerely 
 
Sam Harding, 
Research Psychologist 
Mr David Courtney      Mr Tass Malik 
Consultant Oral & Maxillofacial Surgeon  Consultant ENT Surgeon 
Ms Sam Harding  
Psychologist  
Maxillofacial Department 
Level 7 
Derriford Hospital  
Derriford 
Plymouth 
PL6 8DH 
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Appendix 8: Merseyside regional head and neck cancer centre and current study UoW data 
    Male 55-64 yrs of age Female 55-64 yrs of age Male 65+ yrs of age Female 65+ yrs of age Male Study Data (average age 63.8) Female Study Data (average age 64.5) 
  Response Surgery* Surgery** Radiotherapy Surgery* Surgery** Radiotherapy Surgery* Surgery** Radiotherapy Surgery* Surgery** Radiotherapy Surgery* Surgery** Radiotherapy Surgery* Surgery** Radiotherapy 
P
ai
n
 
0 0 (0) 2 (3.1) 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
25 7 (6.1) 3 (4.7) 1 (50) 1 (1.7) 5 (16.1) 2 (66.7) 2 (1.9) 2 (3.6) 0 (0) 3 (2.8) 0 (0) 1 (100) 4 (4.4) 0 (0.0) 4 (4.7) 1 (2.1) 0 (0.0) 1 (4.3) 
50 22 (19.3) 18 (28.1) 0 (0) 7 (12.1) 7 (22.6) 0 (0) 12 (11.4) 12 (21.8) 0 (0) 20 (18.7) 2 (7.1) 0 (0) 19 (21.1) 10 (23.3) 21 (24.4) 10 (21.3) 11 (33.3) 5 (21.7) 
75 26 (22.8) 16 (25.0) 0 (0) 17 (29.3) 8 (25.8) 0 (0) 22 (21.0) 13 (23.6) 1 (50) 19 (17.8) 6 (21.4) 0 (0) 25 (27.8) 13 (30.2) 19 (22.1) 15 (31.9) 14 (54.5) 3 (13.0) 
100 59 (51.8) 25 (39.1) 1 (50) 33 (56.9) 11 (35.5) 1 (33.3) 68 (64.8) 28 (50.9) 1 (50) 65 (60.7) 20 (71.4) 0 (0) 42 (46.7) 20 (46.5) 42 (48.8) 21 (44.7) 5 (12.1) 14 (60.9) 
A
p
p
ea
ra
n
ce
 
0 2 (1.8) 2 (3.1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.0) 0 (0.0) 
25 3 (2.6) 1 (1.6) 0 (0) 4 (6.9) 7 (22.6) 1 (33.3) 0 (0) 1 (1.9) 0 (0) 4 (3.7) 0 (0) 0 (0) 1 (1.1) 3 (7.0) 3 (3.5) 0 (0.0) 5 (15.2) 1 (4.3) 
50 12 (10.5) 17 (26.6) 0 (0) 4 (6.9) 11 (35.5) 1 (33.3) 9 (8.5) 9 (16.7) 0 (0) 12 (11.1) 4 (40.0) 1 (100) 8 (8.8) 4 (9.3) 7 (8.1) 16 (34.0) 10 (30.3) 2 (8.7) 
75 52 (45.6) 35 (54.7) 1 (50) 22 (37.9) 7 (22.6) 1 (33.3) 44 (41.5) 31 (57.4) 1 (50) 43 (39.8) 12 (46.7) 0 (0) 40 (44.0) 20 (46.5) 45 (52.3) 15 (31.9) 9 (27.3) 9 (39.1) 
100 45 (39.5) 9 (14.1) 1 (50) 28 (48.3) 6 (19.4) 0 (0) 53 (50.0) 13 (24.1) 1 (50) 49 (45.4) 14 (13.3) 0 (0) 42 (46.2) 16 (37.2) 31 (36.0) 16 (34.0) 8 (24.2) 11 (47.8) 
A
ct
iv
it
y 
0 2 (1.8) 0 (0) 1 (50) 3 (5.2) 1 (3.2) 0 (0) 2 (1.9) 4 (7.4) 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.1) 1 (2.3) 1 (1.2) 0 (0.0) 3 (9.1) 0 (0.0) 
25 3 (2.6) 1 (1.6) 0 (0) 1 (1.7) 2 (6.5) 1 (33.3) 1 (1.0) 5 (9.3) 0 (0) 5 (4.6) 0 (0) 0 (0) 3 (3.3) 1 (2.3) 4 (4.7) 1 (2.1) 1 (3.0) 3 (13.0) 
50 43 (37.7) 36 (56.3) 1 (50) 13 (22.4) 14 (45.2) 1 (33.3) 29 (27.6) 17 (31.5) 1 (50) 30 (27.5) 9 (30.0) 1 (100) 23 (25.6) 9 (20.9) 34 (39.5) 20 (42.6) 17 (51.5) 7 (30.4) 
75 29 (25.4) 17 (26.6) 0 (0) 15 (25.9) 6 (19.4) 0 (0) 34 (32.4) 17 (31.5) 1 (50) 35 (32.1) 8 (26.7) 0 (0) 26 (28.9) 19 (44.2) 37 (43.0) 10 (21.3) 11 (33.3) 9 (39.1) 
100 37 (32.5) 10 (15.6) 0 (0) 26 (44.8) 8 (25.8) 1 (33.3) 39 (37.1) 11 (20.4) 0 (0) 39 (35.8) 13 (43.3) 0 (0) 37 (41.1) 13 (30.2) 10 (11.6) 16 (34.0) 1 (3.0) 4 (17.4) 
R
ec
re
at
io
n
 
0 2 (1.8) 1 (1.6) 0 (0) 0 (0) 0 (0) 0 (0) 2 (1.9) 2 (3.6) 0 (0) 1 (0.9) 0 (0) 0 (0) 3 (3.3) 1 (2.3) 2 (2.7) 0 (0.0) 0 (0.0) 0 (0.0) 
25 9 (8.0) 5 (7.8) 1 (50) 6 (10.3) 2 (6.5) 0 (0) 3 (2.8) 8 (14.5) 0 (0) 4 (3.7) 1 (3.3) 0 (0) 4 (4.4) 1 (2.3) 8 (10.7) 2 (4.3) 6 (18.2) 1 (4.3) 
50 20 (17.9) 12 (18.8) 0 (0) 6 (10.3) 12 (38.7) 1 (33.3) 15 (14.2) 15 (27.3) 0 (0) 18 (16.7) 4 (13.3) 1 (100) 12 (13.3) 2 (4.7) 15 (20.0) 12 (25.5) 11 (33.3) 5 (21.7) 
75 42 (37.5) 36 (56.3) 1 (50) 18 (31.0) 9 (29.0) 2 (66.7) 57 (53.8) 20 (36.4) 2 (100) 44 (40.7) 20 (66.7) 0 (0) 30 (33.3) 26 (60.5) 31 (41.3) 16 (34.0) 14 (42.4) 9 (39.1) 
100 39 (34.8) 10 (15.6) 0 (0) 28 (48.3) 8 (25.8) 0 (0) 29 (27.4) 10 (18.2) 0 (0) 41 (38.0) 5 (16.7) 0 (0) 41 (45.6) 13 (30.2) 19 (25.3) 17 (36.2) 2 (6.1) 8 (34.8) 
Sw
al
lo
w
in
g 
0 4 (3.5) 5 (7.7) 1 (50) 1 (1.7) 2 (6.5) 0 (0) 0 (0) 2 (3.6) 0 (0) 1 (0.9) 2 (6.7) 0 (0) 0 (0.0) 2 (4.7) 3 (3.5) 0 (0.0) 1 (3.0) 0 (0.0) 
30 5 (4.4) 10 (15.4) 0 (0) 0 (0) 9 (29.0) 0 (0) 3 (2.9) 11 (20.0) 0 (0) 6 (5.6) 5 (16.7) 0 (0) 1 (1.1) 4 (9.3) 13 (15.1) 5 (10.6) 5 (15.2) 1 (4.3) 
70 45 (39.5) 30 (46.2) 1 (50) 18 (31) 13 (41.9) 3 (100) 28 (26.7) 26 (47.3) 2 (100) 40 (37.0) 14 (46.7) 1 (100) 26 (28.9) 21 (48.8) 40 (46.5) 9 (19.1) 20 (60.6) 15 (65.2) 
100 60 (52.6) 20 (30.8) 0 (0) 39 (67.2) 7 (22.6) 0 (0) 74 (70.5) 16 (29.1) 0 (0) 61 (56.5) 9 (30.0) 0 (0) 63 (70.0) 16 (37.2) 30 (34.9) 33 (70.2) 7 (21.2) 7 (30.4) 
C
h
ew
in
g 
0 7 (6.1) 20 (30.8) 1 (50) 1 (1.8) 11 (36.7) 0 (0) 4 (3.8) 13 (24.1) 0 (0) 9 (8.3) 10 (34.5) 0 (0) 1 (1.1) 5 (11.6) 14 (16.3) 4 (8.5) 4 (12.1) 0 (0.0) 
50 55 (48.2) 34 (52.3) 1 (50) 28 (49.1) 14 (46.7) 3 (100) 42 (40.0) 29 (53.7) 2 (100) 47 (43.1) 16 (55.2) 1 (100) 33 (36.7) 21 (48.8) 30 (34.9) 15 (31.9) 20 (60.6) 13 (56.5) 
100 52 (45.6) 11 (16.9) 0 (0) 28 (49.1) 5 (16.7) 0 (0) 59 (56.2) 12 (22.2) 0 (0) 53 (48.6) 3 (10.3) 0 (0) 56 (62.2) 17 (39.5) 42 (48.8) 28 (59.6) 9 (27.3) 10 (43.5) 
Sp
e
ec
h
 
0 0 (0) 1 (1.6) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (3.9) 0 (0) 1 (0.9) 0 (0) 0 (0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
30 9 (8.0) 7 (10.9) 0 (0) 0 (0) 8 (25.8) 0 (0) 1 (0.9) 5 (9.8) 1 (50) 1 (0.9) 3 (11.1) 0 (0) 3 (3.2) 2 (4.7) 3 (3.6) 1 (2.1) 3 (8.8) 2 (8.7) 
70 57 (50.9) 45 (70.3) 2 (100) 28 (49.1) 15 (48.4) 3 (100) 47 (44.3) 28 (54.9) 1 (50) 41 (37.3) 16 (59.3) 1 (100) 43 (46.2) 26 (60.5) 19 (22.6) 21 (44.7) 19 (55.9) 3 (13.0) 
100 46 (41.1) 11 (17.2) 0 (0) 29 (50.9) 8 (25.8) 0 (0) 58 (54.7) 16 (31.4) 0 (0) 67 (60.9) 8 (29.6) 0 (0) 47 (50.5) 15 (34.9) 62 (73.8) 25 (53.2) 12 (35.3) 18 (78.3) 
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Sh
o
u
ld
er
 
0 8 (7.3) 6 (9.7) 1( 50) 3 (5.4) 4 (12.9) 1 (33.3) 2 (2.0) 3 (5.7) 0 (0) 2 (2.0) 1 (3.4) 0 (0) 3 (3.4) 1 (2.3) 4 (4.8) 1 (2.3) 1 (3.0) 0 (0.0) 
30 12 (10.9) 10 (16.1) 0 (0) 2 (3.6) 7 (22.6) 1 (33.3) 7 (7.1) 3 (5.7) 0 (0) 8 (7.8) 1 (3.4) 0 (0) 8 (9.0) 5 (11.6) 2 (2.4) 9 (20.5) 7 (21.2) 2 (8.7) 
70 23 (20.9) 17 (27.4) 0 (0) 9 (16.1) 4 (12.9) 0 (0) 14 (14.3) 12 (22.6) 0 (0) 20 (19.6) 7 (24.1) 1 (100) 23 (25.8) 13 (30.2) 8 (9.6) 9 (20.5) 3 (9.1) 7 (30.4) 
100 67 (60.9) 29 (46.8) 1 (50) 42 (75.0) 16 (51.6) 1 (33.3) 75 (76.5) 35 (66.0) 2 (100) 72 (70.6) 20 (69.0) 0 (0) 55 (61.8) 24 (55.8) 69 (83.1) 25 (56.8) 22 (66.7) 14 (60.9) 
Ta
st
e 
0 2 (2.1) 4 (7.4) 0 (0) 0 (0) 4 (13.8) 0 (0) 2 (2.2) 5 (12.5) 0 (0) 3 (3.1) 3 (11.5) 0 (0) 5 (5.4) 3 (7.0) 14 (16.7) 0 (0.0) 1 (2.9) 2 (8.7) 
30 19 (19.6) 20 (37.0) 0 (0) 5 (10.0) 9 (31.0) 2 (66.7) 7 (7.7) 9 (22.5) 2 (100) 9 (9.4) 8 (30.8) 1 (100) 11 (12.0) 15 (34.9) 27 (32.1) 11 (23.4) 21 (61.8) 11 (47.8) 
70 24 (24.7) 19 (35.2) 1 (50) 13 (26.0) 10 (34.5) 1 (33.3) 28 (30.8) 13 (32.5) 0 (0) 25 (26.0) 5 (19.2) 0 (0) 28 (30.4) 19 (44.2) 19 (22.6) 11 (23.4) 10 (29.4) 7 (30.4) 
100 52 (53.6) 11 (20.4) 1 (50) 32 (64.0) 6 (20.7) 0 (0) 54 (59.3) 13 (32.5) 0 (0) 59 (61.5) 10 (38.5) 0 48 (52.2) 6 (14.0) 24 (28.6) 25 (53.2) 2 (5.9) 3 (13.0) 
Sa
liv
a 
0 2 (2.2) 4 (7.7) 1 (50) 2 (4.2) 6 (20.0) 0 (0) 2 (2.2) 2 (5.4) 0 (0) 0 (0) 2 (8.0) 0 (0) 2 (2.2) 4 (9.3) 17 (20.2) 0 (0.0) 4 (11.8) 1 (4.3) 
30 11 (11.8) 16 (30.8) 0 (0) 4 (8.3) 10 (33.3) 1 (33.3) 4 (4.4) 8 (21.6) 2 (100) 14 (15.2) 7 (28.0) 1 (100) 7 (7.7) 15 (34.9) 34 (40.5) 3 (6.5) 12 (35.3) 7 (30.4) 
70 22 (23.7) 18 (34.6) 1 (50) 17 (35.4) 9 (30.0) 2 (66.7) 18 (20.0) 14 (37.8) 0 (0) 23 (25.0) 9 (36.0) 0 (0) 17 (18.7) 16 (37.2) 26 (31.0) 13 (28.3) 10 (29.4) 8 (34.8) 
100 58 (62.4) 14 (26.9) 0 (0) 25 (52.1) 5 (16.7) 0 (0) 66 (73.3) 13 (35.1) 0 (0) 55 (59.8) 7 (28.0) 0 (0) 65 (71.4) 8 (18.6) 7 (8.3) 30 (65.2) 8 (23.5) 7 (30.4) 
M
o
o
d
  
0 4 (4.1) 3 (5.5) 0 (0) 2 (4.0) 0 (0) 0 (0) 0 (0) 1 (2.6) 0 (0) 1 (1.1) 0 (0) 0 (0) 1 (1.1) 1 (2.3) 3 (3.6) 0 (0.0) 0 (0.0) 2 (8.7) 
25 19 (19.4) 7 (12.7) 1 (50) 3 (6.0) 9 (31.) 0 (0) 2 (2.3) 5 (12.8) 0 (0) 3 (3.2) 1 (3.8) 1 (100) 5 (5.5) 2 (4.7) 12 (14.5) 3 (6.5) 4 (11.8) 1 (4.3) 
50 11 (11.2) 5 (9.1) 0 (0) 3 (6.0) 3 (10.3) 1 (33.3) 6 (6.9) 4 (10.3) 0 (0) 9 (9.5) 1 (3.8) 0 (0) 13 (14.3) 1 (2.3) 12 (14.5) 4 (8.7) 11 (32.4) 6 (26.1) 
75 34 (34.7) 21 (38.2) 1 (50) 21 (42.0) 11 (37.9) 2 (66.7) 27 (31.0) 7 (17.9) 1 (50) 30 (31.6) 15 (57.7) 0 (0) 24 (26.4) 20 (46.5) 33 (39.8) 20 (43.5) 14 (41.2) 7 (30.4) 
100 30 (30.6) 19 (34.5) 0 (0) 21 (42.0) 6 (20.7) 0 (0) 52 (59.8) 22 (56.4) 1 (50) 52 (54.7) 9 (34.6) 0 (0) 48 (52.7) 19 (44.2) 23 (27.7) 19 (41.3) 5 (14.7) 7 (30.4) 
A
n
xi
et
y 
0 4 (4.1) 3 (5.6) 1 (50) 2 (3.9) 4 (14.3) 0 (0) 1 (1.1) 0 (0) 0 (0) 2 (2.2) 1 (3.8) 0 (0) 2 (2.2) 1 (2.3) 2 (2.4) 0 (0.0) 1 (2.9) 2 (8.7) 
30 16 (16.3) 5 (9.3) 0 (0) 5 (9.8) 6 (21.4) 1 (33.3) 3 (3.4) 4 (10.3) 0 (0) 5 (5.4) 1 (3.8) 0 (0) 5 (5.5) 5 (11.6) 14 (16.7) 2 (4.3) 7 (20.6) 5 (21.4) 
70 45 (45.9) 28 (51.9) 1 (50) 25 (49.0) 13 (46.4) 1 (33.3) 29 (33.3) 11 (28.2) 1 (50) 42 (45.2) 15 (57.7) 1 (100) 26 (28.6) 17 (39.5) 34 (40.5) 32 (69.6) 23 (67.6) 12 (52.2) 
100 33 (33.7) 18 (33.3) 0 (0) 19 (37.3) 5 (17.9) 1 (33.3) 54 (62.1) 24 (61.5) 1 (50) 44 (47.3) 9 (34.6) 0 (0) 58 (63.7) 20 (46.5) 34 (40.5) 12 (26.1) 3 (8.8) 4 (17.4) 
yrs = years, *Surgery without any other treatment, **Surgery followed by radiotherapy, Radiotherapy, with or without chemotherapy (no surgery) 
Comparative data supplied by: http://www.headandneckcancer.co.uk/For+patients/What+will+I+be+like/QOL+Patient+Search+Tool.aspx, accessed 03/03/2015 
The higher the response the better the reported Health Related Quality of Life.  Figures given in the ‘response’ column are the values assigned to the responses for each question.  Some questions have 3 possible responses, others have four or five responses.   
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Appendix 9: Tukey post hoc analysis 
 
Table 22: Tukey post hoc analysis for age at diagnosis 
Age at diagnosis of 
HNC 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Cohort 1 Cohort 2 4.798 2.514 .317 -2.13 11.73 
Cohort 3 5.240 2.276 .149 -1.03 11.51 
Cohort 4 3.177 2.514 .714 -3.75 10.10 
Cohort 5 4.855 3.006 .490 -3.43 13.14 
Cohort 2 Cohort 1 -4.798 2.514 .317 -11.73 2.13 
Cohort 3 .442 2.785 1.000 -7.23 8.12 
Cohort 4 -1.621 2.983 .983 -9.84 6.60 
Cohort 5 .057 3.408 1.000 -9.34 9.45 
Cohort 3 Cohort 1 -5.240 2.276 .149 -11.51 1.03 
Cohort 2 -.442 2.785 1.000 -8.12 7.23 
Cohort 4 -2.063 2.785 .947 -9.74 5.61 
Cohort 5 -.385 3.237 1.000 -9.30 8.54 
Cohort 4 Cohort 1 -3.177 2.514 .714 -10.10 3.75 
Cohort 2 1.621 2.983 .983 -6.60 9.84 
Cohort 3 2.063 2.785 .947 -5.61 9.74 
Cohort 5 1.678 3.408 .988 -7.71 11.07 
Cohort 5  Cohort  -4.855 3.006 .490 -13.14 3.43 
Cohort 2 -.057 3.408 1.000 -9.45 9.34 
Cohort 3 .385 3.237 1.000 -8.54 9.30 
Cohort 4 -1.678 3.408 .988 -11.07 7.71 
Key: HNC = Head and Neck Cancer, Std. Error = Standard Error, Sig = level of significance 
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Table 23: Tukey post hoc analysis for age at time of completion of the questionnaire 
Age at time of 
completion of 
questionnaire 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Cohort 1 Cohort 2 3.990 2.507 .505 -2.92 10.90 
Cohort 3 4.167 2.269 .356 -2.09 10.42 
Cohort 4 3.265 2.507 .690 -3.64 10.17 
Cohort 5  3.959 3.067 .697 -4.49 12.41 
Cohort 2 Cohort 1 -3.990 2.507 .505 -10.90 2.92 
Cohort 3 .178 2.778 1.000 -7.48 7.83 
Cohort 4 -.724 2.975 .999 -8.92 7.47 
Cohort 5 -.030 3.460 1.000 -9.57 9.51 
Cohort 3 Cohort 1 -4.167 2.269 .356 -10.42 2.09 
Cohort 2  -.178 2.778 1.000 -7.83 7.48 
Cohort 4 -.902 2.778 .998 -8.56 6.75 
Cohort 5 -.208 3.292 1.000 -9.28 8.87 
Cohort 4 Cohort 1 -3.265 2.507 .690 -10.17 3.64 
Cohort 2 .724 2.975 .999 -7.47 8.92 
Cohort 3  .902 2.778 .998 -6.75 8.56 
Cohort 5 .694 3.460 1.000 -8.84 10.23 
Cohort 5 Cohort 1 -3.959 3.067 .697 -12.41 4.49 
Cohort 2  .030 3.460 1.000 -9.51 9.57 
Cohort 3 .208 3.292 1.000 -8.87 9.28 
Cohort 4  -.694 3.460 1.000 -10.23 8.84 
Key: Std. Error = Standard Error, Sig = level of significance 
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Table 24: Tukey post hoc analysis for physical component scale 
PCS 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Cohort 1 Cohort 2 -1.05280 3.10088 .997 -9.7001 7.5945 
Cohort 3 2.79561 2.94508 .877 -5.4172 11.0084 
Cohort 4 -.88401 3.01842 .998 -9.3013 7.5333 
Cohort 5 -.14772 3.42560 1.000 -9.7005 9.4051 
Cohort 2 Cohort 1 1.05280 3.10088 .997 -7.5945 9.7001 
Cohort 3 3.84841 3.63138 .826 -6.2782 13.9751 
Cohort 4 .16879 3.69110 1.000 -10.1244 10.4620 
Cohort 5 .90508 4.03090 .999 -10.3357 12.1458 
Cohort 3 Cohort 1 -2.79561 2.94508 .877 -11.0084 5.4172 
Cohort 2 -3.84841 3.63138 .826 -13.9751 6.2782 
Cohort 4 -3.67962 3.56122 .839 -13.6106 6.2514 
Cohort 5 -2.94333 3.91232 .943 -13.8534 7.9668 
Cohort 4 Cohort 1 .88401 3.01842 .998 -7.5333 9.3013 
Cohort 2 -.16879 3.69110 1.000 -10.4620 10.1244 
Cohort 3 3.67962 3.56122 .839 -6.2514 13.6106 
Cohort 5 .73629 3.96781 1.000 -10.3286 11.8011 
Cohort 5 Cohort 1 .14772 3.42560 1.000 -9.4051 9.7005 
Cohort 2 -.90508 4.03090 .999 -12.1458 10.3357 
Cohort 3 2.94333 3.91232 .943 -7.9668 13.8534 
Cohort 4 -.73629 3.96781 1.000 -11.8011 10.3286 
Key: PCS = Physical Component Scale, Std. Error = Standard Error, Sig = level of significance 
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Table 25: Tukey post hoc analysis for mental component scale 
MCS 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Cohort 1 Cohort 2 .73455 2.43902 .998 -6.0670 7.5361 
Cohort 3 -.24217 2.31648 1.000 -6.7020 6.2177 
Cohort 4 -3.50726 2.37416 .580 -10.1280 3.1134 
Cohort 5 -5.66083 2.69443 .229 -13.1747 1.8530 
Cohort 2 Cohort 1 -.73455 2.43902 .998 -7.5361 6.0670 
Cohort 3 -.97672 2.85628 .997 -8.9419 6.9885 
Cohort 4 -4.24181 2.90326 .590 -12.3380 3.8544 
Cohort 5 -6.39538 3.17053 .267 -15.2369 2.4461 
Cohort 3 Cohort 1 .24217 2.31648 1.000 -6.2177 6.7020 
Cohort 2 .97672 2.85628 .997 -6.9885 8.9419 
Cohort 4 -3.26510 2.80110 .771 -11.0764 4.5462 
Cohort 5 -5.41867 3.07726 .403 -14.0001 3.1627 
Cohort 4 Cohort 1 3.50726 2.37416 .580 -3.1134 10.1280 
Cohort 2 4.24181 2.90326 .590 -3.8544 12.3380 
Cohort 3 3.26510 2.80110 .771 -4.5462 11.0764 
Cohort 5 -2.15357 3.12091 .958 -10.8567 6.5496 
Cohort 5 Cohort 1 5.66083 2.69443 .229 -1.8530 13.1747 
Cohort 2 6.39538 3.17053 .267 -2.4461 15.2369 
Cohort 3 5.41867 3.07726 .403 -3.1627 14.0001 
Cohort 4 2.15357 3.12091 .958 -6.5496 10.8567 
Key: MCS = Mental Component Scale, Std. Error = Standard Error, Sig = level of significance 
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Table 26: Tukey post hoc analysis for SLQ 
SLQ 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Cohort 1 Cohort 2 -6.575 7.193 .891 -26.41 13.26 
Cohort 3 .091 6.521 1.000 -17.89 18.07 
Cohort 4 -2.753 6.932 .995 -21.87 16.36 
Cohort 5 .501 8.781 1.000 -23.71 24.71 
Cohort 2 Cohort 1 6.575 7.193 .891 -13.26 26.41 
Cohort 3 6.667 8.034 .921 -15.48 28.82 
Cohort 4 3.822 8.371 .991 -19.26 26.90 
Cohort 5 7.076 9.956 .954 -20.37 34.53 
Cohort 3 Cohort 1 -.091 6.521 1.000 -18.07 17.89 
Cohort 2 -6.667 8.034 .921 -28.82 15.48 
Cohort 4 -2.844 7.801 .996 -24.35 18.66 
Cohort 5 .410 9.482 1.000 -25.73 26.55 
Cohort 4 Cohort 1 2.753 6.932 .995 -16.36 21.87 
Cohort 2 -3.822 8.371 .991 -26.90 19.26 
Cohort 3 2.844 7.801 .996 -18.66 24.35 
Cohort 5 3.254 9.769 .997 -23.68 30.19 
Cohort 5 Cohort 1 -.501 8.781 1.000 -24.71 23.71 
Cohort 2 -7.076 9.956 .954 -34.53 20.37 
Cohort 3 -.410 9.482 1.000 -26.55 25.73 
Cohort 4 -3.254 9.769 .997 -30.19 23.68 
Key: SLQ = Silver Lining Questionnaire, Std. Error = Standard Error, Sig = level of significance 
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Table 27: Tukey post hoc analysis for UoW 
UoW 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Cohort 1 Cohort 2 -57.734 43.871 .682 -178.71 63.24 
Cohort 3 -2.971 39.987 1.000 -113.23 107.29 
Cohort 4 -25.056 43.871 .979 -146.03 95.92 
Cohort 5 -27.073 52.830 .986 -172.75 118.60 
Cohort 2 Cohort 1 57.734 43.871 .682 -63.24 178.71 
Cohort 3 54.764 48.498 .791 -78.97 188.49 
Cohort 4 32.679 51.747 .970 -110.01 175.37 
Cohort 5 30.662 59.532 .986 -133.50 194.82 
Cohort 3 Cohort 1 2.971 39.987 1.000 -107.29 113.23 
Cohort 2 -54.764 48.498 .791 -188.49 78.97 
Cohort 4 -22.085 48.498 .991 -155.82 111.65 
Cohort 5 -24.102 56.731 .993 -180.53 132.33 
Cohort 4 Cohort 1 25.056 43.871 .979 -95.92 146.03 
Cohort 2 -32.679 51.747 .970 -175.37 110.01 
Cohort 3 22.085 48.498 .991 -111.65 155.82 
Cohort 5 -2.017 59.532 1.000 -166.17 162.14 
Cohort 5  Cohort 1  27.073 52.830 .986 -118.60 172.75 
Cohort 2 -30.662 59.532 .986 -194.82 133.50 
Cohort 3  24.102 56.731 .993 -132.33 180.53 
Cohort 4 2.017 59.532 1.000 -162.14 166.17 
Key: UoW = University of Washington, Std. Error = Standard Error, Sig = level of significance 
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Appendix 10: Linear mixed-effect modelling with SLQ as 
dependent variable 
Table 28: Association of demographic, medical and psychosocial characteristics with SLQ scores 
 
  Longitudinal model Change from baseline 
Covariate  Estimate (SE) p-value Estimate (SE) p-value 
IMD 39.873 (3.545) 0.019 
  
Gender  19.671 (6.968)  0.053 
Age at Diagnosis  9.748 (7.053) 0.568 
Family status  19.001 (11.627) 0.366 
Cancer Stage 96.351 (7.027) 0.009 
Treatment Regimen 96.070 (6.871) 0.003 
Time since Treatment 96.704 (10.489)  0.625 
SF-12 Domains       
 MCS 72.708 (36.354)   0.380  - - 
 PCS 81.571 (43.601) 0.479 13.050 (2.338) 0.000 
UoW – Total     - - 
UoW – Domains 87.944 (10.784) 0.009 
109.343 
(38.659) 
0.001 
Key: SE = Standard Error, IMD = Indices of Multiple Deprivation, Dx = Diagnosis, SF-12 = Short Form 12, 
MCS = Mental Component Scale, PCS = Physical Component Scale, SLQ = Silver Lining Questionnaire, 
UoW = University of Washington, - = covariance parameter is redundant, * = insufficient data for 
calculation 
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Appendix 11: Post hoc analysis of cancer stage with 
longitudinal PPC 
 
Table 29: Post hoc analysis of tumour stage with longitudinal PPC 
Stages being compared t statistic Sig 
1 2 1.323 0.188 
1 3 2.706 0.008 
1 4 3.072 0.002 
2 3 0.975 0.328 
2 4 0.891 0.314 
3 4 -0.29 0.755 
Key: Sig = level of significance 
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Appendix 12: Side effect of treatment regimens for HNC 
Treatment Regimen Side Effects 
Acute / 
Chronic 
Surgery Laser technology, 
Excision, Lymph 
node dissection, 
Neck dissection, 
Reconstruction 
Burning A 
Difficulty swallowing A/C 
Excised tissue e.g., jaw, 
skin, pharynx, tongue 
C 
Mastication difficulties: if 
a significant number of 
opposing pairs of teeth 
are lost 
A/C 
Swallowing dysfunction 
requiring feeding tube 
A/C 
Stiffness/loss of mobility 
in shoulder 
A/C 
Surgical ablation and 
reconstruction can cause 
permanent changes in oral 
anatomy making 
prosthetic rehabilitation 
difficult. 
A/C 
Trismus (scaring) may be 
caused by surgical scarring 
C 
Radiotherapy External Beam 
Radiotherapy: 
Intensity modulated 
radiotherapy (IMRT), 
Proton therapy,                 
Internal 
Radiotherapy: 
Brachytherapy 
Change in sense of taste A/C 
  
Changes in voice because 
of scaring 
C 
  
Changes in voice because 
of swelling 
A 
  Difficulty swallowing A/C 
  Fatigue A 
  Fibrosis C 
  Hearing loss A/C 
  Hypothyroidism C 
  Loss of appetite A 
  
Mastication difficulties: if 
a significant number of 
opposing pairs of teeth 
are lost 
A/C 
 217 
Treatment Regimen Side Effects 
Acute / 
Chronic 
  
Mucositis: inflammation 
and ulceration of the 
mucosal lining of the oral 
cavity 
A 
  Nausea A 
  
Osteoradionecrosis: hypo 
vascularity and necrosis of 
bone followed by trauma 
induced or spontaneous 
mucosal breakdown, 
leading to a non-healing 
wound. 
C 
  Radiogenic dental caries  C 
  Skin irritation A 
  
Soft-tissue radio necrosis: 
hypo vascularity and 
necrosis of bone followed 
by trauma induced or 
spontaneous mucosal 
breakdown, leading to a 
non-healing wound. 
C 
  Sore mouth &/or throat A 
  
Swallowing dysfunction 
requiring feeding tube 
A/C 
  Swelling A 
  
Trismus (reduced mouth 
opening): may be caused 
by radiotherapy induced 
fibrosis of the masticatory 
muscles 
A/C 
  
Xerostomia (Dry mouth) 
resulting from a decrease 
in the production of saliva 
A/C 
Chemotherapy   Chemotherapy induced 
neutropenia makes the 
patient susceptible to 
bacterial, viral, and fungal 
infections. Oral candida 
infections are extremely 
common following chemo 
A 
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Treatment Regimen Side Effects 
Acute / 
Chronic 
or radiotherapy. 
    Diarrhoea A 
    Fatigue A 
    Hair loss A 
    Loss of appetite A 
    Nausea & vomiting A 
    Risk of infection A 
Epidermal growth factor receptor 
(EGFR) 
Acneiform rash A 
Hypersensitivity reactions A 
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Appendix 13: Modified Dillman Approach 
Mailing technique (modified Dillman approach): 
First mailing with cover letter, consent forms, questionnaires, and addressed 
prepaid stamped envelope. 
Follow-up postcard at 2 weeks after initial mailing thanking those that responded 
and urging non-responders to participate 
Third mail-out 2 weeks after follow-up postcard included all items of first mailing 
sent to non-responders. 
Cover letter: 
Printed on University Hospital letterhead. 
Limited to 1 page in length. 
Handwritten patient name and title as salutation. 
Sticker label included with patient’s name and address. 
Hand-signed signatures by patient’s surgeon. 
Anonymity and confidentiality assured. 
Informed consent as a separate form (3 pages long). 
Questionnaire structure and design: 
Labelled with study identification number. 
Sensitive questions were avoided. 
Single-sided printing. 
Multiple booklet design with a separate instruction sheet stapled to the beginning 
of each booklet. 
Simple response patterns used (a box for multiple choice responses or a number 
to circle for Likert-type scale responses). 
Envelopes and postcard: 
All mailings used a sticker label with patient name and address 
All outgoing mail included University Hospital logo and return address. 
Envelopes were 22.9cm by 30.5cm and postcards were 16.5cm by 10.2cm. 
First class printed postage used on all envelopes and postcards. 
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Appendix 14: Copyright agreement for Holman and Lorig 
(2000) Data Supplement 
 
